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ABSTRACT 
Mutations in the gene for peripheral myelin protein 22 (PMP22) are associated with 
peripheral neuropathy in mice and humans. PMP22 is produced mainly in Schwann cells in 
the peripheral nervous system where it is localised to compact myelin. The function of 
PMP22 is unclear but its low abundance makes it unlikely to be a structural myelin protein. 
I have studied the peripheral nerves of two different mouse models with alterations 
in the pmp22 gene. (1) The Trembler-J (Till) mouse which has a point mutation [L16P] in the 
first transmembrane domain of PMP22. (2) PAfP22 overexpressing transgenic mice which 
have 7 (C22), 4 (C61) and 2 (C2) copies of the human PMP22 gene in addition to the mouse 
pmp22 gene. 
In the nerves of adult Tr" mice there was considerable evidence of abnormal 
Schwann cell-axon interactions. Abnormal features were reproduced in the early stages of 
regeneration following crush injury. This demonstrates that the abnormalities are a result of 
an intrinsic abnormality of Tr" Schwann cells and not secondary changes related to 
demyelination. In the initial stages of postnatal development the number of axons that were 
singly ensheathed was the same in all the mutants examined, indicating that PNV22 does not 
function in the initial enclosure of groups of axons and subsequent separation of single 
axons. All strains examined had an increased proportion of fibres that were incompletely 
surrounded by Schwann cell cytoplasm indicating that this step is disrupted in PMP22 
mutants. Increasing the number of copies of PMP22 resulted in an increasing severity of 
phenotype. In C22 (7 copy) animals myelin formation was delayed or non-existent in many 
fibres whereas in C61 animals myelination initially appeared normal with abnormality 
appearing later in a small population of fibres. The C2 strain appeared relatively unaffected. 
It is concluded that PMP22 ftinctions in the initiation of myelination and most 
probably involves the ensheathment of the axon by the Schwann cell, and the extension of 
this cell along the axon. Abnormalities are most likely to result from defective interactions 
between the axon and the Schwann cell. 
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Chapter 1 Trembler, Trembler-J and the new Trembler mice 
1.1 DISCOVERY 
The Trembler mouse. The Trembler (Tr) mutant first appeared in Falconer's colony in 
Edinburgh in 1946 (Falconer 195 1). He reported a dominant gene producing spastic paralysis 
with convulsions in the young and generalised tremor in the adult. Braverman investigated 
the Tr mutant as a possible mouse model of neurological disorders (Braverman 1953). 
Examination of acetyl choline function in both the central and peripheral nervous systems, 
parathyroid ftinction, electrocorticograms and histology of the CNS failed to find any 
explanation for the tremor. Peripheral nervous system abnormalities were not noted until 20 
years later when Ayers and Anderson (1973) described hypomyelinated sciatic nerves and 
denervated skeletal muscle. Retarded myelin development and early onion bulb development 
in young animals are followed by hypomyelination, demyelination and well developed onion 
bulbs in adults. 
The Trembler-J mouse. An independently occurring mutation was found in a colony 
of C57BL/6J mice in the Jackson Laboratory (Sidman et al. 1979). Using genetic, 
behavioural and morphological criteria Sidman et al (1979) judged it to be a mutation at the 
trembler locus and termed it Trembler-J (Tr"). There has been very little literature published 
on the TrJ mutation. It has been generally assumed to be an essentially similar but milder 
version of the Tr disorder. The literature presented here relates largely to the Tr model and is 
assumed also to apply generally to the DIJ mutation. Investigations conducted specifically on 
the Ttý' mutation will be reviewed separately. 
The new Trembler mutant. A spontaneous neurological mutant has recently been 
reported in a normal colony of an inbred strain of the gracile axonal dystrophy mouse 
(GAD/Ncnp) at the National Institute of Neuroscience, Japan (Suh et al. 1997). The most 
notable pathological feature of the new Trembler mutant (Tr-Ncnp) was the formation of 
giant vacuoles in the Schwann cell cytoplasm of sciatic nerves of homozygous animals. The 
Schwann cells of homozygotes failed to form myelin at any stage. Heterozygous animals 
showed normal myelination during the early postnatal stages, followed by segmental 
demyelination. 
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1.2 CLINICAL FEATURES 
The Trembler mouse. The clinical features of the Tr mouse have been described by a 
number of investigators (Falconer 195 1; Ayers & Anderson 1973; Henry et al. 1983). 
Affected animals develop an action tremor, 'convulsions', and a gait abnormality between 
postnatal days 10 to 14 (PIO-P14). The tremor, which persists throughout the life of the 
animal is rapid and generalised, most obvious in the head and neck and disappears when the 
animal is at rest. Convulsions are reported as being frequent initially and easily induced by 
sensory stimuli. As the animals get older 'seizures' become less frequent and more difficult 
to evoke, usually ceasing completely by P40-P45 (Ayers & Anderson 1973). 
Fig. 1.1 Trembler heterozygote, 20 days old, showing typical posture during a 
convulsion. Drawn by Mr E. D. Roberts from a photograph. (Taken from Falconer 1951) 
These 'convulsions' were later shown to represent neuromyotonia of peripheral nerve origin 
which appears to be related to PMP22 dosage Joyka et al. 1997a). From an early age the 
limbs of Tr animals are held extended, making their gait awkward. When passively extended 
and flexed the joints are mobile but the limbs are weak (Henry et al. 1983). The gait 
abnormality consisted of extension at the knees and ankles and circumduction of the hind 
limbs at the hips (Henry et al. 1983). The original report by Falconer (Falconer 1951) of a 
non-progressive disorder has subsequently been disputed by Henry et al (1983) who 
described a gait abnormality that worsened throughout the lifespan of the animal. 
When affected/affected and affected/normal Tr animals were mated (Henry et al. 1983; 
Falconer 195 1) all animals could be designated as either affected or normal by P20. This was 
considered to indicate a dominant inheritance pattern (Falconer 195 1). Animals homozygous 
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for the Tr allele (gene symbol TrITr) were behaviourally indistinguishable from 
heterozygous (Tr /+) animals (Henry & Sidman 1988). The oldest TrITr mice examined 
appeared healthy at I year of age, although some TrITr mice developed a more severe 
quadriparesis than was seen in Trl+ animals. 
The Trembler-J mouse. Affected/normal matings of P" animals yielded two distinct 
classes of progeny, normal and mildly affected. The mildly affected (putative Tr" /+) were 
not distinguishable from their litter mates until P20-P25 in contrast to Tr mice which were 
identifiable by P20. They had a tremor with a smaller amplitude than Tr, no obvious seizures 
and a milder although similar gait abnormality that progressed only slightly with age (Henry 
et al. 1983). In contrast to Tr mice, affected/affected matings in the Trj produced three 
classes of progeny. In addition to normal and mildly affected animals one animal from each 
mating was severely affected. These animals were first distinguished by P5-P8 because they 
had grown much less than their litter mates. By PIO they had developed severely dystonic 
ineffective movements and were very poor in righting themselves and seemed certain to die 
before weaning. Such severely affected animals were presumed to be Trj homozygotes, 
TrjlTrj. On this basis Trj has been classified as a semidominant disorder. 
The new Trembler mutant. The affected animals had a gait abnormality which 
appeared at P15-20 and progressed slightly with age. This was followed by motor and 
sensory ataxia, which remained throughout the life of the animal (Suh et al. 1997). Most 
animals survived for more than I year. Offspring of normal/affected matings were 
symptomatically indistinguishable from those from affected/affected matings. The 
segregation patterns of the Tr-Ncnp allele were followed by Southern blot analysis and could 
best be explained by simple autosomal dominant inheritance (Suh et al. 1997). 
1.3 NORMAL DEVELOPMENT 
The process of myelination has been described both qualitatively and quantitatively in a 
range of animal species including chicken (Geren 1954) and rat (Friede & Samorajski 1968; 
Peters & Muir 1959; Webster 197 1; Fraher 1972). It has been divided into three phases. 
Premyelination. The growth of small fetal fibres and the movement of these larger fibres 
to the periphery of each group (Friede & Samorajski 1968). 
Fetal fibres can be identified by three features. They are small, arranged in bundles without 
intervening structures and are wrapped in a single, thin layer of Schwann cell cytoplasm 
which often extends as long narrow processes between groups of fibres. In the rat, bundles of 
fetal fibres are most numerous during the first 2 weeks of life. Their number progressively 
decreased and by the fourth week they could no longer be found. A typical basement 
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membrane surrounded the outer surface of each Schwann cell. Only axons at the periphery 
made contact with the Schwarm cell plasma membrane, and none were completely enclosed 
by Schwarm cell processes. As larger fibres appeared Schwann cell processes began to 
invade the central core of the axons (Peters & Muir 1959). Schwann cell processes then 
separated axons into large bundles that were subsequently subdivided as the Schwann cells 
multiplied rapidly. 
Promyelination. Isolation of the enlarged fibres by individual Schwann cells 
Promyelinated or intermediate myelinated fibres are thought to represent a transitional stage 
between the fetal and myelin forming fibres (Geren 1954; Friede & Samorajski 1968). Friede 
and Samorajski (1968) stated that promyelinated fibres differ from the fetal fibres in the 
large size of their axons and by the separation of axons from the fetal bundle into a 1: 1 
relationship with a Schwann cell (Friede & Samorajski 1968). 
As the myelination process progresses these larger axons became more commonly found at 
the edge of the axon bundles. This suggests that axons destined to become myelinated are 
radially sorted within the longitudinal columns axons and Schwarm cells (Webster et al. 
1973). The sorting sequence involves axons to be myelinated being separated from the others 
by a thin layer of Schwann cell cytoplasm. The establishment of a 1: 1 relationship with a 
single Schwann cell at the outer edge of the bundle occurs as Schwann cells divide. These 
daughter Schwarm cells then become isolated from the family sheath before myelination 
begins (Webster et al. 1973). Promyelin fibres are present in great numbers during the first 
week of life in the rat, but diminish with progressive myelination (Friede & Samorajski 
1968). 
Myelination. The spiral growth and subsequent compaction of the Schwarm cell around 
the axon to form a myelin sheath. 
A flattened Schwann cell sheet becomes spiralled around the axon, the intervening 
extracellular space and the adjoining Schwann cell plasma membranes being referred to as 
the mesaxon. By obliteration of the cytoplasm and apposition of the cytoplasmic surfaces of 
the Schwann cell plasma membrane, the major dense line of myelin is formed. Further 
growth of the myelin sheet and apposition of the spiral layers occurs as the myelin sheath 
matures. The number of myelin lamellae present in the sheath rarely differs by more than 
two turns from the total number of rotations achieved by the Schwann cell (Low 1976a). 
Fibres containing more than two complete turns of the mesaxon without fusion and 
formation of a myelin lamella. are rarely seen (Friede & Samorajski 1968). It has been agreed 
that the Schwann cell, or part of its surface moves around the axon during the growth of the 
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myelin spiral (Webster 1993). As the direction of rotation of the myelin spiral may not be 
the same between adjacent internodes, myelination cannot be the result of axonal rotation. 
In terms of ftinction the three most important dimensions of a myelinated nerve fibre are the 
axon diameter, and the thickness and length of the myelin segments. Generally elongation of 
myelin internodes parallels growth of that body part that contains the nerve fibres (Vizoso & 
Young 1948; Thomas 1955; Schlaepfer & Myers 1973). Although longer myelin sheaths are 
usually thicker and surround larger axons in mature nerves, developmental increases in axon 
calibre and myelin sheath thickness vary and do not necessarily parallel body growth 
throughout the peripheral nervous system. When axon diameters and myelin sheath thickness 
in motor and sensory fibres were compared, different growth patterns were found (Williams 
& Wendell-Smith 1971b). During myelination in the rabbit, myelin sheaths surrounding 
motor axons (nerve to the medial gastrocnemius) were thicker at each time interval (birth to 
8 weeks) than those surrounding sensory axons (sural nerve). Many studies have shown that 
in most fibres up to a certain size, axon calibre, myelin sheath thickness and internodal 
length are related after growth patterns are established (Williams & Wendell-Smith 1971 b; 
Hahn et al. 1987; Fraher 1978a; Fraher 1978b; Carlstedt 1980; Fraher et al. 1988). The 
minimum diameter of axons that Schwarm cells began myelinating is thought to be about I 
pm (Duncan 1934; Matthews 1968). Axon diameter is not a major determinant of the onset 
of myelination, the sheath growth rate (in thickness or length) or the final area of compact 
myelin. The first fibres to be myelinated become the largest fibres in nerves with a bimodal 
distribution of fibres size (Williams & Wendell-Smith 1971 b). 
1.4 DEVELOPMENT OF MORPHOLOGICAL ABNORMALITIES 
Postnatal days 3 to 7. 
The Trembler mouse. As early as P3 abnormalities in Tr sciatic nerve were already 
becoming apparent. The process of myelin initiation appeared retarded and the small amount 
of myelin that had been formed was very thin. The abnormalities present at this early stage 
of development persisted into adult life. Despite having the same number of singly 
ensheathed axons as control animals (Ayers & Anderson 1976) there was a relative increase 
in the number of promyelinated fibres (Low 1976a; Ayers & Anderson 1975; Ayers & 
Anderson 1976) and a decreased number of myelinated fibres in Tr nerves (Ayers & 
Anderson 1976). Axons in Tr nerves were smaller than those in controls at all ages examined 
suggesting a delayed or slow axon growth rate (Ayers & Anderson 1976). Ayers and 
Anderson (1975,1976) considered that the segregation of fetal fibres to promyelinated fibres 
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in Tr sciatic nerve was delayed but this result was not supported by studies of other 
investigators (Low 1976a). 
The number of myelinated fibres present in Tr nerves were decreased and where myelin is 
present it is very thin relative to the size of the axon (Ayers & Anderson 1975; Ayers & 
Anderson 1976; Low 1976a). The few larger myelinated fibres that are normally present in 
control nerves at P3 are absent from Tr nerve (Ayers & Anderson 1976). In most teased 
fibres from Tr nerve myelin was virtually absent and discontinuous along the length of the 
fibre. Nodes of Ranvier were not discernible and supernumerary Schwann cells were 
common (Low 1976a). Compact myelin formation was often incomplete and Tr animals 
could be identified from P2 onwards by the presence of large uncompacted spirals of 
Schwann cell membrane (Low 1976a; Ayers & Anderson 1975). In longitudinal section the 
nodes of Ranvier were frequently widened and covered only by a thin layer of Schwann cell 
cytoplasm or basement membrane (Ayers & Anderson 1975). In some instances axons were 
seen which were only partially covered by Schwann cell cytoplasm or basement membrane 
(Ayers & Anderson 1975). Some completely bare fibres were also seen (Ayers & Anderson 
1975). Some internodes exhibited compaction only in the central region (Ayers & Anderson 
1975). Schwann cells in the Tr mouse showed a high incidence of myelin degeneration 
products and in Tr nerves as early as P6 the number of Schwann cell nuclei was already 
increased relative to normal and Schwarin cells were occasionally seen without axons (Ayers 
& Anderson 1976). 
Postnatal day 7 to2l. 
The Trembler mouse. Although axon diameter had increased and myelin formation had 
progressed in Tr nerves, many myelin sheaths showed breakdown products (Ayers & 
Anderson 1975). Segmental demyelination was prominent and myelin sheaths were often 
uncompacted near the nodes of Ranvier (Ayers & Anderson 1973; Ayers & Anderson 1975). 
Myelin degeneration products were present within the Schwarm cells, particularly in animals 
younger than one month, suggesting active demyelination in these nerves (Ayers & 
Anderson 1975, Ayers & Anderson 1976; Aguayo et al 1977, Bosse et al. 1994). Low 
(1976a) reported that between 7 and 14 days of age 3-5% of fibres were undergoing 
degeneration. 
Some myelin appeared structurally normal but when examined at the ultrastructural level it 
was commonly only partially compacted or undergoing degeneration. Many axons were 
surrounded by large whorls of uncompacted Schwarm cell cytoplasm which extended for the 
length of the internode (Ayers & Anderson 1973). Schwarm cells were retracted from the 
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nodes of Ranvier and the normal interdigitation seen in control animals of this age was 
lacking (Ayers & Anderson 1975). Occasionally accumulations of degenerate mitochondria 
and membranous bodies were found within the axon localised at or near the nodes of Ranvier 
(Ayers & Anderson 1973). The fibre diameter spectrum from proximal, middle and distal 
levels of the sciatic nerve was examined and no difference was found between levels (Ayers 
& Anderson 1976). The number and size of cells in the dorsal root ganglia and spinal horn 
were normal in Tr mice younger than P23 (Ayers & Anderson 1976). 
Many Schwann cells in developing Tr nerve appeared reactive (Ayers & Anderson 1975). 
The volume of cytoplasm and cytoplasmic organelle content was increased and frequently 
contained myelin debris. It has been suggested that the Schwann cells become reactive in the 
presence of myelin debris and undergo hypertrophy and hyperplasia resulting in the 
digestion of myelin debris and remyelination (Ayers & Anderson 1975). There was an 
increasing tendency for some axons to be surrounded by collapsed basement membrane, 
indicating that as Schwann cells become reactive they extended cytoplasmic processes and 
then withdrew them (Ayers & Anderson 1975). It was observed that Schwarm cell cytoplasm 
extended into looped processes, and nuclei often appear lobed and show abnormal surface 
indentations similar to those observed in mild crush injury. The number of Schwann cell 
nuclei was increased and occasionally Schwann cells were not associated with axons (Ayers 
& Anderson 1975). Mitosis of Schwann cell nuclei was occasionally noted. 
Fibroblasts were commonly found and the perineurium showed an increase in thickness 
(Ayers & Anderson 1973). 
The Trembler-J mouse. Notterpeck et al (1997) examined the sciatic nerves of 
developing Tr" animals and found that at P 10 the histological appearance of normal and 
Tr"l+ nerves was similar. However fibre measurement showed a difference in g ratio 
(+/+ = 0.47, Tr" /+= 0.55) and a reduction in axon diameters in Trj animals (Notterpek et a]. 
1997). The number of Schwann cell nuclei was already increased by approximately 2 fold 
and there was an increased amount of extracellular connective tissue. A low frequency of 
fibres with abnormally thick myelin (tomacula) were seen along with myelin fragmentation 
indicative of active myelin breakdown. 
Third postnatal week onward. 
The Trembler mouse. From the third postnatal week onward in Tr mice there was an 
increasing incidence of abnormality. Large numbers of axons were covered only by 
basement membrane or by a thin rim of Schwarm cell cytoplasm without myelin (Ayers & 
Anderson 1975). There was often a partial or complete additional layer of basement 
membrane (Ayers & Anderson 1975). By 6 weeks of age onion bulb formation had begun 
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(Ayers & Anderson 1976). Although a few fibres possess a normal myelin sheath most 
sheaths were very thin relative to axon diameter (Ayers & Anderson 1975). 
1.5 MORPHOLOGICAL ABNORMALITIES IN ADULT MICE 
The Trembler mouse. In adult Trembler nerves the majority of axons had no myelin 
with most fibres being surrounded by only 2-3 turns of uncompacted Schwann cell 
membrane (Ayers & Anderson 1973). There were fewer turns of myelin in Tr mice than in 
control mice at all ages and the myelin deficiency had become more pronounced with age 
(Low 1976a). In elderly Tr animals larger axons were associated with fewer myelin lamellae 
than smaller ones (Low 1976a). The myelinated fibre density in Tr animals always fell below 
control values (Henry et al. 1983; Low 1976b). Fibres that showed more advanced 
myelination often showed bizarre deformations and the internal and external mesaxons were 
often very complex (Ayers & Anderson 1973). In longitudinal section long lengths of axon 
were completely devoid of myelin (Ayers & Anderson 1973; Low 1976a). Approaching the 
node of Ranvier myelin often became uncompacted and looped. Uncompacted myelin was 
also found at random places along the internode. The total number of axons was normal in Tr 
nerves (Aguayo et al. 1977) but axonal area was decreased (Low 1976a; Ayers & Anderson 
1976). The nerves of Tr animals had increased endoneurial and perineurial connective tissue 
(Henry et al. 1983; Ayers & Anderson 1973) when compared with controls yet the fascicular 
area was decreased (Henry et al. 1983). This was ascribed to a decrease in the volume 
usually occupied by myelin sheaths. 
The mean Schwann cell density was increased in Tr nerves at all ages examined (Ayers & 
Anderson 1973; Low 1976a; Henry et al. 1983) and continued increasing throughout the 
animals' lifespan (Perkins et al. 1981 b). The sciatic nerve of an adult Tr mouse contained 8.7 
times more nuclei than controls (Low 1976b). Schwann cell cytoplasm often contained 
myelin debris (Ayers & Anderson 1973; Low 1976a; Henry et al. 1983). In longitudinal 
sections Schwann cell nuclei were seen more frequently than in control nerves indicating 
shortened internodes and not infrequently Schwann cell nuclei were situated within the node 
of Ranvier (Low 1976a; Low 1976b). Tr nerves of all ages contained more promyelin fibres 
than were found in control nerves (Henry et al. 1983). 
In older Tr animals many fibres were surrounded by concentric layers of Schwarm cell 
processes or basement membranes suggestive of ongoing cycles of de/remyelination (Ayers 
& Anderson 1973; Ayers & Anderson 1975; Low 1976a; Low 1976b; Low 1977). The 
evolution of 'onion bulb' formations in the Tr mouse was examined by Low (1977) who 
described the sequence of events leading to their formation. Following demyelination, which 
was prominent between P7 and P28, Schwarm cells divide. One Schwarm cell surrounds the 
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axon and begins remyelination while the supernumerary Schwann cell produced many 
processes which were confined within the limit of the original basement membrane. The 
processes initially appeared normal but the cytoplasm degenerated leaving behind empty 
membrane configurations. As more 'onion bulb' lamellae were added the outer lamellae 
became more degenerate than the central ones. 'Onion bulb' formations have been defined as 
myelinated or demyelinated axons surrounded by concentric arrays of Schwann cell 
processes or empty membrane configurations (Low 1977). They are thought to be produced 
by repeated cycles of demyelination and remyelination (Thomas & Lascelles 1967; Prineas 
1971; Dyck 1975; Low 1977). 
Anterior and posterior roots also showed hypomyelination and onion bulb formation with 
cytoplasmic extensions of Schwann cell cytoplasm being more pronounced and basement 
membrane deposition being less extensive than in the sciatic nerve (Ayers & Anderson 
1973). Very thinly myelinated fibres were also found in the lumbosacral plexus and posterior 
roots, median nerve, posterior tibial nerve and the tail. There was also a relatively abrupt 
change from the severely hypomyelinated dorsal roots to well myelinated dorsal columns 
(Low 1976b). Dorsal ganglion cells appeared normal and their density and diameter 
distribution was found to be the same in Tr and control animals. The number of motor 
neurons in the ventral hom did not differ from that found in controls (Low 1976b). 
Henry and Sidman (1988) examined the nerves of putative TrITr animals and found that they 
have virtually no myelin in their PNS. In the sciatic nerves from Trl+ animals 28% of 
appropriately sized axons were surrounded by thin myelin (Henry & Sidman 1988). In 
contrast the nerves of TrITr animals had at most 6 myelinated fibres. Fibres in both 
genotypes appeared to be blocked at the promyelin stage. 
The Trembler-J mouse. The sciatic and vagus nerves of T? -j mice showed a myelin 
deficiency that was milder than that seen in the nerves from similarly aged Tr animals. By 
P16 nearly all appropriately sized fibres had at least a thin myelin sheath. In contrast to Tr 
animals, where very large fibres were commonly unmyelinated, a thin myelin sheath was 
found on virtually all fibres in older T? -j animals (Henry et al. 1983). The findings of thin 
myelin, small axons, increased extracellular matrix and increased number of Schwann cells 
have been confirmed in a recent study by Notterpek et al (1997). 
The concentration of Schwann cells and fibroblasts was increased in nerves from Tr1j 
animals, but the increase in the amount of interstitial connective tissue was less than in Tr 
animals. Cervical sympathetic trunks appeared normal (Henry et al. 1983). There were 
virtually no onion bulbs in T? " animals. 
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The sciatic and vagus nerves of TiljlTr*' homozygotes were also examined by Henry et al 
(1983). T?, JlTr" animals had a very severe deficiency of peripheral myelination. Only a few 
dozen myelinated fibres were present in nerves which normally would have contained 
thousands. The abnormalities were qualitatively similar to each other and to the nerves of 
young Tr animals although they were much more pervasive in the nerves ftom putative Tr" 
T? Ij animals. 
The new Trembler mutant Hypomyelination was obvious in the peripheral nervous 
system of both the hind and forelegs and the distal segments of the trigeminal nerves of the 
Tr-Ncnp mutants. Pathological alterations were not detected in the CNS. 
Tr-NcnpITr-Ncnp mice. Nerves from homozygote Tr-NcnpITr-Ncnp mice were completely 
devoid of myelin at all ages from P9 to 5 mo. Axons appeared to be at the promyelin stage 
(ensheathed but not myelinated). Electron microscope studies showed many swollen 
vacuolar structures of various sizes. These were located near the Golgi apparatus but were 
generated mostly from the swelling of rough endoplasmic reticulum in the Schwann cells 
and not from the Golgi apparatus. The vesicles localising around the stacks of the Golgi 
cisternae were empty inside and smaller than those derived from the endoplasmic reticulum. 
Occasionally Schwann cells with a dark nucleus and developed Golgi apparatus had a large 
population of free ribosomes (Suh et al. 1997). The collagen fibrils in the homozygous 
animals were less abundant in the intercellular spaces compared with heterozygotes. The 
sciatic nerve contained a number of pyknotic Schwann cell nuclei which stained darker than 
those in the normal mice. In adult homozygous mice apoptotic cells (detected by a variation 
of the TUNEL method) were sparsely distributed across the sciatic nerve and represented 
7.9% of cell nuclei. In normal nerve no positive cells were seen. 
Tr-Ncnpl+ mice. In the heterozygote, segmental demyelination was seen and the degree of 
myelination was variable even within a single internode. The compaction of myelin appeared 
normal. Collagen density was increased and basal lamina was seen irregularly surrounding 
the axons. The Schwann cells had a dark cytoplasm that contained a number of free 
polyribosomes, Golgi apparatus and mitochondria. The vacuoles in the Schwarm cells were 
not as obvious as those in the homozygotes. Fragmented basal lamina surrounded the axons 
(Suh et al. 1997). 
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1.6 UNIVIYELINATED FIBRES 
The Trembler mouse. The morphology of unmyelinated fibres is reported as being 
normal in the cervical sympathetic trunk and in the sciatic nerve of Tr mice (Ayers & 
Anderson 1973; Perkins et al. 198 1 b; Henry et al. 1983). Unmyelinated fibre density and size 
distribution in Tr sciatic nerves did not differ from that of controls (Low 1976a). In animals 
injected with [3 H] thymidine, which labels actively dividing cells, no labelled Schwann cells 
were found in unmyelinated fibres. (Perkins et al. 1981b). In unmyelinated nerves, such as 
the cervical sympathetic trunk (CST), the total number of Schwann cell nuclei in cross 
section was not significantly different from that found in controls (Perkins et al. 1981b). 
When phenotypically normal Schwann cells from the CST are transplanted into the sural 
nerve of normal animals they show typical Tr morphology (Perkins et al. 1981a) suggesting 
that the Tr mutation only affects Schwann cells when they are challenged to myelinate. 
The Trembler-J mouse. In both homozygous and heterozygous Trj the cervical 
sympathetic trunk was ultrastructurally normal with the exception that small numbers of 
larger myelinated fibres normally present in control animals were in the promyelin state in 
Trj animals (Henry et al. 1983). 
1.7 CONDUCTION VELOCITIES. 
Electrophysiological studies were undertaken on the sciatic nerve, median nerve and the 
dorsal nerve of the tail in Tr and control mice by Low and McLeod (1975). The amplitude of 
the evoked muscle action potential, terminal latency and motor conduction velocity (MCV) 
recorded from the sciatic, median and dorsal nerve of the tail of the Tr mice fell outside the 
control range in every case. The distal motor latencies of in all nerves of the Tr mice were 
increased and the MCVs were less than I Orn/s. In control mice the MCV increases with age 
until 4 months but the MCV in Tr mice was less than I Orn/s as early as P6 and did not 
increase with age (Low & McLeod 1975). 
1.8 FAST AXOPLASMIC TRANSPORT. 
Fast axoplasmic transport was measured in Tr sciatic nerves after the injection of ['HI 
leucine into the lumbosacral spinal cord region by Boegman et al (1977). There was no 
difference in the measurements from Tr and control animals, indicating that axoplasmic flow 
is unaffected by demyelination (Boegman et al. 1977). 
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1.9 SCHWANN CELL PROLIFERATION 
During rodent ontogenesis, Schwarm cells in peripheral nerves migrate along the axons and 
begin the process of ensheathment (Peters & Muir 1959; Speidel 1964). Schwann cells then 
divide intensely from the end of gestation until the first days of postnatal development 
(Peters & Muir 1959; Asbury 1967; Terry et al. 1974). The high rate of Schwann cell 
proliferation decreases and rapidly stops totally during the process of myelination (Peters & 
Muir 1959; Asbury 1967). 
The Trembler mouse. Perkins et al (1981b) found abnormal persistence of postnatal 
Schwann cell proliferation in nerves of the Tr mouse. Schwarm cell populations were greater 
in Tr than control nerves at all ages studied. Cross sections of L4 ventral roots at PIO 
contained twice as many Schwann cell nuclei in Tr than in controls. The difference increased 
to five fold by the time Tr animals were one month old and increased again to ten fold at 4 
months of age. Beyond this time their numbers remained stable suggesting that additions to 
the Schwann cell population by mitotic division were balanced by losses due to Schwann 
cell death. 
The density of Schwarm cell nuclei in control animals nuclei decreased gradually from I 
Schwann cell /10 axons at P3 to 1/35 axons at P300. The fall in density in control animals 
corresponded to the elongation of the internodes. In Tr nerve the number of Schwarm cells 
increased regularly from day 4 to day 300. Taking changes in body length in account Koenig 
et al (1991) calculated that the mean axonal length covered by a Schwann cell would 
decrease by a factor of three between P6 and P60 (Koenig et al. 199 1 ). 
When unmyelinated nerve segments of normal appearance from Tr mice are transplanted 
into myelinated nerves of unaffected animals, the regenerated grafts show characteristic Tr 
abnormalities of Schwann cell multiplication and myelination (Perkins et al. 1981a). As 
persistent Schwann cell multiplication was not seen in the intact unmyelinated nerves of Tr 
mice, but develops in the segments that form myelin, the authors postulated that the 
proliferative abnormality of Tr Schwann cells was related to the disorder of myelination but 
was probably not a primary manifestation of the disorder. 
The Trembler-J mouse. In young animals the number of Schwarm cells in the peroneal 
nerve were similar in Trl?, +/+, Trjl+, and P" / T? ý animals (Henry et al. 1983). Schwann 
cell numbers tended to decline in older Tr" animals but not in Tr. 
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1.10 IDENTIFICATION OF A PRIMARY SCHWANN CELL LESION IN THE 
TREMBLER MOUSE 
In normal nerve axons influence Schwann cell proliferation (Wood & Bunge 1975; Aguayo 
et al. 1976c) and myelin formation (Friede & Samorajski 1967; Aguayo et al. 1976a; Aguayo 
et al. 1976b; Weinberg & Spencer 1976). The interdependence of Schwann cell and axon has 
led to suggestions that in certain neuropathies an axon abnormality may be responsible for 
the failure of the Schwann cell to maintain myelin. 
Several authors have postulated that the Tr mutation results from a primary lesion of the 
Schwann cell. Ayers and Anderson (1975) considered that the presence of axons with normal 
morphology suggested a primary Schwann cell change. On the basis of several pieces of 
evidence Low (1976a) also concluded that primary Schwann cell alteration was the most 
likely. (1) Cell bodies in Tr animals are normal in appearance and numbers. (2) Normal fine 
structure of axons persists well into adulthood whereas hypomyelination and demyelination 
commence at an early stage in development. (3) A relatively abrupt transition from severely 
hypomyelinated anterior and posterior roots to well-myelinated central fibres when axons 
pass from the Schwann cell domain into the oligodendrocyte domain. (4) The middle and 
distal levels of Tr nerve are similarly affected (Ayers & Anderson 1976; Low 1976a). 
1.11 NERVE GRAFT EXPERIMENTS IN THE TREMBLER MOUSE 
Aguayo confirmed the Tr mutation as being a primary lesion of the Schwann cell in an 
elegant series of nerve grafting experiments (Aguayo et al. 1977). These consisted of 
transplanting segments of donor sciatic nerve into the midthigh of recipient animals. 
Schwann cells which originated from the donor nerve ensheath and myelinate axons arising 
from nerve cells of the host. Aguayo's experiments consisted of one of three graft 
paradigms, Normal to normal (N-N-N), Trembler to normal (N-T-N), and normal to 
Trembler (T-N-T). In all experiments, as regenerating axons grew into the grafts the 
morphological features of the donor nerve were fully reproduced by the donor Schwarm 
cells. In N-T-N regenerated nerves, the widespread hypomyelination and absence of myelin, 
which are hallmarks of the Tr neuropathy, were duplicated in the grafts and contrasted 
abruptly with the normal myelin in the recipient nerve. Both the percentage of single axons 
with diameters greater than I gm that were surrounded by Schwann cells without myelin and 
the myelin lamellae/axonal circumference ratios were normal for regenerated nerves in the 
N-N-N experiments and in the proximal and distal stumps of the N-T-N nerves. In the 
grafted segments of the N-T-N nerves the proportion of fibres with no mYelin was markedly 
increased, and myelin lamellae/axonal circumference ratios were only one third of those in 
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normal grafts (Aguayo et al. 1979). The manifestations of the Tr gene are fully expressed by 
the transplanted Schwann cells and their daughter cells. These experiments proved 
unequivocally that the Tr mutation is due to a primary disorder of Schwann cells. Schwann 
cells in the Tr mutant are incapable of producing the quantities of myelin needed to ensheath 
axons normally and are unable to sustain the myelin that is formed. There was no indication 
from T-N-T experiments that axonally mediated or general systemic factors were involved in 
the pathogenesis of the neuropathy. 
Pollard and McLeod (1980) inserted sciatic nerve grafts from normal animals into Tr mice. 
Within the normally myelinated graft that resulted, the mean axon area was significantly 
greater than within the proximal segment. Electrophysiological studies found that the mean 
conduction velocity across the demyelinated Tr nerve in the proximal segment was 2.6 m/s, 
the mean value across the graft was 31.3 m/s, a value 75% that of normal mice. 
1.12 LOCALISATION OF THE TREMBLER AND TREMBLER-J GENE 
ABNORMALITIES TO THE PMP22 GENE 
Based upon classical genetics, Tr and Te' were suggested to be allelic mutations leading to a 
similar phenotype (Falconer 195 1). The Tr mutation was mapped to chromosome II 
(Davisson & Roderick 1978). During the early 1990s, descriptions of a new myelin protein, 
peripheral myelin protein 22 (PMP22), were being published (Welcher et al. 1991; 
Manfioletti et al. 1990; De Le6n et al. 1994; Spreyer et al. 1991). The pmp22 gene was 
localised to chromosome II in the mouse, (Suter et al. 1992) residing 4.4 ± 2.1 cM distal to 
the Csfgm and 2.2 ± 1.5 cM proximal to the My& restriction fragment length polymorphisim 
loci (Suter et al. 1992). pmp22 cDNA from behaviourally and histologically characterised 
Trl+ mice was isolated and cloned (Suter et al. 1992). Two classes of cDNA were found, the 
first representing the wild type allele. In the second population of cDNAs, a nucleotide 
exchange was detected within the PMP22 coding region. The detected mutation from 
guanine (G) to adenine (A) leads to the substitution of an aspartic acid residue with a glycine 
in the PMP22 protein at amino acid position 150 (Suter et al. 1992). The results of gene 
mapping studies determined that pmp22 is localised 4.4cM distal to the RFLM locus Csfgm 
and 2.2cM proximal to the locus *hs (Suter et al. 1992). The localisation of pmp22 
between Csfgm and Myhs is consistent with its identity with Tr, which appears to be ; -- 4.4 
cM distal to Csfgm and ztý 2.2cM proximal to Myhs. Thus pmp22 maps to the region where 
the Tr mutation resides. A point mutation in the Tr" mouse was also found within the pmp22 
gene (Suter et al. 1992) supporting evidence that PMP22 was the candidate gene in these two 
murine neuropathies. The transition mutation from thymine (T) to cystine (C) in Tr" 
translates into a nonconservative amino acid exchange from proline to leucine substitution at 
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position 16 of the PMP22 polypeptide. The predicted effect of a mutation in the PMP22 
protein was consistent with the phenotypes of the Tr and Tr" mutants. The PMP22 protein 
was expressed predominantly by Schwarm cells of the PNS and was not detectable in the 
CNS (Snipes et al. 1992). PMP22 protein localised in the compact peripheral myelin sheath; 
this is consistent with the markedly reduced myelination in the PNS but no known 
abnormality in the CNS. 
The distal half of mouse chromosome II shares exclusive conserved synteny with human 
chromosome 17. It appears that the order of genes has been conserved between human 
chromosome 17p and their homologues on mouse chromosome 11. Myhs has been localised 
to 17p I 2-17p 13 in humans. Since pmp22 has been localised proximal to *hs in the mouse, 
Suter (Suter et al. 1992) predicted that if the human homologue of pmp22 mapped to 
chromosome 17 it would reside on 17pll-pl2 (Suter et al. 1992). This location in 
conjunction with its involvement with Tr and Tr", identified PMP22 as the candidate gene to 
be affected in Charcot-Marie-Tooth disease IA (CMT I A). 
The new Trembler mutant. pmp22 cDNA from clinically affected and control mice 
was cloned and sequenced (Suh et al. 1997). Two PCR products of different sizes were 
identified in the sciatic nerve of normal (742 base pairs) and affected mice (601 base pairs). 
Sequence analysis of the two PCR products showed that the smaller product lacks a 141bp 
sequence within the pmp22 coding region. The Tr-Ncnp allele was shown to have a deletion 
of a region containing the whole of exon IV in the pmp22 gene. This corresponds to the loss 
of the whole of the second and part of the third proposed transmembrane domains (Suh et al. 
1997). 
1.13 PMP22 PROTEIN AND GENE EXPRESSION IN TREMBLER MICE 
Gene expression. Steady state levels of mRNAs encoding PMP22, PO, MBP, LP, 
MAG and CNP were examined P8 and P15 wildtype, Trl+ and TrITr nerves (Bascles et al. 
1992). Northern blot analysis showed that the expression of all myelin protein genes were 
affected in the Tr mutation. pmp22 mRNA was the most markedly decreased of all mRNA 
species examined. The amount of pmp22 mRNA in the sciatic nerve of homozygous Tr mice 
is lower than that of heterozygous mice (5% and 10% of normal respectively). The mutation 
of the pmp22 gene in the Tr results in a modified level of expression level of the gene in 
addition to an amino acid substitution in the protein. P0, and MBP genes were also poorly 
expressed in the mutant nerves. But MAG and PLP gene expression was only slightly 
affected and the level of expression of the CNP gene was almost normal. Bascles et al (1992) 
suggested that the mutated protein may not be incorporated into the myelin membrane 
leading to its accumulation in the Schwann cell cytoplasm and that such an accumulation 
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could trigger a feedback repression of the pmp22 gene. Bascles, et al (1994) investigated 
steady state levels of mRNA encoding myelin protein genes in P8 Tr and normal brains a 
time which precedes the onset of clinical symptoms. They measured a two to four fold 
increase for MBP and PLP mRNAs in Tr samples but no such increase in the mRNA level of 
MAG (Bascles et al. 1994). 
Protein expression. The nerves of adult Tr mice showed a 40% increase in the 
concentration of MAG when compared with age matched controls (Inuzuka et al. 1985). By 
contrast the concentrations of Po and MBP were decreased by 27 and 20% respectively. P2 
was also greatly reduced as was the specific activity of CNP. MAG in Tr nerves appeared to 
have a higher than normal Mr in the sciatic nerve but a normal Mr in the brain. The 
maintenance of high levels of MAG despite the severe deficit of myelin is consistent with the 
immunocytochernical localisation of MAG in the periaxonal Schwann cell membranes, 
Schmidt-Lanterman incisures, terminal loops at the node of Ranvier and the outer mesaxon 
and its absence from compact myelin. 
The sciatic nerves of severely affected Trjl Trj mice contained nearly undetectable amounts 
of PO, MBP and essentially no PMP22 (Notterpek et al. 1997). In adult Trýl+ mice the levels 
of PO, MBP and PMP22 were severely reduced. In P18 Trjl+ animals the level of PMP22 
expression is apparently reduced when compared with PO and MBP (Notterpek et al. 1997). 
1.14 ALTERATIONS EXPRESSED IN CULTURES FROM TREMBLER 
MICE 
Myelinating Cultures. Organotypic cultures of dorsal root ganglia from embryonic 
control mice were substantially myelinated after 6 weeks in culture (Mithen et al. 1982). 
They typically developed several consecutive myelinated internodes averaging 80-20OPm in 
length. Tr cultures had either no myelin or very small amounts of abnormally thin and short 
myelin segments (20-60 gm) and unusually long nodal regions. Ultrastructurally Tr cultures 
resembled adult Tr nerve. Myelin was commonly uncompacted, fibres were surrounded by 
redundant basal lamina and the amount of endoneurial and perineurial collagen was 
increased (Mithen et al. 1982). Abnormally short internodes were also seen when Schwann 
cells were cultured in the absence of fibroblasts. This confirmed Aguayo's experiments 
showing that the primary abnormality was in the Schwann cell (Aguayo et al. 1977). 
Cultured Schwann cells. When Schwarm cell cultures were prepared from the nerves 
of P 15 Tr animals they were found to divide less often than control Schwarm cells. After 10 
days in culture the density of normal Schwann cells had increased 32 fold compared with 
only 10 fold in Tr Schwann cell cultures. In cultures obtained from PI or P4 animals there 
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was no difference in the proliferation rates. The authors suggested that the increased 
proliferation in control cultures might result from an increased amount of mitogen provided 
by degrading myelin from the nerve segments used for culture. In normal mice the sciatic 
nerve contained 3 fold more myelin at P 15 than it did at P4 whereas in Tr mice the amount 
of myelin present at the two ages was the same. Both Tr and control Schwann cells elicited a 
dose dependant proliferative response to myelin enriched fractions from both Tr and control 
animals. At high concentrations the proportion of labelled nuclei was almost identical in Tr 
and control derived Schwann cells. However at low concentration proliferation was 2 fold 
higher in Schwann cells derived from Tr animals suggesting that either Tr Schwarm cells are 
more sensitive to low levels of myelin enriched fraction or their receptor numbers are 
increased. 
1.15 EFFECTS OF TREMBLER SERUM ON CULTURED CELLS 
Schwann cells. Tr Schwann cells in vitro proliferate at a lower rate than normal 
Schwann cells whereas in vivo the reverse is true suggesting that the mitogenic factor 
present in the mutant sciatic nerve is absent from culture dishes (Do Thi et al. 1993). When 
both Tr and control cultures were treated with Tr serum Schwann cells in both cultures 
divided rapidly producing a growth response curve similar to that seen with other mitogens. 
The serum of normal animals did not modify the proliferation of normal or Tr Schwann cells 
(Do Thi et al. 1993). 
OligodendrocyteS. Tr serum has two effects on oligodendrocytes. It elicits a mitogenic 
response from oligodendrocytes in culture increasing their relative abundance 10 fold 
(Hantaz-Ambroise et al. 1988). Secondly Tr serum prevents differentiation After two weeks 
in culture with Tr serum oligodendrocytes were either undifferentiated or degenerated. In 
control serum they differentiated normally. Both these effects of Tr serum were negated by 
the addition of laminin. When anti-laminin antiserum was added to control medium, 
differentiation of oligdendrocytes ceased completely but it did not trigger the increase in 
oligodendrocyte number caused by Tr serum, indicating that the Tr serum induced effects 
cannot be completely explained by modification, synthesis and/or expression of laminin. In 
the prescence of anti-laminin antibodies, Tr serum lost its mitogenic activity. 
Neurites. In the presence of Tr serum the outgrowth of rat spinal cord neurons in culture 
was increased two fold when compared with those cultured with control serum. Neurite 
outgrowth was characterised by an increase in both the number of primary neurites emerging 
from the cell body as well as by an increase in the peripheral branching of neurites. As the Tr 
mutant is characterised by hypomyelination and the production of excess basal lamina, 
antibodies to basal larninal components were added to the culture medium. Neurite 
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outgrowth was reduced by the presence of antibodies against heparan sulphate proteoglycan 
and abolished by anti-laminin antibodies. The effect of Tr serum on neurite outgrowth 
decreased when the number of non-neuronal cells in the culture was reduced suggesting that 
the mutant serum did not act directly on neurons but through the intermediary action of non- 
neuronal cells. 
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Chapter 2 Peripheral Myelin Protein 22 (PMP-22) 
2.1 ISOLATION 
Peripheral myelin protein 22 (PMP22) is the name proposed by Snipes et al (1992) for the 
proteins and cDNAs that had previously been designated SR13, CD25, gas3, and PASH 
(Welcher et a]. 199 1; Spreyer et al. 199 1; Kitamura et al. 1976; Manfioletti et al. 1990). 
SRI 3 and CD25. The rat Pmp22 gene was cloned independently in two laboratories by 
the screening of cDNA libraries constructed from regenerating nerve (Welcher et al. 1991; 
Spreyer et al. 199 1). Two different cDNA clones were described, CD25 (Spreyer et al. 199 1) 
and SRI 3 (Welcher et al. 1991), which encode for the same protein. Pmp22 was found to be 
strongly expressed in normal sciatic nerve and down regulated in the initial phases after 
sciatic nerve injury. SR13/CD25 was shown to be a myelin protein on the three following 
pieces of evidence (Welcher et al. 1991). First the SR13 mRNA showed a similar time 
course of down regulation after sciatic nerve injury as observed for the mRNAs encoding the 
classical myelin proteins, protein zero (Po) and myelin basic protein (MBP). Secondly, the 
recombinant SR13 encoded protein expressed in a transformed cell line was specifically 
recognised by an antiserum raised against preparations of purified peripheral nerve myelin. 
Thirdly, SR 13 antibodies localised the SR 13 protein to the myelin sheath of the sciatic nerve. 
gas-3. gas-3 was first isolated from serum starved 3T3 mouse fibroblasts (Manfioletti et al. 
1990). The gas-3 mRNA belongs to a group of genes whose expression is specifically 
associated with the quiescent cell state (Schneider et al. 1988). Their transcripts have been 
isolated from a variety of cell lines including 3T3 mouse fibroblasts and Chinese hamster 
ovary cells. These mRNAs have been hypothesised to be involved in regulation of general 
cell growth. In-vitro translation studies established that the protein product is a 
transmembrane glycoprotein (Manfioletti et al. 1990). 
PAS-11. PAS-H, isolated from bovine peripheral myelin (Kitamura et al. 1976), shares a 
sequence homology of >80% with SRI 3. It has been isolated from purified myelin of various 
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species and shows the same developmental pattern of expression in the chicken sciatic nerve 
as other myelin proteins. 
2.2 SEQUENCE COMPARISONS 
A comparison of the reported Pmp22 cDNA sequences of CD25, SRI 3 and gas3 (Welcher et 
al. 1991; Spreyer et al. 1991; Manfioletti et al. 1990) revealed a very high degree of 
homology (>94%) of the entire protein coding sequences and the 3'UTR. 
Pmp221SR13 cDNA was found to encode a protein of 160 amino acid residues with a 
predicted molecular weight of l8kDa and four putative membrane spanning domains 
(Welcher et al. 1991). The N-terminal sequence possessed the characteristics of a signal 
peptide with one consensus site for N-linked glycosylation. The deduced Pmp221gas3 cDNA 
sequence consisted of 1817 nucleotides and coded for 144 amino acids (Manfioletti et al. 
1990). From hydrophobicity plots, it was deduced that the sequences from amino acids 2-3 1, 
65-91 and 96-119 represented three potential membrane spanning domains. One potential 
glycosylation site was present at residue 4 1. 
When compared with the amino acid sequence for Pmp221CD25, gas3 showed only 5 single 
amino acid exchanges, (000, Arg 35, Ser79, Val 101 and Asp 128) up to Ala 135 (Welcher 
et al. 1991). Beyond that point an additional T in nucleotide position 613 of the CD25 
produced a frame shift that interrupted the amino acid homology for the entire C terminus 
and extended the C terminus of the Schwarm cell protein for 16 amino acids beyond that of 
gas3 introducing an additional putative transmembrane domain. This frame shift was later 
reported to be a sequencing error and the gas3 mouse protein sequence found have an amino 
acid identity of 97.5% with rat Pmp22 (Suter et al. 1992). (Fig. 2.1) 
2.3 TRANSLATION 
Using metabolic labelling and immunoprecipitation De Le6n et al. (1994) determined that 
cultured Schwarm cells produce Pmp221SR]3. The N-linked glycoslyated form arises from 
an 18 kDa precursor which can also be detected in sciatic nerve. The inhibition of 
glycosylation by tunicamycin resulted in the immunoprecipition of an l8kDa protein 
The gas3lPmp22 protein product translated in vitro (Manfioletti et al. 1990) also had an 
apparent molecular size of l8kDa which was increased to 22 kDa when translation was 
performed in the presence of the glycosylating agent dog pancreatic microsomes (DPM). 
When the gas3lPmp22 product was synthesised in the presence of DPM the product was 
found only in the detergent phase, suggesting that it is an integral membrane product 
(Manfioletti et al. 1990). Treatment of the microsomally translated product with proteinase K 
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did not change its apparent mobility with respect to the untreated control suggesting that the 
signal sequence responsible for translocation into the endoplasmic reticulum is not cleaved. 
The nature of the N-linked glycosylated side chains may not be identical in PMP22 from 
cultured Schwarm cells, sciatic nerve and purified myelin (Pareek et al. 1993). An antibody 
to a peptide containing a consensus site for N-linked glycosylation (peptide 1) recognised 
PMP22 in metabolically labelled segments of sciatic nerve but not in cultured Schwarm cells. 
In cultured Schwann cells a second protein was detected (48kDa) which was distinct from 
but immunologically related to PMP22 and unaffected by forskolin. 
A nuclear run on experiment was performed to assess whether or not transcriptional 
regulation is responsible for the decreased expression of gas3lPmp22 RNA after serum 
addition (Manfioletti et al. 1990). Nuclei collected at various times after the addition of fetal 
calf serum synthesised gas3lPmp22 RNA at the same level after growth induction. 
Manfioletti et al (1990) concluded that gas3 is probably regulated at the post-transcriptional 
level. 
The stability of Pmp22 rnRNA was examined in cultured cells using RNA polymerase 
(actinomycin D) and protein synthesis (cycloheximide) inhibitors (Manfioletti et al. 1990), 
neither altered the stability of Pmp22 RNA. The addition of serum to the cultures resulted in 
a decrease in mRNA stability which was abolished in the presence of actinomycin D. This 
suggests that the decrease in stability of gas3 mRNA which follows growth induction may 
be regulated (either directly or indirectly) by de novo transcribed RNA(s) responsible for 
gas3 mRNA degradation. If an RNA product is required for downregulation, it may not 
necessarily be translated into a protein product as cycloheximide did not alter the normal 
downregulation. 
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2.4 REGULATION 
Correlation with myelin formation during sciatic nerve development The 
pattern of expression of PMP22 expression in the PNS during development is essentially 
identical to other proteins of PNS myelin such as P0 and MBP ( Wiggins et al. 1975; Lees & 
Brostoff 1984; Stahl et al. 1990). Northern blot analysis of total RNA isolated from sciatic 
nerves at different time points in development showed that a single 1.8-kb Pmp22 mRNA 
species is initially expressed at low levels in the immediate postnatal period (10% of maximum) 
but is rapidly induced to adult levels over the first three postnatal weeks (Snipes et al. 1992). 
Pmp22 mRNA expression reached half maximal levels between postnatal days two to seven and 
increased to near maximum by postnatal day 21. The production of PMP22 protein lags 
temporarily behind mRNA expression, overall protein and mRNA display parallel expression 
patterns (Snipes et al. 1992). Immunohistochernical analysis showed that PMP22 protein 
expression is restricted to myelin. It correlates temporally with the formation of myelin when 
compared to the expression of MBP, another component of compact myelin, and to myelin 
formation as analysed by examining stained plastic sections (Snipes et al. 1992). 
Correlation with myelin degradation and remyelination during sciatic nerve 
regeneration. In the first 7 days following crush injury Pmp22 mRNA levels rapidly declined 
to between 5-10% of normal levels (Welcher et al. 199 1; Snipes et al. 1992). This was paralleled 
by a slower decline of PMP22 protein expression which was reduced to similar low levels 10-20 
days after crush injury (Snipes et al. 1992). 
Pmp22 mRNA levels had begun to approach normal by 40 days post crush as the regeneration 
process neared completion (Welcher et al. 1991; Snipes et al. 1992). When the nerve was 
permanently transected and regeneration prevented, Pmp22 remained down regulated. Thus the 
Pmp22 m. RNA showed a similar time course to the patterns observed for the major myelin 
proteins Po and MBP (Welcher et al. 1991). The pattern of expression of PMP22 in the distal 
nerve stump after unilateral sciatic nerve crush was also comparable to the expression of other 
PNS myelin proteins (Trapp et al. 1988). 
2.5 LOCALISATION 
TissueS. Northern blot analysis showed Pmp22 mRNA expression was high in normal 
adult rat sciatic nerves (Snipes et al. 1992). When introduced into a eukaryotic expression 
vector the PMP22 protein was immunoprecipitated with a polyclonal antiserurn directed 
against purified myelin protein, demonstrating that the SR13 cDNA encodes a protein 
expressed in normal sciatic nerve. Synthetic peptides corresponding to the two predicted 
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major hydrophilic regions of the PMP22 molecule were used as immunogens. The antisera to 
both peptides were found to be specific for a 22-kDa protein by immunoblot analysis of total 
protein isolated from rat sciatic nerves (Snipes et al. 1992). Immunoperoxidase studies on 
plastic sections localised the PMP22 protein to the compact portion of the myelin sheaths of 
essentially all myelinated axons in the sciatic nerve. (Snipes et al. 1992). In situ hybridisation 
was performed on teased fibre preparations, the signal showing longitudinal periodicity of 
mRNA localised to the perinuclear cytoplasm of Schwann cells. This result was confirmed 
using double labelling combining in situ hybridisation for Pmp22 mRNA and 
immunoperoxidase staining for the SIM protein, a specific marker for Schwann cells in 
peripheral nerves. 
De Le6n et al. (1994) observed immunoreactivity in the myelin sheath but unexpectedly also 
in the DRG both in satellite cells and neurons. RNA blot analysis revealed that Pmp22 
mRNA was present in DRG satellite cells but no accumulation was found in neuronal cells 
(De Le6n et al. 1994). The neural immunostaining was in both the cell somata and nuclei. A 
heavy level of staining was also associated with the cell membrane. In the lumbar spinal cord 
PMP22-like immunoreactivity was seen predominantly within the superficial dorsal hom; 
both immunoreactive somata and processes were seen. Individual immunoreactive fibres and 
glial cells were seen within the spinal cord, and white matter. De Leon's results demonstrate 
that Pmp22 expression may not be restricted to sciatic nerve Schwann cells. Alternatively the 
PMP22 protein may share an epitope with another protein. Pareek et al. (1993) used the same 
antibodies on cultured Schwann cells and found that they immunoprecipitated three proteins, 
19,22 and 45 kDa. 
PMP22 has recently been found to be expressed in the skin and colon epithelium of mouse, 
rat, cattle and human. In the skin statum papillare, stratum spinosum (including stratum 
basale) and the inner layer of stratum corneum were positive but stratum granulosum 
showed no staining. In the colon PMP22 epithelial staining was not limited to secretory cells 
but also intense staining of the covering mucus layer was observed. This has been confirmed 
by mucus positive staining in human colon mucous (Liehr & Rautenstrauss 1997) 
Ultrastructure. In normal nerves immunostaining for both PMP22 and Po detected 
identical populations of myelinated fibres. Immunoreactivity was located over regions of 
compact myelin but not over regions of the internode which contained Schmidt-Lanterman 
incisures; (Haney et al. 1996). In addition to staining compact myelin, perinuclear cytoplasm 
of myelinating Schwann cells was consistently labelled by PMP22 antibodies. This labelling 
was less intense than that found over compact myelin and reflects the relatively low level of 
synthesis in adult nerve (Haney et al. 1996). Many of the gold particles were associated with 
vesicles located near Golgi membranes. This distribution is similar to that described for PO 
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protein in perinuclear regions of myelinating Schwann cells (Trapp et al. 1981; Trapp et al. 
1995). Significant labelling was associated with the Schwann cell membranes that surround 
unmyelinated axons in human peripheral nerve. Most of the immunoreactivity was located at 
or very near the Schwarm cell plasma membrane. 
2.6 EVIDENCE FOR A FUNCTION OF PMP22 OUTSIDE THE PERIPHERAL 
NERVOUS SYSTEM 
2.6.1 Pmp22 mRNA has been identified in a number of non-neural tissues. 
Its high level of expression in myelinating Schwann cells has implicated PMP22 in the 
formation and maintenance of PNS myelin. However, Pmp22 mRNA has also been found by 
Northern blot hybridisation techniques in several non-neural tissues, in particular the lung, the 
intestine, and the heart (Welcher et al. 199 1; Manfioletti et al. 1990; Spreyer et al. 199 1; Patel et 
al. 1992). Minor expression of Pmp22 mRNA can also be found in the CNS, particularly in the 
motor nuclei of most of the cranial nerves and in the motor neurons in the ventral horn of the 
spinal cord (Parmantier et al. 1995). In contrast the sensory nuclei of cranial nerves and dorsal 
root ganglion neurons were PMP22 negative. High levels of pmp22 transcripts are also found in 
the villi of the adult gut (Baechner et al. 1995). 
Baechner et al. (1995) detected Pmp22 expression in various non-neural tissues during 
embryonic mouse development. In early embryogenesis (9.5 days post conception (dpc)), 
pmp22 RNA expression appeared to be restricted to the epithelial ectodermal layer. During 
early organogenesis (11.5 dpc), particularly high levels of expression were present in the 
capsule surrounding the liver and in the forming gut, while low levels of Pmp22 mRNA were 
found in the precartilagous condensations forming the vertebrae and the ventricular layer of the 
myelencephalon. During midgestation development (14.6-16.5 dpc), the number of Pmp22 
positive tissues increased, and high expression was detected in several mesoderm-derived 
tissues, in particular connective tissues of the face region, bones including vertebrae, the lung 
mesenchyme, and in muscles. In addition, high expression was also found in fetal lens and in 
the early ectoderm. (Baechner et al. 1995). In these tissues at this developmental stage, 
mitotically active cells and postmitotic cells which subsequently migrate out of the proliferation 
zone are intermixed with each other. In the two week old mouse, relatively high levels of 
Pmp22 mRNA are observed specifically in the postmitotic epithelial cells of the gut. The 
pattern of Pmp22 mRNA expression during the ongoing processes of differentiation and 
morphogenesis supports a function of PMP22 in cellular proliferation and/or differentiation. 
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2.6.2 PMP22 is a homologue of the growth arrest specific protein gas 3, 
implicating a role in cell cycle regulation. 
The cell cycle concept introduced in 1953 (Howard & Pelc 1953) has helped to delineate many 
events governing the growth of mammalian cells. 
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Fig 2.2. Cell replication. During interphase the cell grows continuously; during M 
phase it divides. DNA replication is confined to the part of interphase known as S 
phase. G1 phase is the gap between M phase and S phase. G2 is the gap between S 
phase and M phase 
The control of cell proliferation occurs mainly in the GI phase, and growth arrest of mammalian 
cell cultures can be accomplished early in this phase by the depletion of serum or growth factors. 
Six cDNA clones preferentially expressed in growth-arrested NIH 3T3 cells (mouse derived 
fibroblast cells) were identified (Schneider et al. 1988). The kinetics of regulation of one of these 
genes (gas 31Pmp22) was investigated in the presence and absence of serum. gas 3IPmp22 was 
expressed in resting but not in proliferating mouse fibroblasts (Schneider et al. 1988). 
43 
Schwann cells and fibroblasts. Pmp22 mRNA is translated into a myelin membrane 
glycoprotein in differentiated quiescent Schwann cells. After nerve injury the mRNA is down 
regulated at the time of Schwann cell proliferation (Welcher et al. 1991). Schwann cells cultured 
in a medium containing forskolin (an adenylate cyclase activator) produced Pmp22 mRNA, the 
removal of forskolin from the medium resulted in downregulation (Pareek et al. 1993). PMP22 
staining was found to be highest on Schwann cells flattened onto the substratum. 
Zoidl et al (1995) demonstrated, in retrovirally transfected Schwann cells, that altered levels of 
Pmp22 mRNA significantly modulated Schwann cell proliferation. Enhanced expression of 
Pmp22 decreased DNA synthesis to 60% of control levels. Conversely, reduced levels of Pmp22 
mRNA led to enhanced DNA synthesis of tý 150%. Over expression of Pmp22 delayed serum 
and forskolin stimulated entry of resting Schwann cells from GO/GI into the S+G2/M phase by 8 
h, whereas underexpression slightly increased the proportion of cells that entered the S+G2/M 
phase. These findings indicated a biological function of PMP22 as a negative modulator of cell 
growth at an early and critical stage. Based on these findings, Zoidl et al (1995) proposed that 
altered levels of Pmp22 gene expression may impair peripheral myelination indirectly through 
abnormal growth of Schwann cells. 
Pmp22 mRNA was also abundantly expressed in differentiated non-proliferating fibroblasts and 
is down regulated when the fibroblasts were induced to proliferate by the addition of serum 
(Manfioletti et al. 1990). Pmp22 mRNA demonstrated density dependant inhibition when cells 
were cultured in high serum concentrations. PMP22 over expression in growing NIH-3T3 
fibroblasts leads to an apoptotic-like phenotype which is characterised by typical membrane 
blebbing, rounding up and chromatin condensation, but with no evidence of DNA fragmentation 
(Fabbretti et al. 1995). On the other hand REF-52 fibroblasts seemed to be completely refractory 
to PMP22 overexpression suggesting that PNV22 does not induce apoptosis directly, but permits 
cellular entry to a state in which apoptosis becomes more readily accessible. When PMP22 point 
mutations (L I 6P, S79C, GI 50D) were over expressed in NIH-3T3 cells, the induced apoptotic 
phenotype was significantly reduced as compared to wild-type. Fabbretti et al (1995) suggested a 
role for altered Schwann cell apoptosis in the pathogenesis of CNIT IA. 
PC12 pheochromocytoma cellS. The PC12 cell line has been used as an in vitro 
model to study sympathetic neuronal cell differentiation. The addition of NGF induces 
differentiating changes including cessation of proliferation and the extension of neurites. 
Untreated PC12 cells expressed low levels of SR131Pmp22 mRNA. When cultured under 
conditions that stimulated growth arrest (the addition of nerve growth factor to the medium) 
Pmp22 mRNA levels increased (De Le6n et al. 1994). 
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Differences between the response of Schwann cells in vivo and in 
CUItUre. In cultured Schwann cells not elaborating myelin, PMP22 antibodies stained most 
heavily on cells flattened onto the culture substratum (Pareek et al. 1993). Staining was 
distributed throughout the cytoplasm and was not specifically localised on the cell membrane 
as might be expected for a myelin protein. Although this may reflect different cellular 
compartmentalisation of the PMP22 protein it could also be related to differences in PMP22 
function between nonmyelinating Schwann cells in vitro and myelinating cells in vivo. Other 
differences between PMP22 in intact nerve and in cultured Schwann cells have also been 
detected. PMP22 expression is markedly lower in cultured Schwann cells than in intact 
nerves, even when production is stimulated by forskolin. The turnover rate of PMP22 is 
rapid in cultured Schwann cells having a half life of 30-60 min. Although it has not been 
directly measured, it seems likely that its turnover in peripheral nerves is much slower. 
Additionally Pmp22 mRNA levels are markedly reduced relative to levels of protein in 
peripheral nerves of aged animals suggesting that once synthesised, PMP22 is not rapidly 
replaced. The cytoplasmic localisation of PMP22 in cultured Schwann cells may be related 
to the increased turnover rate in the absence of myelin formation. Increased quantities of 
PMP22 in the Schwann cell cytoplasm could be consistent with either a 'premyelin' 
localisation or an additional ftinction (growth arrest). 
In experiments comparing myelinating Schwann cells, explanted nerve segments and 
passaged nonmyelinating Schwann cells in vitro, De Le6n et al (1994) found that antibodies 
to peptide I failed to recognise PMP22 protein produced by cultured Schwann cells but did 
recognise the protein synthesised by Schwann cells in segments of sciatic nerve. This 
suggests a difference in the nature of the carbohydrate moieties in PMP22 from the two 
sources. Antibody to peptide I recognised the l8kDa unglycosylated form of the molecule 
synthesised by cultured cells and nerve segments in the presence of tunicamycin, suggesting 
that the antibody recognises the epitopes against which it was raised but not when the 
consensus site is glycosylated by cultured Schwann cells. 
In cultured Schwann cells PMP22 staining was found distributed throughout the cytoplasm 
(Pareek et al. 1993). In later studies additional PMP22 staining was seen when newly 
synthesised PMP22 localised in the ER and golgi apparatus on route to the plasma 
membrane (D'Urso et al. 1997). Examining the ultrastuctural localisation of PMP22 Haney et 
al. (1996) found no significant accumulation of PMP22 within intracellular compartments, 
including the endoplasmic reticulurn (ER) and Golgi apparatus, of either myelinating or 
nonmyelinating Schwann cells or in endoneurial fibroblasts. These results demonstrate 
another difference between the localisation of PMP22 in Schwann cells in vitro and in vivo. 
In tissue culture, there is evidence that a critical signal, presumably originating from axonal 
contact, is required for efficient translocation of PMP22 protein to compact myelin (Pareek 
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et al. 1993). In the absence of this putative signal, PMP22 accumulates and is rapidly 
degraded within the ER and Golgi apparatus in cultured Schwann cells. When cultured cells 
were treated with forskolin (which has been proposed to partially mimic the effects of axonal 
contact on Schwann cell gene expression) the protein was still degraded within the ER and 
Golgi (Pareek et al. 1993). 
2.6.3 STRUCTURE OF THE GENE: TWO PROMOTERS HAVE BEEN 
IDENTIFIED 
Two different Pmp22 cDNA clones, CD25 and SR13, have been identified in the rat by 
northern blot and polymerase chain reaction (Welcher et al. 1991; Spreyer et al. 1991). The 
CD25 and SR13 mRNA species encode the same protein but differ significantly in their 5'- 
untranslated region sequences. Detailed analysis of the 5'-flanking indicate that the Pmp22 
gene is regulated by two alternatively used promoters that are located immediately upstream 
of two alternative non-coding exons (exons IA and 113) (Suter et al. 1994b). While both 
transcripts are co-expressed in tissues and cell lines, the transcripts containing exon IA 
(CD25) are preferentially expressed in myelinating Schwann cells, while the transcripts 
containing exon IB (SR13) are preferentially expressed in tissues that do not form myelin 
(Suter et al. 1994b; Bosse et al. 1994). 
The transcripts are differentially expressed during postnatal sciatic nerve development 
(Bosse et al. 1994; Suter et al. 1994b). The expression of exon IA transcripts steadily 
increases from low levels in neonates to a maximum at P14. This 25 fold increase correlates 
closely with the formation of myelin. In contrast, exon IB levels are elevated at birth but 
decrease throughout adulthood (Bosse et al. 1994). Both exon IA and exon IB are expressed 
in adult and developing brain at very low levels (Bosse et al. 1994). 
In degenerating and regenerating segments of peripheral nerve changes in exon IA mRNA 
levels clearly resemble the expression pattern of other myelin genes. This contrasts with the 
expression of exon IB which is inversely correlated with the time course of Schwann cell 
proliferation (Bosse et al. 1994). Temporal changes in the relative abundance of the 
transcript in sciatic nerve by northern blot were analysed following two types of lesions 
(Bosse et al. 1994): i) crush injury which leads to Wallerian degeneration in the distal nerve 
segment prior to regeneration of axons from the proximal stump into the distal segment and 
ii) transection of nerve and permanent separation of both stumps in order to prevent axonal 
growth into the degenerating distal stump. In the proximal segments of both crush-lesioned 
and transected sciatic nerves only minor changes in mRNA abundance were observed for at 
least 6 and 4 weeks after injury, respectively. In the distal stump however the transcript 
levels rapidly declined within 2 days (crushed) or 7 days (transected). During the second 
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Fig 2.3 Diagram of the position of the two PMP22 transcripts and their 
promoters. 
week, crush injury transcripts began to rise again, reaching near control levels at 6-12 weeks 
post lesion. In non-regenerating stumps of transected and ligated nerve no recovery of exon 
IA or exon IB could be seen, suggesting that the expression of both transcripts in Schwann 
cells is under the control of axonal signals (Bosse et al. 1994). Taken together these results 
substantiate the hypothesis, suggested by Doyle and Colman (1993), Lemke (1993) and 
Suter et al. (1993), that PMP22 serves two functions, one related to myelination (exon I A) 
and another to cel I growth (Exon I B). 
The analysis of the primary sequence of the two alternative PMP22 promoters provides some 
information as to their specific regulation (Suter et al. 1994b). The promoter-I structure is 
similar to the tissue specific promoter with a non-canonical (T)ATA box at the optimal 
distance of 30bp upstream of the major transcription initiation site. An inverted CCAAT box 
is found upstream from the (T)ATA box. The sequence around the transcription initiation 
site, TCAG, is also found at the same or a similar position in several other myelin protein 
genes including Po, MBP and PLP. Co-ordinate myelin gene transcription may involve a 
1A IB 25 31 
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regulatory step using a common "initiation" site. Promoter 2 displays several features of a 
"housekeeping" gene promoter. No obvious TATA like sequence, and a generally high G/C 
content can be found in the first 352bp upstream from the transcription initiation site. There 
is also a consensus sequence for an Sp-I binding site, a transcription factor often found 
involved in the regulation of housekeeping genes (Suter et al. 1994b). 
Numerous studies have established that myelin gene expression is critically dependant on the 
presence of axons. In pure Schwarm cell cultures, forskolin has been shown to upregulate the 
expression of the Po gene that encodes for the major myelin protein component of peripheral 
nerve myelin. This and other findings have led to the hypothesis that forskolin can replace 
the requirement of axonal contact for myelin gene expression in Schwann cells and indirectly 
implicated the cAMP pathway in the signal transduction cascade leading to myelin gene 
expression. In cultured rat meningeal fibroblasts exon IB mRNA expression is strictly 
growth arrest specific and independent of forskolin. Regulation of exonlA mRNA levels in 
these cells is more complex with interfering affects of serum and forskolin. In cultured 
Schwann cells neither exon IA or exon IB expression is growth arrest specific. However 
both transcript levels are consistently enhanced by forskolin under all conditions of cell 
growth tested. Expression of exon IA but not exon IB depends on high Schwann cell density 
(Bosse et al. 1994). 
2.6.4 THE PMP22 GENE FAMILY 
Three proteins have been described that bear considerable sequence homologies to PMP22. 
CL20 (Marvin et al. 1995), epithelial membrane protein -I (EMP- 1) (Taylor et al. 1995), and 
lens specific membrane protein 20 (MP20) (Kumar et al. 1993). All four proteins share 
similar structural characteristics. Their genes code for similar sized proteins of 160,160,160 
and 173 amino acids respectively and their hydrophobicity profiles suggest they all have four 
membrane spanning domains. The transmembrane regions of the proteins are the most highly 
conserved, in particular the second transmembrane domain and its N-linked glycosylation 
site. All the mutations in PMP22 that are known to cause hereditary and motor sensory 
neuropathies; (Suter & Patel 1994a) lie within the putative membrane spanning domains, and 
five of the six are conserved in rat EMP-1. This suggests functional significance for these 
regions. The N-linked glycosylation site has been associated with the carbohydrate epitope 
L2/HN K- I in two of the proteins (PMP22 and CL20). These proteins are thought to function 
in relation both to the switch from proliferation to differentiation and the maintenance of 
critical functions in the differentiated state (Taylor et al. 1995). 
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CL20. The protein most closely related to PMP22 is CL20. The CL20 gene is located on 
chromosome 12 and encodes a 17.8kDa protein which exhibits 43% identity to PMP22 
(Marvin et al. 1995). The positions of the four hydrophobic domains and the N-glycosylation 
site are conserved. In particular the second transmembrane domain is highly homologous 
between PMP22 and CL20, with 18 of the 26 amino acids being identical. CL20 contains 
two glycosylation sites at amino acid positions 35 and 43, the latter being conserved 
between the two proteins. Although the exact carbohydrate structure has not yet been 
established preliminary observations suggest that CL-20 resembles PMP22 in binding 
L2/HNK-1. 
CL20 mRNA is most highly expressed in the squamous-differentiated epithelia of the tongue 
and the oesophagus. CL20 is induced during squamous differentiation of rabbit tracheal cells 
in vitro. Squamous differentiation is a multi-stage process in which irreversible growth arrest 
occurs early and is followed by the expression of squamous cell specific genes. When treated 
with retinoids, which have been shown not to block growth arrest irreversibly but to suppress 
the expression of squamous-specific genes, CL20 expression was repressed, suggesting that 
the function of CL20 protein relates to the differentiated phenotype rather than to growth 
arrest. CL20 was found to be expressed in peripheral nerve but nerve injury and regeneration 
had little effect on mRNA expression levels. 
EMPA EMP- I is a protein of 160 amino acids with four transmembrane domains. It has a 
40% amino acid identity to PMP22 (Taylor et al. 1995). The putative four membrane- 
spanning regions of EMP- I and PMP22 are particularly well conserved. The first and second 
of the hydrophobic domains exhibit the highest degree of amino acid identity, 54% and 67% 
respectively. Translation of the EMP-1 cDNA results in a 4-6 kDa increase in the molecular 
mass of the translation product consistent with the presence of a single N-linked 
glycosylation site. The deglycosylated protein migrates identically to the unglycosylated 
EMP- I protein, suggesting that the putative N-terminal signal peptide is not removed during 
biosynthesis. A similar modification was seen with PMP22 (Kumar et al. 1993). All tissues 
expressing EMP- I mRNA contain the 2.8-kb EMP- I transcript however in some regions and 
additional transcript of 1.7kb was found. 
EMP-1 mRNA transcripts were found in all the organs examined with the exception of the 
liver. The most prominent expression was observed in tail derived skin and in the 
gastrointestinal tract, particularly in the stomach, with lower levels being detectable in the 
caecum and large intestine. The gastrointestinal tract is characterised by continual and rapid 
renewal of its epithelial surface that continues throughout the animal's life. Pluripotent stem 
cells in the isthmus/neck regions of the gastric glands give rise to progeny displaying 
increased proliferation and reduced potentiality, which progress to terminally differentiated 
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mature cells. During this process, the cells are highly migratory, with proliferation, migration 
and differentiation being tightly coupled. EMP-1 is found mainly in the proliferation and 
differentiation zones of the outer gastric glands as well as in the mature epithelial cells of the 
gastric pit region. In these regions EMP-I appears to be associated with the plasma 
membrane, with no clear distinction between basal, apical and lateral aspects. The tissue 
distribution of PMP22 mRNA and EW-1 mRNA is similar but they differ in their relative 
expression levels. EW-1 and PMP22 mRNA are differently regulated after sciatic nerve 
injury and inversely regulated in both Schwarm cells and NIH 3T3 cells during growth arrest. 
The conspicuous inverse regulation of PMP22 and EW-1 during the cell cycle lends 
indirect support to a role of this protein family in the control of cell quiescence and 
proliferation. 
MP20. Additional data base searches with the EMP- I and PMP22 sequences revealed that 
both display a 30% amino acid homology to the lens fibre cell protein MP20 (Kumar et al. 
1993). MP20 is a 173 amino acid protein with similar structural features to EMP-I and 
PMP22. If MP20 is compared with PMP22 and EMP-I simultaneously, the amino acid 
identity increased to 36% including strongly conserved motifs in the putative transmembrane 
domains. As in PMP22 and EMP-1, the CL20 gene does not have a signal cleavage 
consensus sequence and is unmodified at its N-terminus in vivo. MP20 is a lens-specific 
membrane protein that has been localised in fibre cell junctions. MP20 has been shown to be 
absent from proliferating epithelial cells of the lens, with expression becoming prominent in 
differentiating as well as in mature lens fibre cells. 
2.7 L2/HNK-1 EPITOPE 
Cell surface and extracellular matrix molecules are characterised by particular sets of 
carbohydrate structures, some of which are thought to modulate the functional capacities of 
the molecules bearing them (Schachner & Martini 1995a). The RNK-I epitope, originally 
described as a cell surface component of human natural killer cells (Abo & Balch 1981), was 
found to be expressed in the central and peripheral nervous systems (Schuller-Petrovic et a]. 
1983; Wernecke et al. 1985). The epitope consists of a carbohydrate structure and when 
carried by a glycolipid has a 3'sulfated glucuronic acid at the non-reducing end of one or two 
lactosamine repeats (Chou et al. 1986; Ariga et al. 1987). L2/HNK-1 is expressed by many 
neural adhesion molecules (N-CAM, L 1, MAG, Po, JI /Tenascin (Cytotactin), jI /Janusin 01- 
160/180), tag-1, some integrins and endymins (Kruse et al. 1984; Kruse et al. 1985; 
Schachner 1989; Jessell et al. 1990), and some glycolipids (Yoshihara et al. 1991; Chou et al. 
1986, Kruse et al. 1984). 
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Monoclonal antibodies against the L2/HNK-I carbohydate have been shown to disturb the 
migration of neural crest cells, and it has been suggested that the antibody interferes with the 
interaction of the L2/HNK-I carbohydrate and a laminin-heparan sulphate proteoglycan 
complex (Bronner-Fraser 1987). Similarly, neurite outgrowth has been reported to depend on 
the interaction of the L2 carbohydrate with a complex of extracellular matrix molecules 
(Dow et al. 1988). L2/HNK-I is capable of functionally blocking cell-cell and cell-substrate 
interactions. Adhesion of cerebellar cells to larninin could be strongly inhibited by the 
L2/14NK- I carrying glycolipids (Hall et al. 1993), whereas neuron to astrocyte and astrocyte 
to astrocyte adhesion was inhibited to a lesser degree (Kunemund et al. 1988; Keilhauer et al. 
1985). The cell (but not substrate) bound L2/HNK-I epitope is a potent mediator of 
astrocytic and neuronal adhesion to laminin, which was strongly reduced in the prescence of 
the L2/HNK- I carbohydrate-carrying glycolipids or Fab fi-agments of a monoclonal antibody 
against it (Hall et al. 1993). L2/HNK-I interacts directly with the laminin molecule at 
binding site(s) which appear to be distinct from those for the glycosaminoglycan heparin and 
the glycolpid sulphatide (Hall et al. 1993). 
Laminin is not only involved in interactions with other extracellular matrix components, but 
also in the interaction of cells leading to a variety of responses including cell proliferation, 
differentiation, cell migration and neurite outgrowth (Sanes, et al. 1990; Reichardt & 
Tomaselli 1991). 
In human PNS myelin the L24HNK-1 epitope has been found on Po, MAG and a group of 
glycoproteins with molecular masses ranging from 18 to 28 kDa (Inuzuka et al. 1984; 
Noronha et al. 1986; van den Berg et al. 1990). Snipes et al. (1993) demonstrated that at least 
one of these glycoproteins is PMP22. Quantitatively the L2/HNK-I bearing proteins in the 
18-28kDa molecular weight range, seemed to contain as much of the epitope per nerve as 
either Poor MAG. It is plausible that PMP22 is the major L2/HNK- I epitope bearing protein 
in the lower molecular weight range and possibly in the PNS. Although Po has been shown to 
be a carrier of the L2 carbohydrate in human and in bovine nerve, it is not a prominent 
carrier of the L2 carbohydrate in mouse (Schachner et al. 1995b). 
L2/HNK-I has been identified as being involved in the homophilic binding of Po, the major 
glycoprotein in the PNS, a neural recognition molecule. (Griffith et al. 1992). Thus not only 
protein-protein interactions mediate homophilic binding of Po, but also interactions between 
the protein backbone and the L2 carbohydrate appear to be important. It has been suggested 
that the L2 carbohydrate may guide the loops of Schwann cell processes to spiral during 
myelin formation and to stabilise these loops in compact myelin in the adult (trans 
interaction) (Schachner et al. 1995b). It is conceivable that Po may interact with itself in the 
surface membrane (c is- interaction) to form clusters. 
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L2/HNK-1 in development The L2/HNK-I epitope was uniformly expressed in 
developing peripheral nerves where it showed a similar distribution to that observed for Ll 
and NCAM. It was detected on some, but not all, small axons, and intensely stained 
basement membranes and collagen fibrils (Martini & Schachner 1986). L2AHNK-I was 
present on axons and adjacent Schwann cells before completion of 1.5-2 loops of Schwann 
cell membrane, but then disappeared. It is generally downregulated at the onset of 
myelination along with NCAM and LI although it does remain expressed on a subpopulation 
of non-myelinating Schwann cells and small calibre axons (Nieke & Schachner 1985). 
L2/14NK-1 reappears during the third postnatal week in the compact myelin of motor axon- 
associated myelinating Schwann cells (Martini & Schachner 1986; Martini et al. 1992). 
L2/HNK-1 expression in adult mouse nerve. L2/HNK-I is expressed in the adult 
mouse by myelinating Schwann cells of ventral roots and muscle nerves, but rarely by those 
of dorsal roots or cutaneous nerves (Martini et al. 1988). Its characteristic pattern of 
expression and the fact that it is maintained in denervated nerves for 2-3 weeks led authors to 
suggest that it may be involved in pathfinding of motor axons after injury of mixed nerves 
where motor and sensory axons intermingle. 
The possible functional involvement of L2/HNK-I carbohydrate-positive Schwann cells in 
the regeneration of motor axons was tested on cryosections of L2/14NK-1 carbohydrate- 
positive and negative peripheral nerves (Martini et al. 1992). Motor neurons from chick 
embryos grew significantly longer on muscle nerves and ventral roots than on cutaneous 
nerve branches and dorsal roots. This preferential outgrowth of motor neurons on sections of 
ventral roots could be inhibited by L2/HNK-I specific antibodies (Martini et al. 1992). 
Myelinating Schwarm cells previously associated with motor axons have been shown to 
express L2/HNK-I following crush injury while previously sensory associated Schwarm 
cells do not (Martini et al. 1994). Following femoral nerve lesions regenerating axons from 
cutaneous branches did not express L2/HNK-I in muscle or cutaneous branches. Axons 
regenerating from muscle branches provoked a weak expression of L2/HNK-1 in a few 
Schwann cells in the cutaneous branch but a strong expression by many Schwann cells in the 
muscle branch. This upregulation of L2/HNK- I during the early stages of reinnervation may 
provide motor axons regenerating into the appropriate pathway with an advantage over those 
regenerating in to an inappropriate sensory pathway (Martini et al. 1994). 
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Chapter 3 Genetically engineered PMP22 alterations 
3.1 ANIMAL MODELS 
3.1.1 PMP22 deficient mice 
Two investigators have produced mouse models which are deficient in PMP22. 
Adlkofer et al. (1995) engineered a null mutant (PMP22 010) and Maycox (1997) a 
transgenic strain expressing antisense PMP22 RNA. No PMP22 protein was 
detected in sciatic nerve homogenates of P24 or ten week old PMP22 0'0 mice and 
the levels of Po and MBP were reduced (Adlkofer et al. 1995). The transgenic mice 
produced by Maycox expressed antisense RNA under the control of a Po gene 
promoter (Maycox et al. 1997). The strategy of using the Po promoter is known to 
restrict the expression of the transgene to myelinating Schwarm cells (Lemke et al. 
1988; Messing et al. 1992; Messing et al. 1994; Weinstein et al. 1995). Both 
homozygous and heterozygous antisense Pmp22 mice exhibited moderately reduced 
levels of Pmp22 mRN A (15% and 9% respectively) (Maycox et al. 1997). 
Clinical features 
Null mutants. PMP22 0'0 mice could be behaviourally distinguished from their 
litter mates at P14. Affected animals had difficulties walking as a result of 
progressive paralysis of the hind limbs. Occasionally stress induced convulsions and 
tremor were observed. The tremor was reported as being less pronounced than the 
one seen in Tr mice (Adlkofer et al. 1995). Most of the mice heterozygous for the 
null mutation (PMP220") were indistinguishable from wild type mice but 
occasionally some animals showed signs of walking difficulties. In matings of 
heterozygous mice 28% of the offspring were homozygous indicating that 
embryonic development can proceed without PMP22 expression (AdIkofer et al. 
1995). 
Antisense mice. The behavioural phenotype observed in the antisense Pmp22 
transgenic line was characterised by an unusual gait disorder in young animals 
(Maycox et al. 1997). In the published frame by frame video montage a young 
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homozygous mouse shows an extremely high stepping action of the hindlimbs. 
Maycox. also found that homozygous animals tended to avoid walking at all and 
explored the environment with both forelimbs, radially from a single point. The gait 
abnormality was first noted several weeks after birth and worsened with age. 
Morphological abnormalitieS Both strains of PMP22 deficient mice have 
focal myelin thickenings (tomacula) as a prominent feature of their pathology. 
Null mutants 
PMP22 010 mice. The absence of PMP22 resulted in abnormal myelin formation in 
development. 
P4 In the pectineus nerve of P4 mice a population of large calibre axons had 
separated from the fetal bundles and were ensheathed singly by Schwann cells 
(Adlkofer et al. 1995). In wildtype animals 60% of these large calibre axons were 
surrounded by compact myelin whereas only 19% were myelinated in PMP22 010 
mice. In the population of axons that were myelinated, the myelin sheaths were 
already abnormally thickened with respect to axon diameter. 
P24 In the femoral nerve of P24 mice many fibres had redundant myelin loops with 
normal myelin periodicity and a corresponding compression of the axon (Adlkofer et 
al. 1995). The myelin of some tomacula was disorganised and the axons were 
displaced, the authors considered this to reflect an early stage of degeneration. Many 
thinly myelinated axons, basal lamina-covered Schwann cells and onion bulbs were 
seen. Some large calibre axons were seen completely devoid of myelin and the 
Schwann cells ensheathing them were occasionally associated with degenerating 
myelin. Teased fibre analysis showed tomacula associated with every axon-Schwann 
cell unit. They were preferentially found at paranodal regions of myelinated fibres 
but internodal tomacula were also seen. Axonal loss was shown in the pectinous 
nerve at P24. 
10 weeks Tomacula were rare and established signs of degeneration were observed 
in 10 wk mice. No abnormalities were noted outside the PNS. Axonal loss could not 
be quantified due to the presence of axonal sprouts 
PMP22 0'0 mice have abundant tomacula at a young age but show demyelination and 
reduced MNCVs (similar to CMTI) with progressing age. This suggests that 
tomacula are unstable transient structures that degenerate during maturation, their 
presence indicating a predisposition to demyelination. Aldkofer et al. concluded that 
focal hypermyelination followed by myelin degeneration is likely to be a common 
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Tomacula. 
The term 'tomaculal was coined by Madrid and Bradley ( 1975) to describe elongated or 
sausage-shaped thickenings of the myelin sheath (tomaculum, Latin = sausage). The first 
description of globular thickenings of the myelin sheath is credited to Dayan et al. (1968). 
They also noted that the structures occurred in the presence of extensive segmental 
demyelination. Behse et al. (1972) also described sausage-like swellings of the myclin sheath 
and considered them to have arisen by the wrapping of redundant loops of myelin around the 
axon. Madrid and Bradley (1975) examined tomacula in patients with different clinical 
syndromes including hereditary neuropathy with liability to pressure palsies, recurrent 
familial brachial plexus neuropathy and chronic distal sensorimotor neuropathy. They 
described focal enlargements of the myelin sheath usually continuous with a myelin sheath 
of normal thickness. In thickened areas the myelin was frequently swollen, vacuolated and 
irregular in appearance. The tomacula appeared to be formed in different ways, with each of 
the different forms being found in each of the cases examined. Hypermyelination. The most 
simple tomaculurn is an excessive thickening of the myelin sheath. It is thought to result 
from the Schwarm cell failing to stop rotating at the appropriate stage of myelination 
resulting in the production of too many myelin lamellae for the diameter of the axon. The 
simple tomaculum was not found particularly frequently (Madrid & Bradley 1975). Folding. 
The most common form of tomaculurn consisted of folding of the myelin sheath. This varied 
from simple outpouchings to various degrees of complex folding. Redundant myelin loops 
secondarily wrapped around the original myelinated axon either around the outside or turned 
inwards and wrapped internally around the axon. Occasionally redundant loops were derived 
internally within the myelin itself. Degenerative changes. Degenerate swollen myelin 
usually appeared to lie between a relatively preserved part of the myelin sheath and a 
structurally normal but compressed axon (Madrid & Bradley 1975). Focal myelin thickening 
was associated with constriction of the axon resulting in densely packed neurofilaments and 
neurotubules. Some internodes were diffusely thickened but more frequently the 'sausages' 
were paranodal and less frequently internodal. Occasionally there were several thickenings 
within one internode. All the cases examined by Madrid and Bradley (1975) showed 
extensive segmental demyelination and remyelination with the incidence of tomacula being 
highest when segmental demyelination was most prominent. Other features of the tomacula- 
associated demyelinating neuropathy included extensive variability of internodal length, 
abnormally thin myelin sheaths and occasionally onion bulb formation or acute segmental 
demyelination with the presence of myelin ovoids. 
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mechanism in neuropathies involving tomaculum-like structures (AdIkofer et al. 
1995). 
PMP22 01+ mice. Tomacula were less frequently seen in the femoral and pectineus 
nerves of P24 PMP220" mice when compared with age matched PMP220'0 mice. 
Their frequency increased with age so that by 10 wk almost every myelinating 
Schwann cell had formed internodal or paranodal tomacula. Onion bulbs were 
occasionally seen in the quadriceps nerves but there was no significant change in 
axon number. 
In animals from 5 to 15 mo tomacula were prominent (Adlkofer et al. 1997). At 5 
mo multiple tomacula were found within the same internodal segment. They were 
seen both internodally and paranodally but were more frequent in paranodal regions. 
By 10 mo the presence of many very thick tomacula became obvious. These 
expanded structures were interpreted as early onset degeneration in former tomacula 
(Adlkofer et al. 1997). In animals older than 10 mo the axon appeared compressed 
inside hypermyelinated structures. Splitting of the major dense line and intramyelin 
oedema was frequently seen as were Schwann cells with myelin debris present in the 
cytoplasm. At 15 mo tomacula were still seen frequently. Some myelin sheaths 
looked abnormally thin and were surrounded by cellular or basal lamina-type onion 
bulbs. 
Antisense PMp22 mice. 
The sciatic nerve of homozygous, heterozygous and wildtype animals were 
examined morphologically at 7 mo, (Maycox et al. 1997). At the light microscopic 
level the differences between the groups was modest. However under EM 
examination the nerves of every homozygous animal examined exhibited tomacula, 
some of which appeared to be undergoing myelin breakdown. Onion bulb 
formations were prominent, indicating demyelination and subsequent remyelination 
and many axons were almost completely devoid of myelin. No morphological 
abnormalities were seen in either antisense Pmp22 transgenic; heterozygotes or 
normal animals. 
Overall there was a good correlation between the relative reduction in Pmp22 
mRNA levels (Pmp22 antisense homozygotes 15%, PMP2201' 50% and PMP220'0 
mice 100%) and the relative severity of the phenotype observed. The modest 
reductions in Pmp22 levels in antisense transgenic mice eventually leads to the 
development of many features seen in null mutants but with a longer time course 
and with a reduced incidence of tomacula. 
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Nerve conduction studies Electrophysiologically PMP22010 animals showed 
abnormalities typical of a severe myelin disorder. There was dramatic slowing of 
motor nerve conduction velocities (<20% of wildtype values), polyphasic compound 
muscle action potentials and increased motor latencies (Adlkofer et al. 1995). In 
PMP220" mice conduction velocities were near normal in the presence of 
tomacula. In 3-5 mo homozygous antisense animals compound distal latencies were 
no different from those found in wildtype nerves. In older homozygous antisense 
Pmp22 mice (7-9mo) distal caudal nerve compound latencies were prolonged by 
23% and distal sural nerve latencies by 24%. In contrast F wave latencies were 
significantly increased in the 3-5 mo group and by 7-9 mo no F waves were detected 
either in antisense Pmp22 mice or controls. 
3.1.2 PMP22 overexpressing mice 
Pmp22 transgenic mice were identified by Southern blot analysis with 16 and 30 
copies of the mouse PMP22 gene (Magyar et al. 1996). No Pmp22 mRNA was 
detected in the kidney, stomach, thymus, spleen or liver. Low expression was found 
in the heart and the lung. A relative overexpression of approximately two fold was 
found in the heart but no defects were detected by histological analysis (Magyar et 
al. 1996). Pmp22 mRNA expression in the sciatic nerve was reduced to 54% of 
control values. When standardised against Po expression there was a twofold increase 
in PMP22 expression. Both PMP22 and Po protein levels were dramatically reduced 
in transgenic mice. No significant differences were noted between the lines with 
different copy numbers either in phenotype or pathology. 
Clinical features. The first behavioural abnormalities appeared 2 wk after birth 
and manifested as a slight shivering, most obvious in the head. At 4 wk an unsteady 
gait became apparent with signs of muscle atrophy present at 2-3 mo. Progresssion 
of the disease with age often culminated in pronounced paralysis of the hindlimbs. 
The lifespan of transgenic animals generally exceeded 8 mo. 
Morphological abnormalities Morphological analysis at the light microscope 
level failed to demonstrate any detectable myelin in the nerves of PIO, P21 or P70 
Pmp22 overexpressing animals. No other tissue showed any visible difference with 
the exception of neurogenic muscle atrophy and decreased body fat which was 
attributed to feeding difficulties. 
In the sciatic nerve of PIO overexpressing mice most Schwann cells had formed a 
1: 1 relationship with their axons but no myelin sheaths were seen. There was no 
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evidence of either degenerating myelin or myelin debris, suggesting that the absence 
of myelin was a consequence of disrupted myelin formation rather than a result of 
myelin degeneration. By P21 the cytoplasm of Schwarm cells associated with larger 
calibre axons had become more dense than in littermate controls or P 10 mice and all 
the axon/Schwann cell units were now surrounded by redundant basal laminae. A 
few larger calibre axons were surrounded by thin compact myelin sheaths and 
occasionally degenerating myelin and myelin debris was noted. At P72 compact 
myelin was no longer found; this was thought to correlate with the occurrence of 
degeneration at P21. Redundant basal lamina was still frequently seen, but often 
disorganised or disrupted and it rarely contained Schwarm cell processes. Remak 
fibres appeared normal. 
Schwann cell proliferation. The number of nuclei in the nerves of P8 
overexpressing mice was double that seen in wildtYpe littermates; the difference had 
increased to fourfold by 6wk. Continued proliferation was confirmed by 
observations of an increased number of cells incorporating BrdU at both P21 and 
P72. Electron microscope analysis of longitudinal sections showed that most of the 
Schwann cells were in contact with, and had lined up along, axons but had failed to 
elaborate myelin. There was no sign of significant numbers of invading 
macrophages, endoneurial fibroblasts or supernumerary Schwann cells. 
Schwann cell antigen expression. The femoral quadriceps nerves of Pmp22 
overexpressing mice showed a strong upregulation of LNGFR in most Schwann 
cells. NCAM was also upregulated but to a lesser extent and Ll was weakly 
upregulated by some Schwann cells. This characteristic expression profile of 
Schwann cell development markers in combination with the positions of the 
Schwann cell along single axons indicates that the differentiation state of mutant 
Schwann cells closely resembles the characteristics of normal Schwann cells just 
before myelination (Jessen & Mirsky 1991). 
We have recently described five lines of transgenic mice carrying increasing copy 
numbers of the human PMP22 gene and expressing increasing levels of the 
transgene (Huxley et al. 1998). From histological and electrophysiological 
observations there appears to be threshold below which expression of Pmp22 has 
virtually no effect; below a ratio of human/mouse mRNA expression of 0.8, little 
effect is observed. Between a ratio of 0.8 and 1.5, abnormal histological and nerve 
conduction velocities are observed, but there are no behavioural signs of neuropathy. 
An expression ratio of >1.5 leads to a severe neuropathy. The level of expression 
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does not affect the type of demyelination, but influences the severity of involvement. 
The work in this thesis extends the morphological characterisation of a selection of 
these lines. 
3.1.3 PMP22 overexpressing rats 
The rat model generated by Sereda, et al. (1996) had an estimated 3 copies of a 
microinjected mouse DNA fragment in the Pmp22 transgene. There was 
considerable variation in the level of Pmp22 mRNA among both transgenic and non- 
transgcnic rats. Homozygote overexpressing animals showed up to a 6-fold elevation 
in mRNA levels at 4 wk. The degree of overexpression appeared to correlate with 
the severity of the phenotype. 
Clinical features. All animals carrying the Pmp22 gene displayed an unsteady gait 
which the authors considered reminiscent of the 'steppage' gait seen in CMT 
patients. Despite individual variations in phenotype, transgenic rats all failed in the 
bar test, a behavioural test of motor performance and grip strength. Homozygous, 
animals displayed a more severe phenotype than heterozygous animals. They were 
never able to control their limb movements and occasionally spasticity and seizures 
were observed. The neuropathy was progressive many homozygous animals dying 
or having to be killed by I mo. 
Morphological abnormalities. 
HoMozygou& Homozygous rats were completely lacking PNS myelin. Schwann 
cells, whose numbers were increased, had segregated with axons in a normal 1: 1 
ratio and had formed basal lamina, but failed to elaborate myelin. Overt myelin 
debris was not seen although fibroblasts frequently contained lipid droplets. Neither 
supernumerary Schwann cells nor onion bulbs were seen. No abnormalities were 
detected in CNS fibres or unmyelinated fibres of the PNS. 
Heterozygous. The sciatic nerves of heterozygous transgenic rats contained many 
axons that had thin or absent myelin sheaths. The myelin sheaths that were present 
were well compacted with normal periodicity. The severity of abnormality was 
greater in the ventral nerve roots compared with the dorsal roots or the sciatic and 
tibial nerves. Consistent with this finding, predominantly motor (branch to the 
medial gastrocnemius) nerves were more severely affected than those that are 
predominantly sensory (distal tibial) (Sereda et al. 1996). Hypomyelination was 
generally more marked in larger diameter fibres, while many smaller fibres had 
59 
sheaths of normal or even increased thickness. Myelin thickness was found to be 
variable within a single internode. Myelin debris was only seen occasionally in 
Schwann cells, reactive macrophages were also only occasionally seen. At 6 wk 
early onion bulbs were very occasionally seen but by 6 mo, they were commonly 
foundL Axonal degeneration was rare, involving less than 1% of fibres. No 
abnormalities were noted in the cell bodies of the dorsal root ganglia and ventral 
hom or in CNS fibres. 
Nerve conduction studies. At 6 wk Pmp22 transgenic rats showed a decrease in 
conduction velocity and increased latency in both motor and sensory nerves. 
Recordings showed characteristic features which represent physiological signs of 
demyelination (Sereda et al. 1996). 
3.2 CULTURED CELLS. 
3.2.1 Myelinating cultures 
By infecting rat Schwarm cells with retroviruses carrying rat Pmp22 D'Urso, et al. 
(1997) produced Schwann cell lines which over or underexpressed Pmp22. Pmp22 
overexpressing (sense construct), underexpressing (antisense construct) and control 
Schwann cells were co-cultured with purified DRG neurons. Pmp22 overexpression 
reduced the proliferation rate of Schwann cells by 60% under growth conditions in a 
medium which supported Schwarm cell proliferation but did not allow basal lamina 
formation and myelination. When cultures were switched to medium which 
promoted myelination, Pmp22 expression gradually increased in all cultures (D'Urso, 
et al. 1997). Pmp22 mRNA levels were increased in Schwann cells expressing the 
sense construct and slightly decreased in cells expressing the antisense construct 
when compared with control cultures. PMP22 immunoreactive fibres first appeared 
7d after the addition of ascorbate to the medium in all three culture types. Schwann 
cells in all cultures established contacts with axons, ensheathed them and formed 
myelin which looked normal when analysed by electron microscopy. No 
morphological differences were observed between control and recombinant cell- 
cultures in either proliferation or myelination medium. CNerexpression of Pmp22 
did not affect either the onset of myelination or the expression of other myelin genes 
(EYUrso ct al. 1997). Both PO and MBP inimunoreactivity appeared synchronously 
with PMP22 and was correctly targeted to myelin membranes. PMP22 
inummostaining was seen not only in the myelin sheath but also within the 
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cytoplasm of myelinating Schwann cells in overexpressing cultures (IYUrso et al. 
1997). In contrast Po and MBP were localised only in compact myelin. On this basis 
the authors speculated that PMP22 may perform different functions in different 
cellular compartments during myelination. Only myelinating Schwann cells were 
able to target PMP22 to the plasma membrane, non-myelinating cells in 
overexpressing cocultures, had detectable levels of PMP22 but the signal was only 
present in the perinuclear compartments. Ile authors concluded that PW22 was not 
one of the key molecules involved in the early spiralling events that occur soon after 
a 1: 1 relationship between Schwann cell and axon have been established but is more 
involved in controlling myelin thickness. 
3.2.2. Cultured Schwann cellS. Altered Pmp22 levels significantly 
influenced DNA synthesis in cultured Schwarm cells. In Pmp22 overexpressing 
Schwarm cells the level of DNA synthesis dropped to 60% of control values; 
conversely underexpression correlated with enhanced DNA levels (150% of control 
values) (Zoidl et al. 1995). Both the CD25 and the SR13 PNT22 mRNA transcripts 
increased as Schwarm cells stopped proliferating and both were rapidly 
downregulated as they re-entered the cell cycle. Altered levels of Pmp22 expression 
also altered the entry of quiescent cells into the cell cycle. Overexpression of Pmp22 
delayed serum and forskolin stimulated entry of resting cells from GO/GI to the 
S+G2/M phase by 8 h. Cells expressing reduced Pmp22 levels did not enter the cell 
cycle faster than controls, but the proportion of cells that re-entered the cell cycle 
was consistently higher. This suggests that low levels of Pmp22 expression may 
facilitate the transition from GO/GI to S phase for an increased number of resting 
cells. 
The growth of Schwarm cells purified from 3d old Pmp22 overexpressing rats 
(Sereda, et al. 1996) showed growth characteristics very similar to control cultures. 
Pmp22 transgenic Schwann cells showed no signs of premature growth arrest, and 
no evidence of increased apoptotic death. 
3.2.3 Fibroblasts. Cultured fibroblasts overexpressing PAP221PMp22 showed 
morphological hallmarks usually associated with programmed cell death (Fabbretti 
et al. 1995; Zoidl et al. 1997). These included a collapsed cellular body and 
condensed nuclei accompanied by cell rounding and membrane blebbing. Nuclear 
morphology was altered in 54% of PAP22 overexpressing fibroblasts (Fabbretti et 
al. 19951 When transfected with cDNA constructs for PW22 point mutations 
(Ll6P, S79C, TI 18M ) the point mutations showed a significantly decreased ability 
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to induce nuclear condensation and expressed normal nuclear morphology (Fabbretti 
et al. 1995). This decreased ability to induce morphological alterations was also 
found in fibroblasts overexpressing the Trembler alteration PMP22CY' WA (Zoidl et 
al. 1997). They found that the proportion of fragmented nuclei increased during the 
culture period in PMP22 (22% to 61%) and to a lesser extent PNIIP22c'yI5OA (120/6- 
22%) overexpressing cells. This suggests that PMP22 acts in a physiological manner 
because intact PMP22 but not the mutant Tr protein promotes increased cell 
degeneration. 
The lack of the apoptotic-like phenotype in REF-52 cells, which do not normally 
express PMP22, suggests a cell type specific response (Fabbretti et al. 1995). From 
this evidence Fabretti et al. concluded that PMP22 itself does not induce apoptosis 
but permits entry into a state in which apoptosis becomes more accessible (Fabbretti 
et al. 1995). 
Elevated levels of PMP22 and PMP22(2y'50A significantly reduced fibroblast 
proliferation with PMP2VY1-50A having a less marked effect. An accumulation of 
cells in the GI compartment of the cell cycle indicates that elevated expression 
levels prevent NlH3T3 fibroblasts from undergoing DNA replication (Zoidl et al. 
1997). 
3.2.4 Yeast cells. When human PALP22 cDNAs were cloned into yeast cells 
northem blots showed a strong signal, while westem blots did not. This was taken to 
mean that the PMP22 protein was degraded rapidly in yeast cells to protect the cells 
from its toxic cffects. These toxic effects are implied by a decreased growth rate in 
PMP22 induced yeast cells. In contrast, following amplification of the PMP22 gene 
in two human tumour cell lines, PMP22 was detected by western blot (Park et al. 
1997). 
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Chapfer4 Mutations affecting the human PMP22 gene 
Numerically the largest class of hereditary peripheral neuropathies are those which involve 
both the sensory and motor components of the PNS, the hereditary motor sensory 
neuropathies (HMSN). These disorders have traditionally been termed Charcot-Marie-Tooth 
disease (CMT) following the descriptions of Charcot and Marie (1886) and Tooth (1886). 
Charcot-Marie-Tooth disease represents the most common inherited peripheral neuropathy. 
Its prevalence has been estimated to be 36 per 100,000 in Norway (Skre, 1974), 30 per 
100,000 in Minnesota (Dyck et al. 1993) and 20 per 100,000 in the UK (Harding & Reilly 
1995b) 
4.1 HISTORICAL CLASSIFICATION OF INHERITED PERIPHERAL 
NEUROPATHIES 
The CMT syndrome was originally believed to be specific for a single disorder. Symptoms 
listed by Charcot and Marie included progressive muscular weakness and atrophy initially 
involving the feet and legs and only after many years, affecting the hands and later still the 
forearms, together with foot deformity (usually pes cavus), vasomotor abnormalities and 
normal sensation (now known to be incorrect except in the 'spinal form' of CMT disease 
(Dyck & Lambert 1968aý The disorder described by Tooth was a peroneal type of 
progressive muscular atrophy whose features were similar to those listed by Charcot and 
Marie. It was Tooth who concluded that the disorder was due to disease of the peripheral 
nerves. It is now clear that the description of Charcot, Marie and Tooth was of a 
heterogeneous group of patients (Harding 1995a). 
In 1893 Dejerine and Sottas (Dejerine & Sottas 1893) described a more severe form of 
peroneal muscular atrophy with progressive generalised loss of muscle function, severe 
sensory loss, and limb ataxia, Dejerine Sottas disease (DSD). Their patients like many CMT 
cases, showed marked hypertrophy of the peripheral nerves. Thus DSD and some examples 
of CMT disease have been referred to as hypertrophic neuropathies. 
A seemingly unrelated hereditary neuropathy, hereditary neuropathy with liability to 
pressure palsies (HNPP) (also called tornaculous neuropathy) was recognised by Davies et 
A (1954). They described an autosomal dominantly inherited, clinically homogeneous 
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syndrome characterised by a tendency towards repeated sensory and motor nerve palsies, 
brought about by minor pressure or trauffia to individual peripheral nerves. The pathological 
hallmark of this disorder consists of multiple focal thickenings of myclin that form sausage- 
shaped, or tomaculous, enlargements along the nerve (Buchthal & Belise 1977). 
Following the advent of nerve conduction studies in the late 1950s and 1960s it became 
apparent that there was heterogeneity in CMT disease for motor and sensory nerve 
conduction velocities. A widely used classification designates this group of disorders as 
hereditary motor and sensory neuropathies (HMSN). Several groups defined two main types 
of HMSN (Dyck & Lambert 1968a; Dyck & Lambert 1968b; Thomas & Calne 1974; 
Buchthal & Belise 1977). Type I HMSN (HMSNI) denotes individuals with a hypertrophic 
(onion bulb), demyelinating neuropathy and markedly reduced nerve conduction velocity, 
whereas type U (HMSNII) refers to patients with an axonal neuropathy and normal or near 
normal nerve conduction velocities. Dejerine-Sottas disease was designated as HMSNIII by 
Dyck and Lambert and defined as a severe demyelinatingthypomyelinating neuropathy with 
an onset in childhood and very slow nerve conduction velocities (<I 0 m/s) (Dyck & Lambert 
1968a). 
A small number of patients have a purely motor disorder, with evidence of denervated distal 
muscles but normal motor and sensory nerve conduction. This phenotype, the spinal form of 
CMT disease, runs true in families and is generally referred to as distal spinal muscular 
atrophy (SMA) or hereditary distal motor neuronopathy (Harding 1993). Most patients with 
the CMT syndrome, however, have sensory involvement. 
CMT has now been adopted as the main gene symbol for the CMT syndrome (McKusick 
1988). This has resulted in CMT and HMSN being used interchangeably, CNIT I is used to 
refer to HMSNI and CMT7 to HMSNII. This is not strictly correct, as CMT disease should 
include distal SMA but does not (Harding, 1995a). The underlying genetic defect has not 
been found for all of the HMSNs, so classifications using only "CMT" do not include all the 
clinical syndromes (Reilly, 1998). 
4.2 CMT1 (HMSN1) 
The first autosomal dominant HMSN I locus to be mapped was on chromosome I (Bird et al. 
1982; Guiloff et al. 1982; Lebo et al. 1991) and suggested that CMTI was linked to the 
Dufry (Fy) blood group. This type of HMSN has subsequently been found to be rare and has 
been termed CMTIBA[IMSNIB. The human myelin protein gene (Po) became an attractive 
candidate for CMTIB as it mapped to chromosome lq22-q23 in the region of the CMTIB 
locus (Hayasaka ct al. 1991). Po was known to be the major structural component of 
peripheral nervous system myelin (50% by weight) (Lemke et al. 1988). Analysis of PO as a 
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candidate gene for CMTIB detected point mutations in pedigrees with this disorder in four 
families (Hayasaka et at. 1993a; Ilayasaka et al. 1993; Kulkens; et al. 1993; Su et al. 1993) 
suggesting Po abnormalities are responsible for CMTIB. 
At this point, families with CMTI not linked to Duffy were designated CMTIA. The locus 
for the majority of cases was subsequently found to be on the short arm of chromosome 17 
(Vance et al. 1989) and specifically to a duplication of the region 17pl 1.2-12 (Lupski et al. 
1991; Raeymaekers et al. 1991). The majority of CMTI families (>70%) have a duplication 
of the PMP22 gene (type IA, CMTIA/HMSNIA) (Raeymaekers et al. 1991; Lupski et al. 
1991; Pentao et al. 1992; Wise et al. 1993; Nelis & VanBroeckhoven 1996). CMT IA is the 
gene symbol now used for CMFrl patients with abnormalities in the 17plI. 2-12 locus, it 
includes both duplications and point mutations in the PA1P22 gene (Reilly 1998). 
Families have since been described in which is there is no evidence for linkage to either 
chromosome I or 17 (Chance et al. 1990). These pedigrees with autosomal dominant CMTI 
not mapping to chromosome Iq or 17p are designated as CMTIC. 
The pattern of inheritance in other kindreds indicates x-linked inheritance (Rozear et al. 
1987). The clinical features of CMTX include demyelinating neuropathy, absence of male to 
male transmission and a generally earlier and faster rate of progression of illness in males. In 
27 CMTX families 27 different point mutations were found in the connexin32 (CX32) gene 
(Berghoffen et al. 1993). (Reilly, 1998). Connexin32 encodes a major component -of gap 
junctions and is expressed in peripheral nerve (Berghoffen et al. 1993). Kindreds with CX32 
mutations have been termed CMTXl and those which are X linked but with unknown 
location CN= 
Autosomal recessive inheritance, termed CMT4, has been described in HMSNI, H and 111. 
CMT4A which features demyelination and basal laminal onion bulbs has been mapped to 
chromosome Sq in Tunisian families (Bcn Othmane et al. 1993) and some families with a 
neuropathy displaying focally folded myelin (CMT413) to chromosome II (Bolino et al. 
1996). HMSN-Lom,, described in Gypsies, is an autosomal recessive demyelinating 
neuropathy associated with deafness has been mapped to chromosome 8q24 (KalaydJieva et 
al. 1998). A finiher category is congenital hypomyelinating neuropathy (CM4). Affected 
individuals have a severe motor and sensory neuropathy with very reduced nerve conduction 
velocity or inexcitable nerves. Some cases are related to mutations in the early growth 
response gene (EGR2) (Warner et al. 1998). 
4.3 PMP22 MUTATIONS IN CMTIA 
The majority of CMTI families (>70%) have a duplication of the PALP22 gene 
(CMTIA/HMSNIA) (Lupski et al. 1991; Raeymaekers ct al. 1991; Pentao et al. 1992; Wise 
et al. 1993; Nelis & VanBroeckhovcn 1996). PALP22 was proposed to be the candidate gene 
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for the CMT subtype IA (also known as I-IMSNIA) on the basis of three main pieces of 
evidence (Suter et A 1992). 
1. The severe inherited hypomyelinating neuropathy found in the Tr and allelic TI mice 
has been localised to mutations in thepmp22 gene. 
2. The pmp22 gene has been localised on mouse chromosome II in a region of conserved 
synteny with the human chromosome 17 (Buchberg et al. 199 1). 
3. The CMTIA locus had been previously localised to a small portion of the short arm of 
chromosome 17 (Vance et al. 1989). 
Cloning and subsequent analysis of this DNA fragment from affected individuals revealed 
that the major structural defect was a tandem intrachromosomal duplication of approximately 
1.5Mb (Lupski et al. 1991; Raeymaekers et al. 1991). The human gene for PW22 has 
subsequently been analysed by several groups confirming that the entire PW22 gene is 
contained within the 1.5Mb duplicated region of chromosome 17 (17plI. 2-17pl2) 
(Matsunami et al. 1992) (Patel et al. 1992; Timmerman et al. 1992; Valentijn et al. 1992). 
The occurrence of cases with a duplication of PAP22 predicted others in which it was 
deleted or mutatedL Deletion of 17pl 1.2 was established by Chance et al. (1993) and is 
associated with hereditary neuropathy with liability to pressure palsies (HNPP). VAiile some 
point mutations in PW22 give rise to a CMTI phenotype (Valentijn et al. 1992; Roa et al. 
1993b; Marrosu et al. 1997; Nelis et al. 1994; Valentijn 1995; Navon et al. 1996; lonasescu 
et al. 1997b) others have been found in association with the severe congenital hereditary 
peripheral neuropathy DSDII-MSNIII (Roa et al. 1993a; Valentijn et al. 1995; Tyson et al. 
1997). 
Several lines of evidence support the hypothesis that PA1F22 is the main dosage sensitive 
gene within the CMTIA duplication and HNPP deletion. First, the finding of a CMTIA-like 
phenotype in several patients with partial trisomies that encompass the CMTlA-HNPP locus 
(Chance et al. 1992; Lupski et al. 1992; lonasescu et al. 1993; Palau et al. 1993; Upadhyaya 
et al. 1993; Valentijn et al. 1993; Roa, et al. 1996) One particular CMTIA family has been 
found to carry a small duplication of only 460 kilobases (Valentijn et al. 1993). As this 
particular duplication still includes the entire PW22 gene, it excludes most of the other 
genes present in the LSMb CNff IA duplication from fiuther consideration (Valentijn et al. 
1993). Secondly a Dutch family with a severe inherited peripheral neuropathy, known to be 
linked to the PA022 gene but without the duplication, was found to have the same mutation 
as the Te' mouse (Valentijn et al. 1992). Thirdly, a 2bp fi-ame-shifting deletion within the 
first translated cxon of PAlP22 has been found to be associated with HNPP (Nicholson ct al. 
1994). Ws mutation would be expected to generate a null allele. The similarity of the 
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phenotypes generated by this mutation and the HNPP deletion directly implicates PMP22 as 
the critical gene in HNPP. 
Table 4.1 Duplications encompassing the PMP22 gene associated with 
CMTIA 
1.5 Mb duplication on the short arm of chomosome 17. 
(17pll. 2pl2) 
(Raeymaekers et al. 199 1) 
(Lupski et al. 199 1) 
(Feldman et al. 1982) 
Alternatively sized l7p, duplications that encompass the (Magenis et al. 1986) 
PALP22 gene (Chance et al. 1992) 
(Lupski et al. 1992) 
(Upadhyaya et al. 1993) 
(Valentijn et al. 1993) 
(lonasescu. ct al. 1993) 
(Palau et al. 1993) 
(Roa ct al. 1996) 2 cases 
Homzygous l7p, duplication (Lupski et al. 199 1) 
(LeGuern et al. 1997) 
(Sturtz et al. 1997) 
The size of the region which is duplicated or deleted in CMTIA and HNPP is quite 
consistent in multiple unrelated and ethnically diverse families (Chance et al. 1993; Lupski 
et al. 199 1; Matsunami et al. 1992; Patel et al. 1992; Roa, et al. 1995; Wise et al. 1993) and 
even de novo duplication or deletion patients (Wise et al. 1993; Chance et al. 1994; 
Lorenzetti et al. 1995). This implies a precise recombination event generating both the 
CMTIA duplication and the HNPP deletion. CMrlA and HNPP appear to be the result of a 
reciprocal unequal crossing over at meiosis mediated through the misalignment of 
homologous repeated sequences that are flanking the normal 1AMb monomeric region 
(Chance et al. 1994). 
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Normal CMTIA HNPP Point AI mutation fvl. 5Mb 
f-ý r""N r-ý r-'ý 
PMP22 
Fig 4.1 Diagram of the mutational mechanisms in the human PMP22 gene 
17his mutational mechanism explains the high incidence of CMTIA (and probably HNPP) in 
the population and constitutes the first example of two human disorders with a Medelian 
pattern of inheritance that are the reciprocal results of an unequal crossing-over involving 
large internal chromosomal segments. Studies in de novo CMTIA duplication patients 
suggest that this unequal crossing over event is overwhelmingly of paternal origin (Palau et 
al. 1993). Reiter et al (1996) identified a hot spot for homologous recombination within the 
CMTIA repeat sequences (Reiter et al. 1996). Sequence analysis found that these regions 
had a significant homology to an insect transposon protein (African malaria protein mariner 
transposase gpIL10440). The region is thought to be transcribed into an RNA product but 
probably not transcribed into a functional transposase and the authors suggest several ways 
in which the transposon like element could mediate an increase in homologous 
recombination between the CMTIA repetitions. The putative transposon like element from 
the CMT IA repeat sequence was used as a probe; a low level of expression was found in the 
testis but no expression was found in the ovaries (Reiter et al. 1996). This may provide and 
explanation for the predominant paternal inheritance pattern common to CMTIA and HNPP. 
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4.4 CMT1A 17P11.2-12 DUPLICATION 
Clinical presentation of patients with the 17pil. 2-12 duplication. only a 
modest percentage of patients (<10%) with RMSN I are thought to seek the help of a 
physician or neurologist, which suggests that many have few or no symptoms (Dyck et al. 
1993). 
Thomas et al. (1997) reported the clinical features of 61 patients with confirmed PW22 
duplication. Thirty four of the cases were considered to have classical CMT syndrome. 
Evidence of RMSN was initially detected within the first decade of life in 75% of patients, 
10% were noted during the second and only 7% in the thirdL The most consistent clinical 
abnormality was muscle wasting and weakness which was more prominent distally. 
Weakness in the limbs was usually associated with loss of tendon reflexes and foot 
deformity. If sensation was impaired it was distally accentuated and mild/moderately severe. 
Eight patients with confirmed 17pll. 2-12 duplication displayed a prominent upper limb 
postural tremor associated with tendon areflexia, pes cavus and variable distal weakness and 
sensory loss, features typical of Roussy-Livy syndrome. Additional features seen in 
association with classical CMT included CNS signs, associated focal peripheral nerve 
lesions, prominent muscle cramps, IgM paraproteinaernia, diabetes mellitus, parkinsonism. 
Some of these may be chance associations. Some patients with Roussy-Levy syndrome also 
had other symptoms including focal peripheral nerve lesions and hypertrophic 
cardiomyopathy. Other unusual presentations included neuropathy with prominent sensory 
loss, neuropathy with cramps, calf hypertrophy and atypical neuromyotonia. One patient was 
asymptornatic 
LeGuem et al. (1997) studied a consanguinous CMTI family with 4 affected siblings 3 of 
whom were homozygous for the 17pl 1.2-12 duplication and one who was heterozygous. The 
disease was variable among the homozygotes, one of whom was no more severely affected 
than the heterozygote. In another case an 8 year old homozygous child had a more severe 
clinical phenotype that his two beterozygote siblings but his MNCVs were in the same range 
as heterozygous CMTIA patients possibly due to his young age (Sturtz et al. 1997). Yet 
another patient carrying four copies of the PW22 gene had a severe disorder reported to 
resemble DSD (Lupski et al. 1991; Kaku et al. 1993). This suggests that the severity of the 
disease is not determined solely by the number of copies of the PMP22 gene (LeGuern et al. 
1997). 
Pathological features of patients with the 17pil. 2-12 duplication. many 
authors have descnibed pathological changes in HMSNI patients (Dyck et al. 1970; Dyck et 
al. 1968; Dyck & Lais 1970; Smith et al. 1980). As these are now known to be a 
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heterogeneous group of patients the summary of the pathology presented here will be limited 
to recent studies in which patient genotypes have been confirmed. 
Thomas et al. (1997a) examined biopsies of 10 patients with confirmed 17plI. 2-17pl2 
duplication. All showed a decrease in myelinated nerve fibre density (0.003% to 13% of 
control values). A study by Gabreals-Festen et al. (1995) also found decreased myelinated 
fibre densities, but to a lesser degree (11-50% of control values). The difference in the 
degree of density decrease had been attributed largely to the different age spectra examined 
in the two studies. The majority of the patients (90%) studied by Thomas et al. (1997) were 
over 25 y, whereas in the study by Gabr6els-Festm et al. (1995) the oldest patient examined 
was 26 y. From these two studies it appeared that the density of myelinated fibres decreased 
progressively with age. This theory is not supported by a recent study in which the density of 
myelinated fibres did not appear to differ between patients in three age groups (<15y, 16-44y 
and >45y) (Fabrizi et al. 1998). 
Density decreases can in part be attributed to the hypertrophic changes in the nerves of 
patients, fasicular areas being increased by 100400% (Gabredls-Festen et al. 1995). As 
fascicular area does not appear to change with age Gabrdels-Festen considered that this 
implied a degree of fibre loss in older patients. The data from the Fabrizi study does not 
support this (Fabrizi et al. 1998). 
Onion bulbs, typically consisting of concentrically proliferating Schwann cells surrounding a 
central myelinated axon or a cluster of regenerating axons, were reported by Thomas et al. 
(1997a) as being most evident in cases with higher myelinated fibre densities. This is in 
contrast to what was found in the younger patients where onion bulbs were found to increase 
in number with age, and decreasing myelinated fibre densities (Gabretls-Festen et al. 1995). 
In the Fabrizi study neither the myelinated fibre or onion bulb densities altered with age 
(Fabrizi et al. 1998). It is likely that the incidence of onion bulbs increases progressively 
during childhood and adolescence and later regresses. 
Changes in the thickness of the myelin sheath also appear to be age related. In the older 
patients examined by Thomas et al. (1997a) there was an increase in the proportion of thinly 
myelinated fibres when compared with controls (mean g ratio: patients =0.66, 
controls=-0.58). However g ratios in younger patients suggested thickening of the myelin 
sheath (mean g ratio: patients =0.56, controls=0.66) (GabreEls-Festen et al. 1995). An 
increase in myelin sheath thickness has previously been reported for RMSN patients 
(Nukada et al. 1983). The Fabrizi paper again differs from the other two, finding no 
difference in g ratios with age and a decrease in the percentage of demyelinated internodes 
with age (Fabrizi et al. 1998). Gabrals-Festen et al. (1995) recorded active demyelination 
during childhood, whereas this is rare in adults. 
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Motor nerve conduction velocities in the lower limbs of CMT duplication patients were 
examined by Thomas et al. (1997). When they were obtainable, velocities in the lower limbs 
had a mean value of 17 m/s. In the upper limbs this value was 19.9 m1s. Sensory nerve action 
potentials were usually absent or severely depressed. Killian et al. (1996) examined 8 
patients from a single pedigree with a proven CMTIA duplication and demonstrated that the 
MNCVs did not change appreciably over 22 years. 
Ultrastructural localisation of PMP22 in CMTIA nerves. Although CMTIA 
nerves have significantly less myelin than normal nerves PMP22 was found to be present 
within compact myelin of the remaining myelin sheaths, even those with a reduced diameter 
(Haney et al. 1996). There was no evidence suggesting that myelin in CMTIA nerves was 
abnormal in periodicity or compaction, neither was there any evidence for abnormal 
intracellular accumulations of PMP22 protein (Haney et al. 1996). Based on these 
observations, it is apparent that the CMTIA phenotype does not prevent delivery of Po or 
PMP22 to compact myelin (Haney et al. 1996). In CMTIA nerves Schwann cell processes 
surrounding or associated with unmyelinated axon bundles or collagen pockets, were also 
PMP22 positive. In CMTIA patients PMP22 immunoreactivity was associated with both the 
axonal and adaxonal Schwann cell membranes. Schwann cell membranes comprising the 
layers of the classical onion bulbs in CMTIA nerves also contain PMP22 immunoreactivity, 
mostly located near the Schwann cell plasma membrane. 
4.5 PMP22 POINT MUTATIONS IN CMTIA 
The finding of CMTlA patients with point mutations in the PMP22 gene confirmed 
evidence that PMP22 has a primary role in the CMTIA phenotype (Valentijn et al. 1992; 
Roa et al. 1993b). A common feature of PMP22 point mutations found so far in CMTIA, 
DSD, Tr, Tr-ncnp and Trj is their location in putative transmembrane domains. Because 
these domains are the most strongly conserved parts, evolutionarily, of the PMP22 protein it 
has been speculated that the membrane associated regions are significant to the proper 
function of PMP22 (Patel et al. 1992). 
The l7pl 1.2-12 duplication and point mutations in the PMP22 gene result in overlapping 
clinical and neurophysiological phenotypes, although generally the phenotype of the point 
mutations is more severe (GabreEls-Festen et al. 1995). Gabreels-Festen et al. (1995) 
compared the morphological phenotype of 12 cases of CMTIA duplication with 4 cases of 
point mutations in the PALP22 gene. Three patients from one family had the Leu 16 Pro 
substitution (as found in the TV mouse) and the other patient a Leul05 Arg substitution 
(Valentijn et al. 1992; Valentijn 1995). 
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The reduction in myelinated fibre density showed a large degree of overlap between the two 
genotypes but on average was more severe in the cases with point mutations. In duplication 
patients the density of myelinated fibres was reduced to 31% of normal values whereas in 
patients with point mutations it was reduced to only 17% of control values. Small onion 
bulbs were present in approximately 30% of the myelinated fibres in younger duplication 
patients (3-5y); this proportion increased to 90% of fibres in older patients. In cases with 
point mutations onion bulbs were abundantly present from an early age surrounding nearly 
all fibres. This is thought to indicate an early, even prenatal, demyelinating process 
(Gabredls-Festen et A 1995). In PW22 duplicated cases the mean g-ratio was significantly 
lower than normal, implying that on average the myelin sheath exceeds normal thickness, 
despite the presence of demyelinated and incompletely remyelinated fibres. In contrast the 
average g-ratio in point mutations was 0.85, which means that nearly all fibres are 
demyelinated or severely hypomyelinated in relation to axonal diameter. 
Table 4.2 Point mutations in the PMP22 gene associated with CMTIA 
Mutation First identified by Further details 
L16P (Valcntijn et al. 1992) Allelic heterogeneity was first 
noted by Hoogendijk 1993 
(Hoogendijk et al. 1993) 
Transmembrane domain I 
S79C (Roa et al. 1993b) Transmembrane domain 2 
LIOSR (Valentijn 1995) Transmembrane domain 3 
VaII07GIy (Marrosu et al. 1997) Transmembrane domain 3 
TI 18M (Roa et al. 1993a) It has recently been suggested 
(recessive) that this mutation is a 
polymorphism (Nelis et al. 1997) 
L147R (Navon et al. 1996) Transmembrane domain 4 
G to A change at the (Nelis et al. 1994) 5" splice site mutation 
first nucleot ide of 
intron 3 
Deletion of one (Ionasescu et al. Predicted to be associated with a 
nucleotide at position 1997b) frameshift mutation 
G330 
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4.6 PMP22 MUTATIONS IN DEJERINE-SOTTAS DISEASE 
Dejerine-Sottas disease (DSD; alternatively known as RMSN HI or hypertrophic neuropathy 
of infancy) is a severe infantile and childhood onset, hypertrophic demyelinatingl 
hypomyelinating neuropathy. Gabreels-Festen et al. (1994) stated that the disease was 
characterised by a chronic demyelinating motor and sensory neuropathy without CNS 
involvement, congenital or infantile onset, motor nerve conduction velocities of less am 6 
m/s in all nerves and normal parents. The clinical features of DSD overlap with severe 
CMT I A- In the Dutch kindred described by Hoogendijk et al. (1993), later found to have the 
L16P mutation (Valentijn et al. 1992ý the symptoms in most patients were severe and they 
would be given the diagnosis of HMSNIH (Tyson et al. 1997). 
As in HMSNI the DSD phenotype has recently been shown to consist of more than one 
entity. Some cases are probably nongenetic phenocopies consisting of chronic iniflammatory 
demyelinating polyneuropathy (Gabredls-Festen & GabredIs 1993). Others have been shown 
to be associated with de novo mutations of the PjW22 (Roa et al. 1993a) or Po genes 
(Hayasaka, et al. 1993b). They have been referred to as Dejerine-Sottas disease A and B 
respectively. Some authors consider it uncertain whether the DSD category should be 
retained or whether case may be better classified in terms of the specific mutation. 
Many patients with DSD appear to represent sporadic cases and were traditionally presumed 
to result from an autosomal recessive gene. Yet all the mutations studied to date have been 
present in the heterozygous state suggesting that DSD may be caused by dominantly acting 
genetic defects which are often de novo mutations. 
Molecular genetic data have made it clear that the pathogenesis of HMSN III is not distinct. 
Patients have severe peripheral neuropathy but this is not specific to any particular type of 
inherited or acquired demyelinating neuropathy (Chance & Fischbeck 1994). 
Clinical features of DSD patients with PMP22 mutations. DSD is 
characterised by generalised muscle weakness and atrophy especially in distal muscles, 
tendon areflexia and sensory loss. Typically motor development is much delayed in infancy, 
skeletal deformities including kyphoscoliosis, are common. 
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Table 4.3 Point mutations in the PMP22 gene associated with DSD 
Mutation First Identified by Further details 
H12Q (Valentijn et al. 1995) Transmembrane domain 1. 
Patient first described by 
(Ouvrier et al. 1987) case 13 
M69K (Roa et al. 1993a) Transmembrane domain 2. 
Patient described (Dyck 1966) 
PATIENT 111.2, kinship 5-13 
S72L (Roa et al. 1993a) Transmembrane domain 2. 
Different families described by 
(Ionasescu et al. 1995) and 
(Marques et al. 1998) 
Ser 72 Trp (Tyson et al. 1997) Transmembrane domain 2. 
S761 (Tyson et al. 1997) Transmembrane domain 2. 
S79C (Roa et al. 1993 b) Not thought to generate a 
CMIT IA phenotype change in secondary structure 
S79P (Bort ct al. 1998) Could act by destabilising the 
backbone torsional angles 
leading to a modification of 
structure in 2o domain. More 
aggressive phenotype than 
S79C 
L80 2 bp deletion (Ikegami et al. 1998) Altered reading frame to 
produce a 49aa longer protein 
Leu 80 Pro (Tyson et al. 1997) Transmembrane domain 2. 
Deletion of Phe 84 (Silander et al. 1998) 
GIOOR (Marques et al. 1998) Transmembrane domain 3 
G150D (Ikegami et al. 1998) Transmembrane domain 4 
point mutation (intron 2) (Muglia et al. 1998) 
Gin to Aspartic acid (Ionasescu et al. 1997a) Mother and son with the same 
nucleotide 498 of the cDNA point mutation 
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Table 4.4 Summary of the clincial features of DSD patients with PMP22 
mutations 
FIRST 
WALKED 
AREFLEXIC ATAXIC MUSCLE 
WEAKNESS 
SENSORY 
DEFICIT 
ENLARGED 
NERVES]7 
Met69Lys 15mo Yes Yes Yes Yes 
Ser72Leu 7y Yes Yes Yes 
24mo Yes Yes 
never walked 
unsupported 
Yes Yes No No 
Hisl2GIn 2y Yes Yes Yes No Yes 
Ser 76 lie 5yr Yes Yes Yes Yes 
Ser 72 Try 2y Yes Yes Yes No 
3y Yes Yes Yes No 
Ser 79 Pro not at 3y Yes Yes 
Leu 80 2bp 
deletion 
7y Yes Yes Yes 
Leu8O Pro Ily Yes Yes Yes Possible 
GIn49 sp 6y Yes Yes Yes 
Gly 150 Cys Normal Yes Yes Yes 
75 
Pathology of DSD patients with known PMP22 mutations. Morphological studies 
have been undertaken on a limited number of patients. The results are summarised below. 
Table 4.5 Summary of the pathology of DSD patients with PMP22 
mutations 
Increased 
fascicle 
area 
Decreased 
myelinated 
fibre density 
Hypomyelination Onion 
bulbs 
Largest 
fibres 
Met69Lys Yes Yes g ratio = 0.85 Yes 4pm 
Some large axons with no myelin 
His12GIn Yes Yes I g ratio = 0.85 83% 8[tm 
Normal density of unmyelinated fibres 
Ser761le Yes I I No 
Excess collagen 
Ser 72 Try Yes I Yes -- Tm-any I 
Nerve largely occupied by onion bulb formations occasionally with a 
demyelinated. or thinly myelinated. axon at their centre 
Ser 72 Leu Yes Yes 
Ser 79 Pro Yes Yes 
Evidence of segmental demyelination and remyelination 
4.7 INHERITED LIABILITY TO PRESSURE PALSIES (HNPP) 
Hereditary neuropathy with liability to pressure palsies (HNPP; also called tornaculous 
neuropathy or recurrent pressure-sensitive neuropathy) is an autosomal dominant disorder 
that produces an episodic, recurrent demyelinating neuropathy (Windebank 1993). The 
BNPP locus has been assigned to chromosome 17p 11.2-12 (Chance et al. 1993) and is 
associated with a I. SMb deletion. HNPP and CMTIA are thought to be the reciprocal 
products of unequal crossing over during meiosis. The l7p]. 1.2 duplication is the most 
common cause of HNPP. It has been detected in 13/13 Finnish, 3/3 Belgian, 7/7 French, 
15/22 Dutch and 19 British patients from 12 of 13 families in which HNPP had been 
considered the most likely diagnosis (Silander et al. 1994; Verhalle et al. 1994; LeGuern et 
al. 1994; Mariman et al. 1994b; Tyson et al. 1996). Point mutations in the PMP22 gene have 
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also been recorded. It is clear that defects in PAP22 are not exclusively responsible for 
HNPP. Linkage to 17plI. 2 has been excluded in one of the seven non deletion Dutch 
families (Mariman et al. 1994a). In one patient with typical clinical features of HNPP (Tyson 
et al. 1996) sequencing of the PW22 gene subsequently proved to be normal (Thomas et al. 
1996). 
Clinical presentation HNPP generally develops during adolescence and may cause 
attacks of numbness, muscular weakness and atrophy. Peroneal palsies, carpal tunnel 
syndrome and other entrapment neuropathies are frequent manifestations of this disorder. 
Motor and sensory nerve conduction studies usually show evidence of an underlying 
generalised neuropathy, with moderate slowing of conduction velocities and prolonged distal. 
motor and sensory latencies. Nerve biopsy specimens show segmental demyelination and 
remyelination, focal myelin thickenings (tomacula) and a variable degree of axonal loss 
(Windebank 1993; Verhagen et al. 1993). 
Pathological features of patients with HNPP. Peripheral nerve pathology has not 
been specifically reported in patients with confirmed l7pll. 2 deletions. The following 
accounts of nerve pathology may be assumed to largely, but not exclusively, pertain to 
HNPP deletion patients. 
The most distinctive feature of HNPP is the presence of sausage-shaped enlargements of the 
myelin sheath (tomacula: discussed in chapter 3.1.1) (Behse et al. 1972: Madrid & Bradley 
1975). Windebank (1993) summarised histological findings of 25 nerve biopsies (largely 
sural nerve) from HNPP patients. In 17 of them focal thickening of the myelin sheath is 
reported and although not specifically commented on, suggested in photographs of two 
others. Six cases did not show these changes but showed non-specific findings with either 
extensive loss of fibres or excessive variability in thickness and length of myelin internodes, 
suggesting recurrent demyelination and remyelination. Generally the cases where 
tomaculous changes are not found are those which have a more advanced neuropathy and the 
major changes have included extensive fibre loss or demyelination and remyelination 
(CruzMartinez et al. 1997). A teased fibre study by Behse et al. (1972) demonstrated focal 
thickenings in 12.5 to 27.5% of fibres and serial photographs suggested that the axonal area 
was reduced in these regions. Tomacula are not specific to HNPP and may be found in other 
neuropathies (Thomas et al. 1996; Windebank 1993). Nerve biopsy specimens also show 
segmental demyelination and remyelination, focal myelin thickening and a variable degree 
of axonal loss (Windebank 1993; Verhagen et al. 1993). 
In a study of six BNPP patients, both myelinated and unmyelinated fibre counts fell within 
the normal range (Behse et al. 1972). There appeared to be a relative shift to a population of 
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smaller diameter myelinated, fibres in the affected cases compared with controls. The mean g 
ratios of ten patients with HNPP were examined by Gabreels-Festen et al. (1995) and found 
to average 0.63, which is slightly but not significantly below the normal values for age 
(0.66). The presence of only one PMP22 gene copy appears sufficient for normal 
myelination formation in view of the normal g ratios (Gabreals-Festen et al. 1995). 
Table 4.6 Point mutations in the PMP22 gene associated with HNPP 
Mutation First identified by Further details 
Val 30 Met (Chen et al. 1998) 
Insertion at codon 94 (Lenssen et al. 1998) Predicted to result in an 
enlarged protein of 221 aa 
Guanosine insertion at codon (Young et al. 1997) Predicted to result in a 
94 reading frameshift and a 
delayed termination signal 
Nonsense mutation at codon (Pareyson & Taroni 1996) Predicted to result in a 
124 truncated protein 
AI nucleotide deletion in (Taroni et al. 1995) Predicted to result in a 
the Leu 145 codon premature stop codon and to 
result in a truncated protein 
2bp frameshifting deletion in (Nicholson et al. 1994) Predicted to result in a 
first exon erraturn appears in Nature truncated protein 
Genetics (1994) 7: 113 
G to T mutation in the S' (Bort et al. 1997) 
donor splice site 
4.8 EXPRESSION OF THE PMP22 GENE IN CMTl A AND HNPP 
Expression of the PMP22 gene in CNIT IA nerves has been examined by two sets of authors. 
Consistent with the overexpression of the geneYoshikawa et al (1994) reported that PAIP22 
mRNA was overexpressed in CMTIA nerves when normalised to PO mRNA levels. This is 
supported by an ultrstructural immunocytochemical study in which PMP22 levels were 
increased in CMTIA and decreased in HNPP patients when compared with controls (Vallat 
et al. 1996). In contrast, an immunochemical and reverse transcriptase polymerase chain 
reaction (RT-PCR) study of PMP22 in CMTIA nerves, reported that total PMP22 protein 
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and mRNA expression was reduced in diseased compared to normal nerves (Hanemann et al. 
1994). The apparent difference in the findings of the two studies may be related to the way 
the results were expressed. It is likely that both the PO and PMP22 levels are decreased in 
affected nerves reflecting the small amount of myelin formed, with the relative expression of 
PMP22 being higher than normal. Schenone et al. (1997) examined the sural nerves of 
HNPP deletion patients and found lowered PMP22mRNA levels. As there was no decrease 
in PO mRNA this demonstrates that decreased dosage of PMP22 is the most likely 
pathogenic mechanism in HNPP and directly related to a decrease in PMP22 gene product 
and not to the underlying demyelinating process (Schenone et al. 1997). PMP22 protein 
expression was examined relative to PO and MBP levels in CMTIA duplication and HNPP 
patients (Gabriel et al. 1997). When compared with controls PMP22 protein expression was 
increased in duplication and decreased in HNPP patients. 
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Chapter 5 Wallerian degeneration and regeneration 
5.1 WALLERIAN DEGENERATION 
The classical description of the sequence of events that occur when peripheral nerves are 
transected was made by Waller (1850). He examined and described the microscopic 
appearance of the hypoglossal and glossopharyngeal nerves of the frog following nerve 
section. 
" At the end of the third orfourth day, we detect thefirst alteration by a 
slightly turbid or coagulated appearance of the medulla (myelin sheath). 
On the tenth day and upwards ... the coagulatedparticles lose their amorphous 
structure and assume a granulated texture. About the twentieth day the 
medullaryparticles are completely reduced to a granular state .... the presence 
of the nervous element merely indicated by numerous black granules, 
generally arranged in a row like the beads of a necklace 
Waller 1850 
Many subsequent studies have documented different aspects of the breakdown of axons and 
the progressive degeneration of the myelin sheath (Ram6n y Cajal 1928; Nageotte 1932; 
Holmes & Young 1942; Lubinska 1982) which results in either fibrosis or axonal and myelin 
regeneration. 
5.2 AXONAL CHANGES 
Following crush or transection injury the first visible change in the axon is the fragmentation 
of the endoplasmic reticulum into rows of vesicles. Between 24 and 48 h neurofilaments lose 
their longitudinal orientation, undergo dissolution and are replaced by a finely granular 
material which subsequently becomes clumped, lying within a clear matrix (Vial 1958; 
Honjin et al. 1959). The triggering event for axonal degeneration appears to be an 
intracellular increase in calcium concentration. Axonal disintegration is mediated by calcium 
sensitive proteases that are intrinsic to the axon (Schlaepfer 1974; Schlaepfer 1977). After 
nerve transection, axons continue to conduct for a variable period of time depending upon 
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the length of the distal stump and the species of animals examined. (Griffin & Hoffman 
1993). In the mouse C57BL6/Ola substrain axons survive for long periods of time (over 28 
days) after nerve transection (Lunn et al. 1989). This trait is under the control of a single 
dominant gene and the responsible defect appears to lie in the in Ola axon itself. The 
breakdown of axonal integrity varies with species but corresponds with the loss of its 
capacity to generate and conduct a nerve action potential (Griffin & Hoffman 1993). 
5.3 SCHWANN CELL RESPONSES 
Changes in the myelin sheath. During the first 24 h following axotomy there are 
few visible alterations in the distal stump. There is a rapid decrease in the synthesis of 
myelin lipids (White et al. 1989) and a down regulation in the levels of myelin protein 
mRNAs (Trapp et al. 1988). The first visible sign of the onset of myelin degeneration is the 
retraction of the myelin sheath from the nodes of Ranvier and the development of a wrinkled 
outline in the myelin sheath (Webster 1965). At the Schmidt-Lanterman incisures there is a 
widening of the incisural intraperiod line gap together with a splitting of the intraperiod line 
in the myelin adjacent to the incisure. The myelin sheath then collapses into these spaces and 
is progressively broken down into smaller 'digestive chambers' or 'ellipsoids' which are 
degraded along with the remnants of the axoplasm and axolemma. This process begins in the 
Schwann cell perikaryon and in the Schmidt -Lanterman incisures; the myelin ellipsoids are 
then increasingly divided into smaller fragments and finally spherical droplets (Webster 
1965). Some of these droplets are situated within Schwann cell cytoplasm; others lie within 
the basal laminal tube (Thomas 1964). During the course of the progressive breakdown of 
myelin debris, Schwann cell processes become interlaced within the original basement 
membrane. Within two weeks of sustaining injury these processes develop cytoskeletal 
structure characterised by an increase in the number and density of intermediate filaments. 
Three weeks following injury most of the myelin in rodent nerve has been cleared. 
Following the removal of the myelin and axon debris the Schwann cell basal laminal tubes 
persist (Thomas 1964). The distal stump contains columns of Schwann cells enclosed within 
the tube of the old Schwann cell basement membrane, collectively named the bands of 
BUngner. 
Schwann cell proliferation. In normal and intact myelinated and unmyelinated fibres 
Schwann cell division is rare (Asbury 1967). Following nerve transection, while myelin 
breakdown is taking place, Schwann cells throughout the distal stump undergo a series of 
mitosies within basal laminal tubes (Abercrombie & Johnson 1946; Abercrombie et al. 1959; 
Archer & Griffin 1993; Thomas 1948). The prelude to mitosis is a phase of "hypertrophy" of 
the Schwann cell perikaryon. The perikaryon occupies the whole cross sectional area of the 
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nerve fibre, during this process the myelin sheath is divided into two halves (Stoll et al. 
1989). Division occurs longitudinally and as a result the two daughter nuclei are adjacent to 
each other encircled by their own Golgi apparatus and granular endoplasmic reticulum. With 
each subsequent division the Schwann cell nuclei become increasingly scattered throughout 
the old intemode. In contrast to Schwann cell behaviour during segmental demyelination, 
Schwann cells do not leave the basal laminal tube during Wallerian degeneration in vivo 
(Griffin & Hoffman 1993). 
During Wallerian degeneration in the sciatic nerve of the rabbit, the number of intratubal 
nuclei (Schwann cell and macrophage) increases to a maximum at around 25 d after section 
(Abercrombie & Johnson 1946). At this stage nuclei are 13.4 times more numerous than in 
uninjured nerve. This initial increase is followed by a rapid decline in numbers and by 225 
days after section the number of nuclei appears to be stable at 7.3 times basal levels. Thomas 
(1948) examined the nuclear population in the nerve to the medial head of the gastrocnemius 
muscle (ngm) which consists mainly of large fibres and compared it with the sural nerve 
which consists mostly of small fibres. The nuclear populations showed the same general 
trend with an increase in nuclei number up to 25 d and then a decline. At its maximum the 
number of intratubal nuclei in the ngm had increased to 17 times that of control values 
whereas in the sural nerve the increase was only five times. The peroneal nerve, with an 
intermediate fibre size spectrum, showed an intermediate level of nuclei increase. Thomas 
(1948) considered that there was a relation between nuclear multiplication and the amount of 
degenerating myelin in the nerve. Abercrombie et al. (1959) and colleagues examined the 
proliferation of Schwann cells in uninyelinated fibres in the abdominal vagus nerve of the 
rabbit. They found a 60% increase in nuclei number during the first 5 days after transection 
and then a decline beginning 10 days after injury. Twenty five days after nerve injury the 
numbers of Schwann cell nuclei had decreased to near normal levels. 
The stimuli for Schwann cell division in Wallerian degeneration remain to be defined. The 
onset of mitogenesis is synchronous in the Schwann cells of myelinated and umnyelinated 
fibre populations (Clemence et al. 1989; Archer & Griffin 1993) and also in several other 
cell types including fibroblasts, endothelial cells and mast cells. That the mitogenic stimulus 
affects Schwann cells of uninyelinated fibres even though their axons are intact was 
demonstrated by Archer & Griffin (1993). Transection of the L5 ventral root, which contains 
only myelinated fibres, results in wallerian degeneration of these fibres throughout the sciatic 
nerve with an associated proliferation of Schwann cells. No unmyelinated fibres are injured 
in the transection yet the Schwann cells of many of the unmyelinated fibres in the sciatic 
nerve proliferate. This observation strongly suggests that at least some of the stimuli from 
Schwann cell proliferation are diffusible. 
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Wood & Bunge (1975) first reported that when a mitotically quiescent population of 
Schwann cells was presented to neurites in vitro, the Schwann cells proliferated vigorously. 
This was corroborated with an in vivo model which demonstrated that Schwann cells in the 
reinnervated distal stump undergo mitosis coincident with the arrival of regenerating axons 
(Pellegrino & Spencer 1985). Many trophic factors that signal and/or trigger Schwann cell 
mitosis have been identified in cell culture studies. 
In mature nerve and in established co-cultures Schwann cells eventually cease to proliferate 
even in the continued presence of neurons (Salzer & Bunge 1980; Muir et al. 1990). Even 
though cultured Schwann cells can produce a number of potential autocrine mitogens 
(laminin, glial maturation factor, transforming growth factor -P) they remain virtually 
quiescent even in high cell density, long term cultures. Muir et al (1990) demonstrated that 
Schwann cells negatively regulated their own proliferation by showing that conditioned 
media from Schwann cell cultures inhibited the proliferation of mitogen-stimulated test 
cultures. 
Siironen et al. (1994) compared Schwann cell proliferation following nerve transection under 
three different conditions. The continuous presence of axons (proximal stump), loss of 
axonal contact and subsequent reirinvervation (distal stump) and after permanent loss of 
axonal contact (denervated distal stump). The extent of Schwann cell proliferation was found 
to be similar with and without axonal innervation. Siironen et al (1994) concluded that 
during the first 56 d after rat sciatic nerve section proliferation is regulated by degenerative 
or nerve trauma associated factors rather than 'regenerative mitotic factors'. 
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Table 5.1 Factors that are known to either signal or trigger Schwann cell 
mitosis 
Trophic factors 
Leukocyte derived factor 
* Growth factors 
Platelet derived growth factor 
e Glial maturation factor 
Transforming growth factors B, and B2 
Fibroblast growth factor 
(Lisak et al. 1985) 
(Davis & Stroobant 1990) 
(Yong et al. 1988) 
(Bosh et al. 1984) 
(Ridley et al. 1989) 
(Davis & Stroobant 1990) 
Factors which raise intracellular 
cAMP levels 
Cholera toxin (Muir et al. 1989) 
Forskolin (Sobue et al. 1986) 
(Stewart et al. 199 1) 
Extracellular matrix components 
Laminin (Muir et al. 1989) 
Fibronectin 
Myelin fractions/degradation products (Komiyama & Suzuki 1992) 
* Myelin fractions (Perry et al. 1987). 
Myelin degradation products (Baichwal & DeVries 1989) 
MBP processed by macrophages 
Axolemmal fragments 
Tissue culture studies (Dent et al. 1992; Ratner et al. 1985; 
Ratner et al. 1988; Sobue et al. 1984; 
Wood & Bunge 1975) 
in vivo 
tý 
(Pellegrino & Spencer 1985) 
MI 
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5.4 MACROPHAGE RESPONSE. Normal peripheral nerves contain a population of 
resident macrophages which are usually found closely associated with blood vessels. Two- 
three days after nerve in ury the number of macrophages increases dramatically although the 
resident population only responds to a limited extent (Stoll et al. 1989; Hann Bonnekoh et al. 
1989). Evidence suggests that the majority are recruited from the circulation. These 
macrophages migrate specifically to degenerating fibres and are so closely associated with 
them that they are isolated with the degenerating fibre during teasing (Stoll et al. 1989). 
Williams and Hall (1971a) identified three main cell populations within the endoneruial 
space distal to a crush site at 7d after injury: these were the original Schwann cells 
containing myelin ellipsoids, small electron dense gobules and axonal remnants. Cells 
identified as newly differentiating Schwann cells containing 'active' cytoplasm and a few 
small dense globules and globule containing macrophages. Macrophages were not implicated 
in the initial lysis of myelin but arrived when myelin breakdown was already 
microscopically evident. Degenerating myelin has been shown to be important in 
macrophage recruitment. In the Ola mouse axonal degeneration is markedly delayed, as a 
result myelin breakdown and macrophage recruitment are also delayed (Lunn et al. 1989). 
During lysophosphatidyl choline induced demyelination in the Ola mouse macrophages are 
recruited into the nerve in the absence of axonal breakdown (Hall 1993). 
The relative roles of the Schwann cell and the macrophage in the early and late catabolism of 
degenerating myelin in the INS are still controversial (Goodrum et al. 1994). Studies of 
nerve segments degenerating in situations that exclude macrophages suggest that the 
macrophage has an essential and exclusive role in myelin degradation ( Beuche & Friede 
1984; Crang & Blakemore 1986). Beuche and Friede (1984; 1986) demonstrated that 
macrophages participate in phagocytosis of large degenerating nerve fibres. When nerves 
were allowed to degenerate within millipore filters within the abdominal cavity, myelin 
debris remained for weeks as the pore sizes were to small too admit macrophages; larger 
pore sizes resulted in prompt myelin clearance. Information from morphological studies of 
cell types containing myelin debris and lipid droplets following nerve crush suggest that the 
Schwann cell is solely responsible for the absorption and degradation of degenerating myelin 
(Boyles et al. 1990). Immunochemical determination of cell types combined with 
morphology concluded that the Schwarm cell participates in the early degradation of myelin, 
but the macrophage is responsible for most of the myelin degradation in peripheral nerve 
(Stoll et al. 1989). 
Fatty acids are released during the breakdown of phospholipids which occurs in the early 
stages following nerve crush. At least a portion of the myelin cholesterol in peripheral nerve 
is also retained within the nerve following a nerve crush, and is subsequently reutilized for 
the synthesis of new myelin during regeneration of the nerve (Rawlins et al. 1970; Rawlins 
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et al. 1972). Following the distribution of radiolabelled myelin lipids using electron 
microscopy, Goodrum et al. (1994) confirmed the reutilization of myelin cholesterol by 
Schwann cells to form new myelin. However most of the myelin debris was phagocytosed by 
macrophages within 1-2 weeks following nerve injury. These debris laden macrophages 
persist within the nerve for many weeks, indicating that much of the salvaged cholesterol is 
not reutilized for myelin regeneration. 
5.5 REGENERATION. 
The growth cone, the extending terminal of the axonal sprout, represents the site at which the 
regenerating neuron meets the local environment. It expresses receptors for laminin, and 
extracellular matrix and basal lamina components (Griffin & Hoffman 1993). Following 
degeneration the original basement membrane is slowly broken down so that for a period of 
time this provides a source of laminin and other materials that are the preferred substrate for 
axonal growth (Griffin & Hoffman 1993). Schwarm cells in the BUngner bands express 
surface adhesion molecules such as Ll and NG-CAM and both NGF and NGF receptors 
(Burgoon et al. 1991; Heumann et al. 1987; Martini & Schachner 1986). This results in an 
attractive environment for invasion by regenerating sprouts and a highly favourable one for 
effective axonal elongation 
The growth cone extends highly motile spike-like processes (filopodia) as well as motile 
expansions of the membrane (lamellipodia) (Bunge et al. 1972; Yamada et al. 1971). In 
responsive neurites NGF has the direct effect of increasing the rate of outgrowth of the 
growing tip. In the absence of nerve growth factor, extension is halted and filopodia make 
exploratory movements (Griffiri & Hoffman 1993). The growth cone contains specialisations 
of the axonal cytoskeleton and the smooth membrane system with the filopodia and 
lamellpodia extending on a meshwork of actin microfilaments (Bray & Chapman 1985). 
The success of nerve regeneration after enrve transection depends largely on the axonal 
sprouts passing between the proximal and distal stumps and then reaching the appropriate 
connections to the periphery. Like any surgical wound, the intersturnp zone is characterised 
by exudation, cell proliferation and collagen synthesis. Schwann cells emerge into the gap 
from the proximal and distal stumps forming cords or columns in the gap approaching each 
other. Both matrix formation and non-neuronal cellular bridges are necessary to ensure 
axonal regeneration. Sprouts reaching a band of BUngner initially lie on the surface of the 
Schwann cells, but later become embedded in the Schwann cell cytoplasm (Allt 1976) 
Early regenerating units are structurally very similar to normal umnyelinated nerve fibres. 
The presence of reduplicated basal lamina and very small axons suggests that they are 
regenerating fibres (Griffiri & Hoffman 1993). Schwann cell mitoses are frequently 
associated with regenerating units of this type. 
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Maturation of the axonal Sprouts. Limited maturation of the axon occurs before the 
growing tip reaches an appropriate target. Schwarm cells ensheath bundles of regenerating 
axons and then develop a one-to-one relationship with those destined to become myelinated 
(Griffm & Hoffman 1993). This process recapitulates the process of segregation seen in 
development and is a necessary prelude to myelination. Nerve transplant studies demonstrate 
that the axon contains the signal for maturation into segregated and myelinated axon- 
Schwarm cell units; the regenerating sprouts of unmyelinated nerve fibres remain as typical 
unmyelinated nerve fibres (Aguayo et al. 1976a; Weinberg & Spencer 1976). The onset of 
myelination of regenerating sprouts results in an increase in axonal calibre with associated 
changes in the cytoskeleton (Windebank et al. 1985). The thickness of the myelin sheath of 
regenerating sprouts rarely reaches that of the parent axons, even though axonal calibre may 
approach that of the parent. This is related to the reduced intemodal length of regenerated 
fibres (see section 5.6). 
5.6 MYELIN SHEATH REMODELLING IN REGENERATED NERVE. 
In normal nerves, the internodal length increases regularly with fibre diameter (Hildebrand et 
al. 1994). This pattern is the combined result of the initial Schwann cell length, the 
elongation of the nerve related to body growth following the initiation of myelination and, in 
some nerves, myelin sheath remodelling. The largest fibres are the first to myelinate and thus 
are subject to the greatest elongation during growth (Jacobs & Cavanagh 1969; Harel et al. 
1989). In regeneration following crush injury in an adult animal, myelination occurs without 
the intemodal elongation since no growth in length is occuff ing in that part of the body. 
Regenerated mammalian myelinated fibres do not recover the normal linear relationship 
between length and diameter (Hiscoe 1947; Vizoso & Young 1948; Cragg & Thomas 1964; 
Ghabriel & Allt 1977). Since post-crush regenerated nerves in adult animals do not grow in 
length, it has been assumed that the nodal spacing in regenerated mammalian nerve (approx 
300pm) reflects the basic Schwann cell length at the onset of myelination (Hiscoe 1947). 
The large surplus of Schwann cells in regenerated nerve together with the lack of length 
growth explains why the internodes which first form along regenerated axons are so short. 
Friede and coworkers (Friede & Bischhausen 1980; Friede et al. 1981; Friede & Bischhausen 
1982) have suggested that in some fashion the Schwann cell responds to intemodal distance 
as well as to axonal calibre in determining number of myelin lamellae and total myelin 
volume. They postulate that the failure of myelin sheaths to obtain their original UD ratio 
reflects the shorter intemodal distances present in regenerating fibres. 
Fewer very short intemodcs are noted after long periods of regeneration. The greater 
intemodal length variation at early stages was thought to suggest the disappearance of some 
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short sheaths through their fusion into longer ones (Vizoso & Young 1948). In regenerating 
rat nerve the total number of Schwann cells associated with myelinated axons decreases 
dramatically 2-12 months after surgery, long after the cessation of active regeneration. There 
is no corresponding drop in the number of myelinated axons. LugnegArd et al. 1984) 
calculated that one third of the myelin-related Schwarm cells present at two months have 
disappeared by one year. Schwarm cell competition for longitudinal axonal space results in 
elimination of some internodes in regenerated rat sciatic nerve (Hildebrand et al. 1994). The 
process of elimination includes internodal shortening and nodal migration, myelin sheath 
breakdown and demyelination, elimination of redundant Schwann cells and nodal fusion 
(Hildebrand et al. 1985; Hildebrand et al. 1986). The eventual fate of the eliminated 
Schwarm cells in regenerated nerves is unknown. They might join the pool of endoneurial 
Schwann cells without axonal contact (Hildebrand et al. 1994). The occasional presence of 
necrotic cells suggests that some of the eliminated Schwann cells die (Spencer & Weinberg 
1978; Hildebrand et al. 1986). 
5.7 EXPERIMENTAL DEMYELINATION AND REMYELINATION. 
In the peripheral nervous system, experimental demyelination is usually followed by a 
period of remyelination. It has been suggested that there are two mechanisms by which 
repair of damaged paranodal regions occurs (Cavanagh & Jacobs 1964; Jacobs 1967). If the 
damaged region exceeds 15 pm in length, a new Schwann cell is inserted into the gap and 
forms a short intercalated segment. These segments vary in length but are never shorter than 
15 pm. This is thought to be associated with the formation of new myelin internodes where 
nodes and paranodal regions have been extensively damaged. If the widening of the nodal 
gap was less than 15[im, the original damaged Schwann cell is thought to reconstruct the 
damaged myelin and the node of Ranvier. 
Most internodes in remyelinating regions exhibit morphological characteristics similar to 
those described in newly myelinating fibres (Allt 1969b). The cytoplasm in the nuclear 
region of the regenerating Schwann cell 22 d, after the injection of diptheria toxin, contains 
abundant ER, ribosomes, mitochondria and Golgi apparatus, similar to that seen in the 
immature rat (Allt 1969b; Allt & Cavanagh 1969). The initial stage of remyelination is 
represented by loose lamellae with Schwann cell cytoplasm between them (Allt 1969a). As 
more lamellae are laid down compaction begins to occur in the outer lamellae. When the 
sheath is compact it has the same spacing and appearance as normal adult myelin (Allt 
1969a). 
The regenerating node of Ranvier has the same shape as the developing node in the 
immature rat (Allt 1969a). Paranodal bulbs of the axon and nodal constriction of the axon are 
slight or absent. The nodal axoplasm generally does not show an increased electron density 
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compared with the internode as it does in a mature node. Myelin lamellae terminate in the 
same was as they do in the developing node, lamellae separate from each other and open out 
into a loop containing Schwann cell cytoplasm. All loops reach the axolemma presenting a 
longitudinal series, unlike the situation seen in the adult node where many loops fail to meet 
the axolemma and instead form a "herringbone" configuration. Adjacent Schwann cells may 
simply abut or overlap at the node (Alit 1969a) each of these parallels the situation in normal 
development (Alit 1969b). This can be interpreted in terms of the establishment of a whole 
new internodal segment by a Schwann cell laying down myelin de novo onto a denuded 
axon. The second type of nodal regeneration occurs when a nodal gap has not been grossly 
widened. It seems to be that the original internodal length and contact with the adjacent cell 
has been re-established by the superimposition of new myelin lamellae on the withdrawn 
sheath. 
5.8 ABNORMAL REMYELINATION 
In a proportion of fibres remyelination does not proceed as in development but shows 
abnormal features (Geren 1954, Alit 1972, Ballin & Thomas 1969). 
Attenuation of the normal paranodal myelin sheath. In some cases the whole 
thickness ofthe sheath does not round oil' into a typical paranodal bulb. Small groups of 5-6 
lamellae peel off from the main sheath, indistinguishable from those associated with a 
normal paranode. The rest of the sheath continues, much thinned, along the fibre for a further 
20- 30[im finally forming a new paranodal bulb (Hall 1973; King et al. 1975). 
AXON 
Fig 5.1 Diagramatic representation of attenuation of the normal 
paranodal myelin sheath 
Pseudonodes Pseudonodes closely resemble nodes of Ranvier in some aspects of their 
basic organisation. They have two groups of apposing Schwarm cell cytoplasm filled loops, 
separated by Schwarm cell cytoplasm continuous with that in the loops (King et al. 1975: 
Hall 1973). Pseudonodes are often asymmetrical with differences in the thickness of the 
internodal myelin sheaths on either side of the pseudonode. When myelin lamellae terminate 
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at an insisure, the axolemma in contact with the terminal loops of the lamellae may be 
specialised in the same manner as the nodes of Ranvier (Hall 1973). As the remyelinating 
sheath increases in thickness continuity is established between the two sides of the 
pseudonode. At this stage it is not unusual to find Schmidt-Lanterman insisures in which the 
innermost lamellae terminate at the axolemma in node-like loops. These features disappear 
as remyelination progresses suggesting that the cytoplasmic processes are withdrawn as 
remyelination proceeds and/or incorporated into a remodelled sheath (Hall 1973). 
AXON 
Fig 5.2 Diagramatic representation of a pseudonode 
Overriding The overriding by a Schwarm cell in contact with an axon may occur over an 
adjacent Sch, ýNann cell in contact with the same axon. The outer Schwarm cell could produce 
myelin around the inner cell which itself may have already myelinated the axon (Ballin & 
Thomas 1969, Hall 1973) 
AXCIN 
Fig 5.3 Diagramatic representation of overriding 
Tunication Raine et al. (1969) described a mechanism of early remyelination in which an 
axon is enveloped by several Schwarm cell processes which appose to form new myelin. The 
number of lamellae vary in number around the axon circumference. At a later stage of 
remyelination only one Schwann cell process surrounds the axon and the myelin sheath is 
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uniform in thickness. In remyelinated internodes following EAN 29% of axons were 
surrounded by more than one Schwann cell process (Alit 1972). The processes were closely 
apposed to each other giving the appearance of multiple mesaxons which were not seen 
when the myelin sheath consisted of more than 5-6 lamellae. It is thought to be most likely 
that the overlapping processes are all derived from the same Schwann cell (Hall 1973). 
These 'supernumerary' processes were frequently seen within the confines of the original 
basement membrane. Occasionally they assumed the concentric array characteristic of 'onion 
bulbs' (Ballin & Thomas 1969; Alit 1972). 
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Fig 5.4 Diagrammatic representation of myelination by tunication 
Other abnormal features include short apparently normally myelinated internodes in 
continuity with remyelinating internodes; proximally and distally. The paranodal bulbs of the 
internode with normal myelin thickness show considerable infolding and occasional 
osmiophillic globules within the Schwann cell cytoplasm (Hall 1973). Irregularities of the 
myelin sheath thickness along the remyelinating intemode particularly near the Schwann cell 
nucleus are seen (Hall 1973). Node-like discontinuities in the remyelinating sheath are 
frequently observed in perinuclear regions (Hall 1973). 
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5.9 MULTIPLE EPISODES OF DEMYELINATION 
The most prominent finding in nerves that have undergone episodes of multiple injury is an 
increased number of Schwann cells (Hall 1984; Ohara & Ikuta 1988; Thomas 1970). Ohara 
and Ikuta (1988) studied the effects of multiple crush injuries on the phrenic nerve of young 
adult mice. The number of Schwann cell nuclei (SCN) increased with each successive crush 
reaching 10- 1 5x their normal value after 4 successive crushes on the same site. In all crushes 
70-80% of the Schwann cell nuclei were supernumerary and most of these were found as 
part of onion-bulb formations. Basal laminal onion bulbs were also seen. 
Thomas (1970) examined multiple crush injury (up to 9X) in the peroneal nerve of rabbits 
and also found a progressive increase in the numbers of SCN with successive crushes. In 
contrast to Ohara and Ikuta's study, Thomas found that 'clusters' of Schwann cells formed 
longitudinal columns in the nerve and did not form 'onion bulbs'. 
Hall (1984) looked at the effect of multiple intraneural injections of lysophosphatidy1choline 
(LPQ in adult mouse tibial nerve. Following intraneural injections of LPC the myelin sheath 
undergoes a characteristic progressive vesicular breakdown, while the axon and the Schwann 
cell apparently remain undamaged (Hall & Gregson 1971). In singly injected nerves a 
moderate proliferation of Schwarin cells is seen (60% of which are supernumerary Schwann 
cells (SSC)). These SSC progressively disappeared and by 240 days many remyelinated 
axons were found surrounded by empty basal laminal tubes, or by double or single fragments 
of basal lamina (Hall 1973). Following multiple LPC injections the pattern of myelin 
breakdown was essentially similar to that seen in single injected nerves but the time course 
differed. The early phases of repair, from the initiation of myelinolysis to the appearance of 
promyelinated fibres, were achieved more rapidly in multiple injected nerves. During days 5- 
10 post injection this early lead was reversed. The majority of axons in 8X injected nerves 
were still either promyelinated or associated with debris laden cells, presumably Schwann 
cells, within the basal lamina. During the first three days post injection most SSC within the 
lesion had disappeared, although their basal laminae remained in close association with the 
demyelinating axons. This is interesting in view of the assumption that repeated episodes of 
demyelination and remyelination will produce layers of Schwann cell cytoplasm around the 
axon in the form of onion bulbs, and may explain why onion bulbs were not seen in this 
study. 
The effects of the initial demyelination produced by LPC were exacerbated in multiple 
injected nerves by a local, self limiting, immune mediated demyelination. The presence of 
macrophages; in these lesions suggests that either the cells or some factors released by them 
may play a role in initiating myelin damage. Compartmentalisation of the endoneurium by 
fine cytoplasmic processes of perineurial cells was a feature of multiple injected nerve (Hall 
1984; Hall 1983). It occurred in some nerves injected 4 times and in most injected 8 times. 
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The cytoplasmic processes frequently enclosed axons, either singly or in small groups of two 
or three. 
93 
Chapter 6 Materials and Methods 
6.1 THE BREEDING COLONY 
Proven breeding pairs of Trembler-J mice were imported from Jackson laboratories (USA). 
The semidominant Trj gene was maintained in animals of the C57BL/6 strain and was linked 
to a rex (Re) coat marker. Both heterozygous and homozygous Re animals should have curly 
whiskers and a wavy coat (Carter 195 1; Crew & Auerbach 193 9). The waviness of the coat 
disappears in adults, but the vibrissae and guard hairs remain curly (Carter 1951; Crew & 
Auerbach 1939). The Re gene is a dominant and is located on chromosome 11. It is known to 
be 23 recombination units away from the Tr gene on linkage group five (Falconer & Sobey 
1953). Falconer (1953) estimated that 15% of animals with the Re phenotype would not be 
affected. This was confirmed by Low (1976b) who found that 15% of animals that were 
phenotypically Re at birth were subsequently found not to be carrying the Tr mutation. 
Specific linkage data for the Trj is not available but as the mutation is located on the same 
gene as Tr we have assumed that these figures also apply to Trý. The Re gene should allow 
recognition of animals carrying the TV gene; this was intended to be used before the, clinical 
syndrome become apparent. 
Six heterozygote Trjl+ breeding pairs were imported. One affected female died before 
leaving quarantine. The five remaining pairs were transferred to the RFHSM animal facility. 
Two of the pairs failed to produce any progeny. The remaining three pairs produced ten, five 
and two offspring each. The colony was maintained for 4-6 generations on the basis of the 
Re coat marker. We were unable to identify curly whiskers in any of the Re animals. 
DNA analysis using PCR was established to determine the genotype of animals in the early 
postnatal stages of development. Initially P7-Pl0 animals from RelRe matings were 
processed for microscopy and tissue taken for DNA analysis. Of the 27 animals examined 
none were found to be carrying the Trj gene. We then performed DNA analysis on a further 
41 Re progeny from 16 breeding pairs, only 4 animals were carrying the TI gene. At this 
stage the use of the Re marker was abandoned and the breeding colony maintained using 
animals unequivocally showing clinical symptoms at 8 wk of age. 
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Breeding statistics were compared for TI and C57BL/6 colonies maintained in the same 
facility. In breeding pairs where one of the parents was Tr*ll+, significantly fewer litters were 
produced per pair than in the control colony. Neither the mean litter size (n) or the proportion 
of progeny weaned differed between Till and control colonies. 
Table 6.1 Comparison of the breeding success of T? compared with C57BL/6 
colonies 
Lifter number Mean lifter size Progeny 
pair 
per Weaning 
success 
C57BU6 
II pairs 6.0 ± 0.45 7.8 0.38 47.0 ± 4.6 81.9% ± 4.7% 
TrJ 
39 pairs 3.3 ±0.31 6.8 0.26 22.7 ±2.3 73.5%±3.2% 
p value P<0.001 NS P<0.001 NS 
(Mean ± SEM) Mann-Whitney U test 
Breeding pairs containing affected TV males were compared with those containing affected 
females. There was no difference in litter number, size of litter or weaning success indicating 
that either of the two breeding strategies was equally viable. This differs from that found in 
the Tr mouse (Henry & Sidman 1988). Henry (1988) found that Tr /+ and TrITr females 
mated and bore progeny easily, but males of both genotypes mated poorly. 
Table 6.2 Comparison of the breeding success with sex of the affected parent 
Lifter number Progeny per pair Weaning success 
TO affected female 
19 pairs 3.8 ± 0.42 26.2 ± 3.2 72.9%±3.8% 
TrJ affected male 
20 pairs 2.9 ± 0.40 19.4 ±3.3 66.4%±7.2% 
p value NS NS NS 
Mean ± STD Mann-Whitney U test 
To ensure the continuance of the Trj line 20 breeding pairs were maintained. Animals clearly 
affected at 8 Wk of age usually became severely affected by 3 mo . The overall clinical 
severity of the Tr" disorder in the colony then increased to a point where many 8 wk old 
animals were to severely affected to be used for breeding. This combined with the small 
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number of litters from Trj pairs has resulted in a larger number of breeding pairs than usual 
being kept to ensure the continuation of the gene in the colony. 
6.2 MICROSCOPY 
Perfusion fixation. Animals were perfused with fixative while under deep anaesthesia 
(Sagatal 18 mg/animal). The thorax was opened and a butterfly needle attached to a cannula 
inserted into the left ventricle of the heart. The right atrium was incised and blood washed 
out with IN saline at 370C. This was followed by perfusion with 1% paraformaldehyde 
(BDH) and 1% glutaraldehyde in 0. IM PIPES (piperazine-NN'-bis-[2-ethanesulfonic acid]) 
buffer (pH 7.4), initially at 370C and then at room temperature. The sciatic nerves were 
removed and laid on pieces of card which were then placed in fresh fixative for I h. The 
vertebral column was removed and immersion fixed for I h, it was then opened to expose the 
spinal cord, nerve roots and ganglion and fixed for a further I h. The dorsal and ventral roots 
were excised together with the dorsal root ganglia. The lumbosacral spinal cord was also 
removed. 
In situ fixation. Early postnatal animals (<P15) and transgenic animals were not perfused. 
The sciatic nerve and spinal cord were fixed in situ for at least 15 min and then were 
removed and immersion fixed for a minimum of Ih before dissection. The vertebral column 
was opened to expose the spinal roots and ganglia to the fixative. 
Processing 
All tissue was then fixed for a finther 2 h, washed in PIPES buffer plus 2% sucrose and then 
postfixed in 1% osmium tetroxide in PIPES buffer with 2% sucrose, 3% sodium iodate and 
1.5% potassium ferricyanide. The specimens were dehydrated in increasing concentrations 
of ethanol (15% 2X 5min, 30% 2X 10min, 50% 2X 15min, 70% 2X 30 min, 100% 3X 20 
min followed by 2X 60 min) and transferred to epoxy resin via 1,2 epoxypropane as an 
intermediary (2 X 15 min propylene oxide, 60 min 1: 1 resin/ propylene oxide mixture, 
overnight 3: 1 resin/ propylene oxide mixture). The following day samples were transferred 
to 100% resin for 24 h and then embedded or stored at -20'C and embedded at a later date. 
Tissue staining 
Semithin sections were cut and stained with thionin and counterstained with acridine orange. 
Thin sections (yellow to gold inference pattern) were stained with 0.25% lead citrate (BDH 
Chemicals Ltd, Poole, UK) and counterstained with a saturated solution of uranyl acetate 
(Agar Scientific Ltd, Stanstead, UK) dissolved in 50% methyl alcohol (BDH Laboratory 
Supplies, Poole, UK). 
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6.3 MORPHOMETRY 
Measurements of axon diameter, total fibre diameter and g ratio (axon diameter/ total fibre 
diameter) were confined to fibres with a one-to-one axon/Schwann cell relationship; these 
included amyelinate or demyelinated fibres. The numbers of Schwann cell nuclei in each 
section was counted and supernumerary Schwann cells recorded separately. All 
measurements were taken from whole fascicles viewed with a XIOO objective and a XI. 2 
optivar on a Zeiss Axioplan microscope (Zeiss UK Ltd, Welwyn Garden City, Herts, UK) 
connected on-line through a television camera to a Kontron IBAS AT image analyser 
(Imaging Associates, Thame, UK). Many fibres in T? -J and C22 animals had myelin that was 
too thin to be identified (less than 5 myelin lamellae) at the light microscope level. In these 
cases the axon was measured and the fibres assigned ag ratio of 1. The proportion of fibres 
incompletely surrounded by Schwarm cell cytoplasm was counted in non overlapping 
electron micrographs. At least 200 fibres from each dorsal and ventral root were counted. 
Sections were taken from pairs of dorsal and ventral roots immediately proximal to the 
dorsal root ganglia. 
6.4 CRUSH INJURY 
Animals were anaesthetised with 0.2 ml of Sagatal (6mg/ml) and maintained under 
Halothane vapour. While this was satisfactory for control animals it proved to be fatal to 
many affected Trj animals and was discontinued in favour of Halothane alone. The sciatic 
nerve was exposed at the upper thigh and traced upwards to the sciatic notch and crushed 
using No 7 curved forceps. Pressure was applied until the contents of the perineurium could 
be seen to be separated with care being taken not to transect the perineurium itself The 
wound was then closed with Mitchell clips, sprayed with Op site and the animal taken to the 
recovejy room. 
6.5 DNA ANALYSIS 
Extraction. DNA was extracted from heart muscle and purified using a phenol/chloroform 
extraction method modified from Blin and Safford (1976). Tissue was taken, placed in liquid 
nitrogen and stored at -70 T until use. The sample was placed on a cleaned glass slide and 
cut with a scalpel blade until it was a pulpy consistency. It was then transferred to a 
glass/teflon homogeniser and 2 ml of extraction buffer was added (75mM NaCl, 5OmM 
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EDTA (K+) ) and homogenised until no pieces of tissue were visible (at least 20X). The 
homogenate was transferred to a sterile test tube where filter sterilised SDS (final 
concentration 0.5%) and proteinase K (final concentration 2mg/ml) were added. The mixture 
was incubated at 56 T while shaking (150 rpm) for 3 h. A fin-ther 2 mg/ml of proteinase K 
was added, the temperature lowered to 37.5C and the digestion continued overnight. The 
following day an equal volume of TE saturated phenol was added to the sample which was 
mixed for 20 min on a whirly wheel. The suspension was then spun at 4000 rpm in a 
Beckmann GPR centrifuge. The aqueous phase was withdrawn with a sterile plastic pipette, 
with care taken not to disturb the interface layer, and transferred to new sterile tube. This 
process was repeated three times. To the final aqueous phase and equal volume of a 25: 1 
Chloroform/isopropanol mixture was added and mixed on the whirly wheel for 5 min then 
spun for 20 min at 4000 rpm and the upper phase removed to a sterile tube. To each ml of the 
upper phase 100 gl of 3M sodium acetate and 2 ml of ice cold 100 % ethanol was added and 
the mix placed at -70'C for at least 2h. The tubes were spun at 10000 rpm for 20 min, the 
ethanol tipped off and the pellet rinsed with cold 70% ethanol and left to dry. Once all the 
ethanol had evaporated the pellet was resuspended in 200 pl of TE buffer and left for a least 
3h to dissolve. An aliquot was then used for spectrophotometry and the concentration and 
purity of the DNA determined (Harris 1987). 
Polymerase Chain Reaction (PCR) Specific segments of DNA were amplified using 
the polymerase chain reaction (PCR) (Mullis et al. 1986; Mullis & Faloona, 1987). The PCR 
reaction was performed in a 50 gI reaction volume under the following conditions. IgI of 
DNA lOOng/gl was added to a PCR mixture containing 50 mM KCI, 10 mm Tris HCI (PH 
9.0), 0.1% Triton-X 100,0.32 mM of each ATC and G dNTP, 1.5 mM MgC12,0.2RM of 
upstream primer TrJU5 and 0.2 ItM of the downstream primer TrJUIThe reaction mixture 
was overlayed with 80gl of sterile liquid parafm oil and placed in a Hybaid Tm TR2 thermal 
reactor (Hybaid Ltd, Teddington, UK) for the following reaction cycle. 94T for 4 min, 72T 
for 30 sec; at this stage the reaction was paused and 1.25 Units of Taq DNA polymerase, 
(Promega, UK Ltd, Southampton, UK) added then restarted. 94*C 30 s, 55T for I min, 72T 
for 40 s for thirty cycles followed by an extension period of 10 min at 72T . 
Table 6.3 Primer sequences used for DNA analysis 
TrJU5 5'-GAT CCC GAG CCC AAC TC-3' 
TrJU3 5'-CTG ACG GTG GAG AC-3' 
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Analysis. 15gl of the reaction product was restricted with 4 units of Ban I (Stratagene Ltd, 
Cambridge, UK) in the reaction buffer supplied at 37.5 T overnight and then run on a 2% 
agarose gel. The total PCR product was 103 bp in length; the mutated allele is visualised by 
the appearance of 70bp and 33 bp fragments. 
Ban I Recognition sequences 5'G/GPyPuCC3' and 3'CCPuPyG/G5' 
The primers were tested using mouse PMP22 cDNA (a gift from Prof. Dr. U. Suter) to 
confirm that they were amplifying the correct sequence. 
6.6 mRNA ANALYSIS 
Animals were killed by exposure to an increasing concentration of C02, death was conf Irmed 
by cervical dislocation. The sciatic nerve was exposed from the bifurcation of the tibial and 
peroneal branches to above the sciatic notch, quickly excised and placed into a liquid 
nitrogen filled petri dish which was placed in a tray of ice. The nerves were then cut into at 
least two pieces each and placed in a liquid nitrogen filled cryotube and stored in liquid 
nitrogen until use. 
rnRNA extraction. mRNA was extracted using the Micro-FastTrack TM mRNA isolation 
kit ( Invitrogen BV, De Schelp, Netherlands). Samples were tipped from the cryotubes into a 
glass homogenising tube quickly covered with Iml of lysis buffer (Iml of Stock buffer and 
20 gl of Protein/RNase degrader) and homogenised until no pieces of tissue were visible 
(approx. 20 X). This mixture was transferred to a 1.5ml eppendorf tube and the process 
continued according to the manufacturers instructions. In brief, the kit utilises a detergent 
based lysis step followed by binding of mRNA to oligo dT cellulose, a low salt wash to 
reduce the amount of rRNA , and the elution of mRNA. The mRNA pellet was resuspended 
in 5 gl of elution buffer and immediately following determination of mRNA concentration 
(DNA Dipsticks), used for first strand cDNA synthesis. 
First strand cDNA synthesis. First strand cDNA was synthesised using, cDNA cycle kit 
( Invitrogen BV, De Schelp, Netherlands). mRNA was reverse transcribed using oligo dT 
primer and AMV reverse transcriptase and then purified with a phenol extraction and ethanol 
precipitation prior to freezing at -70*C until use. 
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PCR and analysis. Control and Ter smples were paired and the cDNA concentrations 
adjusted until they were identical (3-5 jig/reaction). Aliquots of the PCR mixture containing 
the downstream primer, cDNA and 32p were split between two tubes containing alternative 
upstream primers. PCR was performed in a reaction volume of 20ýLl, with final 
concentrations of 10 mM Tris-HCI pH 8.3,50 mM KCI, 1.5 mM MgC12,0.001% gelatin, 0.1 
mM each of dNTPs, 0.2 PCi of [a 32p] dCTP (1000 Ci/mM ), 1.2 units of AmpliTaq Gold Tm 
(Perkin Elmer), 0.32 tLM of the downstream primer and 0.32 ILM of either the myelin 
associated (CD25) or the growth arrest related (SR13) upstream primers. The sequence for 
the different 5' regions was taken from the published mouse SR13 sequence. Primers 
specific for the SR13 (growth arrest specific) (Manfloletti et al. 1990) transcript produce a 
486 bp reaction product whereas those for the myelin related CD25 transcript produce a 524 
bp fragment. The CD25 S' region is not specifically published for the mouse gene so the 
published sequence of the rat transcript was used (Bosse et al. 1994). Primers sequences for 
the house keeping gene hypoxanthine-guanine phosphoribosyl transferase (BPRT) were used 
in addition to amplifying both PMP22 trancripts. BPRT is a salvage enzyme in the 
nucleotide metabolic pathway. cDNA would be expected to amplify in any peripheral nerve 
sample providing a marker of mRNA/cDNA viability. 
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Table 6.4 Primer sequences used for mRNA analysis 
Downstream primer 5' GTGTCTCACTGTGTAGGCCGCTGCACT3' 
I 
Myelin associated 5' AGC AGC AGA GCT CCG AGT CTG GTC TGC TGT 3' 
(CD25) 
Growth arrest related 5' GGG GGA AGC CAG CAA CCT AGA GGA CGC 3' 
(SR13) I 
HPRT 5' CAT GAA TTC TrA TGC TGA GGA TTT GGA AAG GGT G 3' 
F 
1 
CAT AAG CTT AAG TCT GCA TTG TTT TGC CAG TGT G 3' 1 
PCR was performed for I cycle of 12 min at 95"C followed by 27 cycles of 20 s at 96*C, I 
min at 57 *C, 2 min at 72 OC, and a final 10 min extension at 720C. A 10 jil aliquot of the 
reaction product was run on an 1.6% agarose gel which was dried and the amount of 
incorporated radioactivity quantified on a phosphoimager. 
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Chapter 7 Results 
7.1 ADULT TREMBLER-J 
7.1.1. CLINICAL FEATURES. Affected TY-j animals developed a neuropathy that could be 
detected in the most severely affected animals at between 4 and 6 wk of age. The disorder 
primarily affected the hind limbs, resulting in an abnormal gait with splaying of the hind 
limbs, muscle wasting and weakness. Severity varied within a litter but breeding pairs which 
produced severely affected offspring did so consistently. Clinical phenotype was not seen in 
some mildly affected animals until several months of age and often worsened in females 
after giving birth. 'Convulsions', which were described as a feature in the Tr mouse 
(Braverman 1953), were not observed. 
7.1.2 MORPHOLOGY The sciatic nerve, dorsal and ventral roots and dorsal root ganglia 
were examined by light and electron microscopy in adult animals. The most obvious features 
of Trj nerves were a lack of myelin and an increased number of Schwann cell nuclei, as 
previously reported for both the Till and Tr (Ayers & Anderson 1973; Henry et al. 1983; 
Low & McLeod 1975; Aguayo et al. 1977; Perkins et al. 1981a). Myelination was most 
severely affected in the ventral roots and both posterior and anterior roots were more 
severely affected than the sciatic nerve (Fig 7.1. a-e. ). Only minor structural changes were 
seen in the dorsal root ganglion cells. There was no evidence of active demyelination at any 
of the sites sampled and Schwann cell mitoses were not encountered. 
In the spinal roots examined, myelin was very thin and in many fibres consisted of only I or 
2 turns. Myelin was frequently uncompacted, especially near the nodes of Ranvier. The 
nodes of Ranvier were often widened similar to those seen during development. Sections of 
severely affected roots showed axons incompletely surrounded by Schwann cell cytoplasm 
ffig7.2a. ). The proportion of such fibres was not significantly different between the dorsal 
and ventral roots (Table 7.1). 
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Figure 7.1. 
Electronmicrographs from the spinal roots and sciatic nerves of 3 mo Tt-j and 
control mice 
(a, c, e) Electron micrographs from the same 3 mo TrIj mouse. (a) Ventral root. Axons of a 
size that would normally be myelinated are completely devoid of myelin (open arrows). 
Others are surrounded by myelin which is inappropriately thin for the size of the axon. 
Where myelin is present it is commonly uncompacted (filled arrows). (c) Dorsal root. Fibres 
are surrounded by more myelin than those in the ventral root. Myelin is uncompacted (filled 
arrows). (e) Sciatic nerve. Many thinly myelinated fibres, occasionally with uncompacted 
myelin (filled arrow) 
(b, d, f) Electron micrographs from the same 3 mo, control mouse. (b) Ventral root. (d) 
Dorsal root. (f) Sciatic nerve. 
Scale Bar, 10 ýtrn (applies to all panels) 
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Figure 7.2. 
Abnormal features found in the sciatic nerve of a 12mo T? animal 
(a) Dorsal root of a3 mo Tr' animal. Maný' fibres are incompleteIN surrounded bN Schý%ann 
cell cytoplasm, (arrows). Scale bar, I ýim. (b) Dorsal root of a3 mo Te, animal. Schwann cell 
processes project into the endoneurium (open arrow). Paired redundant basement membrane 
(filled arrows), one with a small amount of remaining cytoplasm, are considered to be 
indicative of the Schwann cell extending processes and then withdrawing them. Scale bar, I 
ýIrn 
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TABLE 7.1. Proportion of fibres incompletely surrounded by Schwann cell 
cytoplasm in the spinal roots of adult T? mice 
Proportion of incompletely surrounded fibres 
Dorsal root (n=4) 29.0 %± 1.7% 
Ventral root (n=4) 24.5% ± 3.4% 
p value Mann-Whitney U 0.49 
Mean ± SEM 
Supernumerary Schwann cells unassociated with axons were not seen and concentric 
Schwann cell proliferation producing 'classical' onion bulbs was not evident. Instead many 
'basal larninal onion bulbs' consisting of concentric or sectorial arrays of cell processes were 
frequently seen (Fig 7.2b, 7.3a). These were much more prominent in the sciatic nerve than 
in either of the nerve roots and consisted of many more layers. 
Several previously unreported abnormalities for the Te' mouse were observed. Schwarm cell 
nuclei were often not located at the centre of the internode as is usually the case but were 
found very close to one end of the internode, often over the terminal loops (Fig. 7.3c, d). The 
incidence of this increased with the severity of the neuropathy. Their nuclei had abnormally 
rounded profiles. Exuberant protrusions of Schwarm cell cytoplasm into the endoneurium 
was also a feature of the TY' animals (Fig 7.2b). The cytoplasm of Schwann cells in Te' 
animals tended to be concentrated in the perinuclear region with an attenuated layer 
extending on either side towards the nodes of Ranvier. Terminal loops of the myelin sheaths 
were occasionally found turning outwards into the extracellular space instead of terminating 
on the axon (Fig. 7.3b). 
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Figure 7.3. 
Electron micrographs from the sciatic nerve of a 12 mo Trý animal. (a) Fibres encircled 
by layers of redundant basal lamina Scale bar, I ýLrn. (b) Terminal myelin loops turning 
outwards from the axon (arrow). Scale bar 2 ýtm. (c) Schwann cell nuclei placed at the ends 
of the internode, close to the nodes of Ranvier (arrows). Scale bar 5 ýLrn. (d) Nucleus located 
over a node of Ranvier (arrow). Scale bar I 4m. 
ftkký 
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7.1.3. MORPHOMETRY 
Myelin thickness. Many axons in Tr" animals were either devoid of myelin or surrounded 
by myelin too thin to be measured at the light microscopic level (20% in the sciatic nerve 
increasing to 60% in the ventral root) (Fig7.4). In 12 m old animals myelination was most 
affected in the ventral root where 60-65% of fibres had myelin that was considered too thin to 
quantify accurately (less than 5 turns of myelin). The dorsal roots were significantly less 
affected than the ventral with only 40-50% of fibres falling into this category (P<0.01). The 
sciatic nerve was less affected than either of the spinal roots, only 20% of fibres were severely 
dysmyelinated. The dorsal/ventral root difference was not significant in the 3 mo animals. 
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Figure 7.4. The proportion of fibres lacking measurable myelin in the spinal 
roots and sciatic nerves of Tr*j and control mice (less than 5 turns). 
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When the myelin thickness was measured in the remainder of fibres, Tr" animals had a higher 
proportion of fibres with inappropriately thin myelin (g ratio >0.8) than controls (Fig 7.5). 
The ventral roots were more severely affected (20-26%) than the dorsal root (4-6%) both in 3 
and 12 mo animals (P---0.004 and P---0.04) with the sciatic nerve showing a level of 
affectedness between the two. 
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Fig 7.5. The proportion of fibres with thin myelin in the spinal roots and sciatic 
nerves of T? and control mice (excluding fibres lacking measurable myelin). 
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Schwann cell numbers. The number of Schwann cell nuclei / 100 axons in cross sections 
of dorsal and ventral roots was 4-5 times higher in the spinal roots both in 3 and 12-mo-old 
Tr" animals when compared with age matched controls. There was no alteration with age in 
the number of nuclei/100 axons either in control or Tr" animals (Fig 7.6). The number of 
Schwann cell nuclei/100 axons did not alter in the different levels of the nerves examined 
despite a large variation in severity of demyelination. 
Schwann cell nuclei 
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M 3mo dorsal root M 3mo ventral root 
Fig 7.6 The number of Schwann cell nuclei counted in the spinal roots and 
sciatic nerves of Tr*j and control mice (expressed as counts per 100 axons). 
Fascicle area and fibre density. Total fascicular area was not significantly affected 
either by strain or age (Table 7.2). In the ventral root there was no difference in fibre density 
between Tr" and controls, although both strains demonstrated a significant age related 
decrease in density (Fig 7.7). In the dorsal roots, however, there was a significant decrease in 
fibre density in T? " animals when compared with age matched controls (Fig 7.7). As there 
were no significant alterations in fascicle area this probably represents axonal loss in the 
dorsal roots of Te' animals. 
Trembler-J Control 
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TABLE 7.2. Fascicle areas (ýtM) in the spinal roots and sciatic nerves of T? 
and control mice 
12 months 3 months 
Dorsal root Ventral Sciatic nerve Dorsal root Ventral root 
root 
Tr" 15151±1072 50539± 9052 141283± 16158 41931± 4432 3551 ±3288 
Control 34173± 4333 74526±14361 129178 ±15154 34244± 5179 4316± 7060 
NS NS NS NS NS 
p value Mann-Whitney U. Mean ± SEM 
Fibre densitv 
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Fig 7.7. The density of fibres /MM2 in the spinal roots and sciatic nerves of T? 
and control mice 
Fibre sizes. In all the Trj nerves examined there was a significant increase in the proportion 
of small fibres and a concomitant decrease in the proportion of large fibres (Fig 7.8 a-e). 
Axon diameters followed the same pattern as fibre diameters with an increased proportion of 
small and a decreased proportion of large fibres (data not shown). In the ventral roots of Tr" 
animals both fibre and axon diameters increased with age. 
Trembler-J Control 
0 12mo dorsal root M 12mo ventral root M 12 mo sciatic nerve 
N 3mo dorsal root M 3mo ventral root 
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7.2 PATIENTS WITH THE P16L (TRJ) MUTATION 
Tbree patients with the P16L mutation have been reported and their morphological 
phenotype published (Gabredls-Festen et al. 1995). Schwann cell nuclear counts were not 
done on these patients. To allow me to make of better comparison of the human and mouse 
phenotypes Anneke Gabredls-Festen kindly sent me a block from each of these patients. In 
addition to the published data she also sent me some further information about the clinical 
features of the patients and some data relating to their myelinated fibre distributions. 
CLINICAL INFORMATION 
Patient 1. Female. The patient first walked at 12 mo. She showed progressive deterioration 
from the age of three and by 27 y she was using a wheelchair. The child's first neurological 
examination at 8y of age showed weakness and atrophy of distal lower limbs, dysfunction of 
vibration/position sense in lower limbs, slight sensory ataxia, areflexia and slight 
kyphoscoliosis. Daughter of patient 3. 
Electrophysiological tests: Peroneal nerve MNCV, no response. Ulnar nerve, no motor or 
sensory responses. 
Patient 2. Male. The patient's first neurological examination at 17 y was undertaken at the 
request of the school medical officer. The examination showed distal weakness of the lower 
legs, slight sensory ataxia, areflexia, pes cavus, slight scoliosis, no palpable nerves. 
Electrophysiological tests: Median nerve MNCV 7m/s, distal motor latency 7. InL/s, distal 
sensory conduction latency 17.0 m/s, amplitude 2 ýX. Peroneal nerve MNCV, no response. 
Patient 3. Male. There was no reliable information about the patient's first years of life. He 
had poliomyelitis at the age of 6 y. The patient had several orthopaedic corrections of the 
right foot for pes equinovarus. His first neurological examination (27 y) showed weakness 
and severe atrophy of the hand muscles, lower legs and feet, R>L, distal sensory loss in the 
legs, areflexia, left foot pes cavus, mild clawing of hands, slight scoliosis. Peripheral nerves 
were thickened. His mother (deceased) and four brothers showed distal paresis and atrophy. 
Electrophysiological tests: Ulnar MNCV unrecordable. 
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Table 7.3. Previously published morphometric data from patients with 
the P16L mutation 
Total Myelinated Onion bulbs g ratio 
fascicular fibre density (% of 
area (% of normal) myelinated 
(% of normal) fibres) 
Patient 1 458 15 90 0.88 
Patient 2 448 20 97 0.72 
Patient 3 is 99 0.81 
Fibre size distributions 
In the mouse I have divided the fibre size distribution into three classes, small (0<5 pm), 
medium (5<10gm) and large (10<15gm). As the fibre size distribution in humans is bimodal 
I have used only two size classes, small (0<4pm) and large (>4pm). 
Table 7.4. Myelinated fibre distribution; data from patients with the P16L 
mutation (percent of total fibre number) 
Small Large 
(0<41im) (>4gm). 
Human Trj mutation 
Patient 1 79% 21% 
Patient 2 90% 10% 
Patient 3 70% 30% 
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Schwann cell numbers 
Additional counts of Schwann cell nuclei and axons were performed at the Royal Free 
Hospital School of Medicine on the material from the three patients provided by Anneke 
Gabreals-Festen. 
Table 7.5. Schwann cell nuclei 1100 axons in patients with the P16L 
mutation 
Axon associated Supernumerary 
Human Tr' mutation 
Patient 19y (mean of 3 fascicles) 20.6 35.2 
Patient 2 17 y 
Patient 3 30 y 
(mean of 3 fascicles) 
(mean of 2 fascicles) 
17.0 
15.0 
19.7 
50.0 
TrJ mice (n7-5) 13.9 ±0.8 rarely seen 
The number of axon associated Schwann cell nuclei was similar in mice and humans but the 
patients had a large number of supernumerary Schwann cell nuclei. These were very rarely 
seen in the mice. 
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Figure 7.9. 
Light microscope photos of mice and humans with the P16L mutation. 
(a)Light micrograph from a Trembler-J mouse. Scale bar 100 pm. 
(b) Light micrograph from a patient with the same mutation. Scale bar I 00ýun. 
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7.3 Adult Transgenic 
A summary of the results of a preliminary study has been published (Huxley et al 1998). The 
summary table and histological results are included here. 
Table 7.6 Previously published features of Transgenic mice 
Mouse 
genotype 
Copy 
number 
Ratio 
human/mouse 
mRNA 
Mean 
MNCV 
m/s 
Histology Visible 
phenotype 
Wildtype 0 - 38 normal none 
C2 het 1 0.4 not done normal none 
C2 horn 2 0.8 41 normal none 
CI het 2 0.5 46 normal none 
C58 het 2 0.6 49 normal none 
CI horn 4 1.3 26 mild 
demyelination 
do not mate well 
C58 horn 4 not done 21 mild 
demyelination 
do not mate well 
C61 het 4 1.0 25 mild 
demyelination 
none 
C22 het 7 1.6 4 demyelination peripheral 
neuropathy 
C61 horn 8 not done 4 demyelination peripheral 
neuropathy 
C22 horn 14 - never produced 
7.3.1. MORPHOLOGY. Comparison of sections of sciatic nerves from the same mice as 
used for the nerve conduction studies showed different degrees of severity of demyelination 
depending on the genotype. C22 heterozygous and C61 homozygous mice showed severe 
demyelination affecting most of the large axons. CI homozygotes, C58 homozygotes and 
C61 heterozygotes all had intermediate degrees of demyelination, while C2 homozygotes, 
CI heterozygotes and C58 heterozygotes showed only occasional demyel ination. Electron 
microscopic examination of the nerves of mice of different genotypes showed that they had a 
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similar pattern of demyelination although different numbers of fibres were affected. Features 
included uncompacted myelin characteristically on the outsides of the myelin sheaths of 
medium sized axons (Fig. 7.10 a), demyelination of large axons; with reduplicated basal 
lamina (basal laminal onion bulbs) (Fig. 7.10 b), completely demyelinated large axons (Fig. 
7.10 c), and macrophages indicating the occurrence of active demyelination (Fig. 7.10d). 
Three lines of adult (7mo) transgenic mice with a range of PMP22 mRNA expression and 
copy numbers were chosen for further study. C22 het (7 copy), C61 het (4 copy) and C2 (2 
copy) (Fig. 7.11 ab, cd. ). 
7.3.2. MORPHOMETRY 
Myelin thickness. The degree of myelin deficit was quantified using categories of g ratio 
(axon diameter/fibre diameter). Demyelinated fibres and those with extremely thin myelin 
(less than 5 turns) were given ag ratio of 1.1. Those with values between 0.8 and I were 
considered to have myelin that was too thin for the size of the axon. Fibres with ag ratio 
below 0.4 are considered to have unusually thick myelin. 
Both seven and four copy animals had an increased percentage of fibres with extremely thin 
myelin (g ratio = 1.1). In C22 animals a large proportion of axons, (40%) were either devoid 
of myelin or surrounded by myelin too thin to be measured at the light microscopic level. In 
the C61 strain only 3% of fibres fell into this severe hypomyelination category. Animals with 
2 additional copies of PMP22 did not differ from controls. All the transgenic animals had 
significantly more fibres with thin myelin (g ratio 0.8-1.0). The percentage of thinly 
myelinated fibres increased with increasing copy number. An increase in the proportion of 
thinly myelinated fibres was the only discernible abnormality in C2 animals. There were 
only a few fibres with thick myelin (<0.4) in any of the genotypes. 
Table 7.7 g ratios in transgenic mice 
Control 7 copy 
(C22) 
4 copy 
(C61) 
2 copy 
(C2) 
Extremely thin or no 
myelin (1.1) 0.89±0.3 42.4 4.6 3.1±2.1 1.0±0.3 
Thin myelin 
(0.8-1.0) 0.69 ±0.4 8.82 0.2 4.36±2.1 1.46±0.6 
Thick myelin 
(<0.4) 0.07±. 14 0.32 0.33 0.57 ±0.71 0.0 ±0.0 
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Figure 7.10. 
Electron micrographs fiom the sciatic nerve of a severely affected C61 homozygote 
mouse (8 copies of the human PMP22 gene). (a) Uncompacted myelin characteristically on 
the outside of the myelin sheath of medium sized axons. Scale bar I PM. (b) 
Hypomyelination of large axons with reduplicated basal lamina (centre). Scale bar 2 pm. (c) 
Thin myelin or complete lack of myelin around large axons which are often incompletely 
surrounded be Schwann cell cytoplasm (arrows). Scale bar 2 pm. (d) Macrophage indicating 
active demyelination or fibre degeneration. Scale bar 2 Wn. 
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Figure 7.11. 
Transverse sections of the sciatic nerves of mice with different copy numbers of the 
human transgene. (a) C22 heterozygote (se,, en copies). Nerves showed severe 
demyelination with most of the large axons being surrounded either by very, few turns of 
myelin or none at all. (b) C61 heterozygote (four copies). Some thinlý myelinated fibres are 
present. (c) C2 homozygote (two copies). Degenerating or demyelinated fibres were rare, (d) 
Control sciatic nerve. 
Scale bar 10 ýtrn, applies for all panels. 
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Schwann cell numbers. 
Only the C22 strain had an increased number of Schwarm cell nuclei. 
Table 7.8 Schwann cell nuclei/ 100 axons in transgenic mice 
Control 7 copy 4 copy 2 copy 
(C22) (C61) (C2) 
Number of Schwann 4.6± 0.3 
cell nuclei per fascicle 
12.8 ± 1.0 5.4 ± 0.5 4.9 ± 0.4 
Fascicle area and fibre density. Fibre density was not decreased in any of the 
transgenic mutants when compared with controls. The opposite was true of the most severely 
affected C22 strain which had an increased fibre density due to a decreased fascicle size, 
presumably related to the lack of myelin in the nerves. There was no evidence of 
hypertrophy in any of the nerves examined. 
Table 7.9 Fibre density in sciatic nerves of adult transgenic mice (includes 
axons with very thin or no myelin) 
Control 7 copy 4 copy 2 copy 
(C22) (C61) (C2) 
Fibres/ MM2 20598 ±1505 33777± 3268 20947 ±4757 20167 ±2087 
Mean ± S. E. M. 
Table 7.10 Fascicle area in transgenic mice 
Control 7 copy 4 copy 2 copy 
(C22) (C61) (C2) 
Fascicle area (ýtm') 103616 ±6714 64197 ±8255 107803 ±6492 106269 ±6269 
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Fibre sizes The C22 strain had an altered fibre diameter spectrum with an increased 
proportion of small diameter fibres (<0.5 ýtm) and a concomi medium itant decrease in both 
(5-10 ýtm) and large (10-15 ýtm ) fibres. The more mildly affected C61 animals had a 
decreased proportion of large fibres. The axon size distribution paralleled that of the fibre 
sizes (data not shown). 
Table 7.11 The spectrum of fibre diameters in transgenic mice 
Control 7 Copy 4 copy 2 copy 
(C22) (C61) (C2) 
0<5 Pm 33.7 ± 5.1 85.2 2.4 42.9 12.9 35.6 ±4.11 
5<10 Pm 55.9 ± 3.0 14.6 2.3 54.6 11.8 56.1 ± 1.8 
10<15 ýIm 10.3 ± 3.2 0.2 0.1 2.5 1.8 8.3 ±2.4 
Mean ± S. E. M. 
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7.4 CRUSH INJURY 
At 14 d post injury regeneration in the sciatic nerve was well established and myelination 
beginning in a large proportion of fibres. There was still a large amount of myelin debris 
present in the nerves of control animals but virtually none in the nerves of Ty' animals. 
7.4.1 MORPHOLOGY. Previous work on the Tr" model has shown ultrastructural 
abnormalities of the Schwarm cell which suggest cytoskeletal abnormalites affecting 
Schwarm cells and their relationship with the axon and extracellular matrix. These include 
terminal myelin loops at the node of Ranvier that are directed outwards instead of being 
attached to the paranodal axolemma (Fig. 7.12), abnormally positioned Schwann cell nuclei 
(Fig. 7.13a), and 'spiky' external protrusions of cytoplasm particularly in fibres lacking 
myelin but with axonal diameters in the myelinated fibre range (Fig. 7.13b) (associated with 
basement membrane). All these abnormal ultrastructural features found in Tr, ' mice were 
reproduced in the early stage of regeneration following crush injury with a greater frequency 
than found in uninjured nerve. The 'spiky' projections seen in D" animals appeared to be 
associated with the original basement membrane of the fibres (Fig. 7.14a). In addition 
regenerating fibres from Tr" animals had a tendency to have a prolonged association with the 
original basal lamina. They were more commonly found in promyelinated fibres from TY' 
animals than in control animals but were found in both. (Fig. 7.14a. b) In Tr" animals 
myelinated fibres were occasionally seen still associated with the original basement 
membrane; this association was never seen in control animals (Fig. 7.14c, d ). 
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Fibre counts. Axonal regeneration appeared to proceed normally in D" mice. Both the 
total number of regenerating axons and the proportion of those axons that were unmyelinated 
were the same in regenerating nerve from T), ' and control animals (Table 7.12). The 
proportion of promyelinated fibres was increased and myelinated fibres decreased in Te' 
animals when compared with controls (Fig. 7.15) indicating a delay in the initiation of the 
myelination process. 
Table 7.12. Axon numbers in TrJ and control sciatic nerves 14 days after crush 
injury 
Total number of Unmyelinated axons 
axons (% of total axons) 
Control (n=6) 1892 148 83.5 ± 0.8 
Trj (n=5) 1632 99 78.9 ± 3.3 
Mann Whitney U test NS NS 
Mean ± S. E. M 
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Figure 7.12. 
Electron micrograph from the sciatic nerve of a TrJ animal 14 days post crush 
injury. 
The terminal myelin loops at the node of Ranvier are directed outAards instead of being 
attached to the paranodal axolernma. Scale bar I ýirn- 
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Figure 7.13. 
Electron micrographs from the sciatic nerve of T? animals 14 days post crush 
injury. (a) Schwann cell nuclei positioned abnormally close to the node of Ranvier 
(arrow). Scale bar 10 ýtm (b) 'Spikey' cytoplasmic projections associated with regions of the 
axons that are not covered with myelin. Processes appear to be adhering to original basement 
membrane (arrow). Scale bar 4 ltm. 
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Figure 7.14. 
Electron micrographs from the sciatic nerve of T? and control animals 14 
days post crush injury. 
(a) A promyelin fibre from a regenerating Te' nerve. Cytoplasmic processes appear to be 
associated with the original basement membrane (arrow). Scale bar I l. Lm. (b) A typical 
promyelinated fibre from a regenerating control nerve. Scale bar I ýtm. (c) A recently 
regenerated fibre from a Tr'j animal. The fibre has cytoplasmic processes that appear to be 
associated with remnants of the original basement membrane (arrow). Scale bar I ýtm. (d) A 
recently regenerated fibre from a control animal. The new fibre is within the original 
basement membrane but is not adhering to it. Scale bar I gm. 
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Control 
7.1 ± 0.9 
9.7 ± 0.7 
Myelinated 
Trembler-J 
15.7± 1.0 
4.3 ± 1.2 
II Promyelinated 
Figure 7.15 The proportion of myelinated and promyelin axons in TrJ and 
control mice 14 days after crush injury. 
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Schwann cell numbers. Surprisingly we found an increase in the number of Schwann 
cells associated with unmyelinated axons. In crushed control nerve there were 13.4 Remak 
bundles/ 100 unmyelinated axons; in T? 'j animals the number had increased to 20.8 (Fig 
7.16). The increase in the number of Schwann cells associated with unmyelinated axons was 
not confined to regenerating TrJ nerve but was also found in uninjured TrJ sciatic nerve 
(control 8.1/100, T? 'J 12.7/100) (Fig. 7.16). The proportional increase in crushed (55%) and 
uninjured (56%) nerve was remarkably similar and therefore unlikely to be related to the 
injury but a feature of the T? -J phenotype. (See discussion). 
Crushed Uninjured 
20.6 ± 1.7 
13.4 ±1.2 
12.0 1.0 
8.1 0.4 
Control Trembler-J 
Fig 7.16 Number of Schwann cell nuceli MOO axons in injured and uninjured 
sciatic nerve of TrJ and control mice 
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7.4.2 rnRNA 
Levels of the two PMP22 transcripts. The level of the myelination associated transcript 
(CD25) was decreased in Trj animals compared with controls (82% ± 26%) but there was no 
alteration in the growth arrest (SR13) transcript, which showed a much greater variation 
(168% ± 166%). 
Table 7.13. The expression of alternative PMP22 transcripts in Trj nerve as a 
percentage of control values. 
CD25 SR1 3 
Mean percentage of control value. 82% 168% 
S. D. 26% 166% 
Mann-Whitney U test P<0.0 I NS 
Table 7.14. The ratio of mRNA transcripts in injured and uninjured mutant and 
control nerve 
TI-I Control 
1.34 ± 0.5 (n=8) 0.77 ± 0.2 (n=6) 
Uninjured 
Crushed 1.22 ± 0.3 (n=6) Not detected (n=6) 
Mann-Whitney U test p=0.75 
Mean ± SD. 
Neither of the two PMP22 transcripts were detected in the regenerating nerve of control 
animals two weeks after crush injury. To confirm that this was not due to degradation of the 
mRNA these experiments were repeated in a further 6 control and 5 Tr'J animals. Primer 
sequences for the house keeping gene hypoxanthine-guanine phosphoribosyl transferase 
(HPRT) were used in addition to amplifying both PMP22 trancripts. HPRT is a salvage 
enzyme in the nucleotide metabolic pathway. cDNA would be expected to amplify in any 
peripheral nerve sample providing a marker of mRNA/cDNA viability. The previous results 
were confirmed, cDNA from all samples amplified with the HPRT primers but only the 
cDNA from Trj resulted in PMP22 transcript amplification. 
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7.5. DEVELOPMENTAL STUDIES 
On examination of semithin sections at postnatal day 4, affected C22 and homozygous TrJ 
animals were easily recognised as they had markedly decreased numbers of myelinated 
fibres (Fig. 7.17 ace) In heterozygous Tr'J animals, the decrease in myelinated fibres was 
difficult to judge by eye but they also could be distinguished from controls by the presence 
of many fibres with irregular contours (Fig. 7.17f ). The C61 strain could not be 
distinguished morphologically from controls (Fig. 7.17b). 
Fibre counts In all mutant strains the process of axon separation from fetal bundles into a 
1: 1 relationship with individual Schwann cells appeared to proceed normally. At P4 there 
was no difference in the total number of singly ensheathed fibres in the different strains 
(rable 7.15). 
Table 7.15. Total number of singly ensheathed fibres in transgenic 
animals at postnatal day 4. 
Control 4 copies (C61) 7 copies (C22) Trj het T? hom 
P4 643 ± 20 630 ± 62 657 ± 25 538 ± 98 761 ± 68 
Mean ± S. E. (n7-6) 
A myelination deficit was already present at P4 in C22 (7 copy) and both heterozygous and 
homozygous TV animals. Homozygous Tr*' animals were the most severely affected with less 
than 2% of the singly ensheathed axons; being myelinated. The proportion of myelinated 
fibres increased with age in control, C61(4 copies) and heterozygous TV animals but C22 (7 
copies) remained very poorly myelinated and homozygous TV animals developed very little 
myelin before their death around weaning (Figure7.18). 
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Figure 7.17. 
Electron micrographs of the sciatic nerve of PIO-12 transgenic and T? 
animals. (a) Control. (b) 4 copies of PMP22 (C61). (c) 7 copies of PMP22 (C22). (a) T? 'J 
heterozygote; Incompletely surrounded axons (filled arrow), Naked axons (open arrows). (e) 
Tel homozygote. (/) Trj heterozygote, Schwann cell cytoplasm with an irregular outline. 
Such irregular outlines as were commonly seen in heterozygotes and permitted them to be 
distinguished from C61 and control animals as early as P4. Uncompacted myelin (open 
arrow). Scale bar, I ýim. 
Scale bar 2.5 ýtrn applies for panels a-e 
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Figure 7.18. Percentage of singly ensheathed fibres that were myelinated in 
transgenic and T? animals at the different ages examined. 
* Indicates significantly different from controls at the same age. 
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An increased number of Schwann cells is a feature of most PMP22 disorders. At P4 the C22 
mutants already had a significantly higher number of Schwann cells compared with controls. 
By P 12 DIJ heterozygotes and Tr" homozygotes also had significantly increased numbers of 
Schwann cells. Between P4 and P12 the number of Schwann cells per 100 axons decreased 
both in controls and in the mildly affected C61 strains as myelination progressed. In the other 
mutants the number of Schwann cells increased (Fig 7.19). When comparing early postnatal 
and adult values the percentage of Schwann cells decreases in control and C61 animals. In 
almost all the singly ensheathed fibres are myelinated. In C22 and D" heterozygote nerves the 
percentage of Schwann cells does not alter from early postnatal values. 
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Fig 7.19 Schwann cell nuclei/100 axons in the sciatic nerve of P10-P12 
transgenic and Tr'j animals 
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Incompletely surrounded fibres. At both P4 and P 12 all the mutants had all increased 
number of fibres that were incompletely surrounded by Schwann cell cytoplasm. In C22 
animals this number did not alter during development but in all the other strains the number 
decreased with age (Fig 7.20). It is interesting to note that the only feature ill which C61 mice 
differ from control animals is the inability of the Schwann cell to surround a fibre completely. 
180 
8--120 
-0 4-- 
4- 
6C 
lnr-nrnnlp-tp-lv nurrnundp-ri fihrp--c. - 
= P4 m P10-12 
Fig 7.20 The number of fibres incompletely surrounded by Schwann cell 
cytoplasm in the sciatic nerve of PI O-PI 2 transgenic and Tr`j animals 
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The two most affected strains (T, -, ýrj and C22) could be morphologically distinguished 
from each other by P10-12. Schwann cell cytoplasm in the promyelin fibres of Te'ITY' 
animals failed to complete a full turn around the axon (Fig 7.21 a), in C22 animals many had 
progressed so that a mesaxon had been formed (Fig 7.21 b). 
Beyond P1 0-12. Sciatic nerve sections of transgenic animals were examined at P28-29,3 
mo and 6 mo in addition to those used for morphometric analysis at 7 mo. C2 animals, with 
2 extra copies of PMP22 were not noticeably affected at any of the ages we examined. C61 
animals appeared to myelinate more or less normally in the first 10- 12 d. The first indication 
of a myelin deficit was seen at P28 when occasional thinly myelinated large fibres could be 
seen in some animals. At 3 mo a few more fibres were becoming affected and by 6 mo a 
population of thinly myelinated fibres and axons with no myelin were clearly seen. 
Demyelination specifically affected the large fibre population. In C22 animals the degree of 
myelination improves steadily from PIO-12 through to adulthood but never approaches 
normal levels. Even in adult animals less than 60% of fibres fall within the normal g ratio 
spectrum of normal fibres. 
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Figure 7.21. Features of the stage at which delay in myelination occurs in 
fibres from Trj homozygous and C22 animals at PIO-12 
(a) Fibres from a7 copy (C22) animal in which the Schwann cell cytoplasm has completed 
a full turn around the axon. Scale bar, I ýLrn. (b) Fibres from a Trhomozygous animal in 
which the Schwann cell cytoplasm fails to complete a full turn around the axon. Scale bar, I 
ýlm. 
ý 
ak. 
Ll 
I 
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Chapter 8 Discussion 
8.1 THE RESULTS OF THESE STUDIES 
Adult T? morphology. The dominant features of the Te' neuropathy are a myelinatiOll 
deficit. an increased number of Schwann cells and a failure of the Schwann cells to ensheath 
the axons fully. Myelination was most severely affected in the ventral roots both ill the 3 and 
12 mo animals. The dorsal roots were significantly less affected and the sciatic nerve less so. 
Fibre density was significantly reduced in the dorsal roots both in the 3 and 12 mo Tr" 
animals when compared with controls. As there was no alteration in fascicular area this 
indicates a degree of axonal loss. Axonal loss was limited to the dorsal roots and was not 
related to the degree of myelination or to the lack of ensheathment of axons by Schwalm 
cells. There are no comparable data currently available on axonal loss in the other rnurine 
models with point mutations in PMP22 ( Tr and Tr-Ncnp). There is no loss in the 1A ventra I 
root or in the u1nar nerve (Perkins et al. 1981 b) of Tr mice. 
As the distribution of PMP22 is not known to differ significantly between the dorsal and 
ventral roots, it is difficult to suggest a mechanism whereby the dorsal roots shou Id be more 
susceptible to axonal loss than the ventral, or why myelination should be more affected in 
the ventral roots. 
There are two possible contributing factors; firstly, the different expression ofthe 1,2/HNK- I 
epitope in motor and sensory nerves (Martini et al. 1994) and secondly, a minor disease 
contributing effect of motorneuron- expressed PMP22 (Parmantier et al. 1995). 
The number of Schwann cell nuclei was 3-5 times higher in D" than in age matched control 
animals and did not alter with age. The number of nuclei was higher in the dorsal roots when 
compared with the ventral roots this difference was significant in 12 mo D" animals but not 
in 3 mo Te' animals or controls. The increase in Schwarm cell number does not reflect the 
severity of dysmyelination. 
No classical onion bulbs were seen in any D" nerves. In contrast basal laminal onion bulbs 
were more common. These layers of collapsed basement membrane have been suggested as 
indicating that the Schwarm cells become reactive, extend cytoplasmic processes and then 
withdraw them (Ayers & Anderson 1975). Schwarm cell protrusions were evident in tile 
present material (see Fig 7.2). The occasional sectorial distribution of the empty basal larninal 
layers (Fig 7.2) would favour this explanation. An alternative explanation for the presence of 
basal lamina] rather than classical onion bulbs would be ongoing Schwarm cell proliferation 
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with loss of the redundant supernumerary Schwarm cells . Against this explanation is the 
lack of morphological evidence of cell death. 
Additional abnormal morphological features were seen in the nerves of Iy Tel nerves which 
we suggest provides ultrastructural evidence of altered axon-Schwann cell interactions. 
Schwann cell nuclei have been found adjacent to the nodes of Ranvier whereas in normal 
animals they are located near the centre of the internodes. This altered positioning may 
reflect either a mistaken sense of position or altered interaction with the Schwann cell 
cytoskeleton. In some fibres the terminal myelin loops faced outwards into the extracellular 
space instead of turning inwards and terminating on the axon. The frequency of these 
abnormalities increased with increasing severity of the disorder. 
Crush morphology. We have found that the nerves of elderly Te'mice show a number 
of morphological abnormalities (Robertson et al. 1997); however, because of the advanced 
age of the animals used in this study, it was possible that the alterations seen were secondary 
to repeated cycles of de/remyelination. In the crush injury study we found that all the 
abnormal features seen in elderly Tr" mice were reproduced during nerve regeneration 
following crush injury. This indicates that these alterations are due to an intrinsic 
abnormality of Tit' Schwarm cells and their interactions with axons and tile ECM and not a 
result of repeated cycles of demyel ination/remyel i nation. Ultrastructural alterations in Tr, ' 
nerves. apart from the hypomyelination, appeared to be based around abnormal interactions 
of the Schwann cells with the cytoskeleton and also, particularly with the original basal 
lamina. The previously noted 'spikey' projections (Robertson et al. 1997) and the new 
observation of prolonged association of the Schwarm cells of regenerating fibres with the 
original basal lamina suggest this as the main site of abnormal interaction. 
Schwann cell proliferation is a well documented feature of the pathology in disorders 
associated with PMP22 defects, but has been thought only to affect fibres that are challenged 
to form myelin (Aguayo et al. 1977; Perkins et al. 1981a). Unmyelinated fibres in the nerves 
of Trembler animals are reported as appearing morphologically normal and are not 
associated either with increased Schwarm cell numbers or the altered proliferation rates that 
affect myelinated nerves (Perkins et al. 1981b). The results presented here provide the first 
evidence of a significant increase in Schwarm cells associated with unmyelmated axon 
bundles. The proportion of Schwarm cell increase (50%) is much less than that seen in 
myelinated fibres in the sciatic nerve (340 %). As PMP22 is found localised in the Schwann 
cell plasmalemma of unmyelinated fibres, this result suggests that the increase in Schwarm 
cell numbers is a feature of all PMP22 producing Schwann cells. This also suggests that the 
abnormality in Teý does not lie solely in its role as a myelin protein. Given the putative 
function of PMP22 as a growth arrest associated protein, it seemed possible that the 
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increased number of Schwarm cells was related to a dysfunction in the PMP22 transcript 
which has been associated with growth arrest (SR 13). 
Crush mRNA Peripheral nerve expresses both the myelin associated (transcript 1) and 
growth arrest associated (transcript 2) transcripts. A dysfunction of transcript I is likely to 
affect myelination directly but it is also possible that a dysfunction in transcript 2 may result 
in the Te' phenotype. If PMP22 in peripheral nerve acts as a growth arrest protein whose 
effect is impaired by the mutation, persistent Schwann cell division could lead to 
dedifferentiation of the cell and consequent demyelination. 
Transcript I 
Demyelination 
Debris and naked axons 
stimulate Schwann 
cell division 
Transcript 2 
D 
Fersisfenf Schwann cell 
division 
Myelination commences 
only in quiescent cells 
Lack of myelination 
and an excess of 
Schwann cells 
Figure 8.1 Alternative mechanisms which may result in excess Schwann cell 
production 
We examined the expression of both transcripts in the nerves of injured and uninjured D"' 
and control nerves. In both crushed and uninjured Tr" nerve there was an increase in the ratio 
of SRI 3/CD25 when compared with control animals. This was found to be due to a decrease 
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in the amount of the myelin related transcript (CD25) rather than an increase in the growth 
arrest associated transcript (SRI 3). In crushed control nerve neither transcript was detected 
in any of the animals suggesting that there may be a degree of myelin protein reutilization in 
regenerating nerve. 
Following the identification of two different PMP22 mRNA transcripts, Garbay et al. (1995) 
examined their respective levels of expression in the peripheral nervous system of the 
Trembler mouse during the myelination period. Steady state levels of the exon IA- 
containing transcript were greatly reduced in both heterozygous and homozygous Trembler 
mice when compared with controls. No such difference was noted for the exon 113- 
containing transcript. It is well documented that Schwarm cells continue to proliferate 
throughout the lifespan of Tr animals but the results of both these studies indicate that 
Schwann cell proliferation is not directly linked to a down regulation of the IB transcript. 
Adult transgenic morphology In this study we found that increasing the number of 
copies of PMP22 resulted in an increasing severity of phenotype. Rather than the phenotype 
becoming increasingly more severe with each increase in dose of PMP22, It became more 
severe in a stepped manner. Animals with 2 extra copies of PMP22 were scarcely affected. 
The only difference between the C2 strain and control animals was a 0.8% increase in the 
number of thinly myelinated fibres (g ratio >0.8<1.0). This is unlikely to represent any 
degree of functional deficit. C61 animals with 4 additional copies of the human PMP22 gene 
have a mild peripheral neuropathy with a small percentage of both thinly myelinated and 
extremely thinly myelinated fibres. Myelination appears to develop normally in C61 animals 
until P28 when occasional thinly myelinated large fibres could be seen in some animals. At 
3mo a few fibres were affected in most animals. At 6mo a distinct population of thinly 
myelinated or demyelinated axons was seen in affected animals. Myelin loss only affected 
the large fibre population. This indicates that the myelin initially forms normally but is in 
some way unstable and breaks down in larger fibres. In C22 animals the myelin deficit is of 
a completely different nature, myelin formation is delayed or non-existent in many fibres. In 
the population of fibres which do myelinate, the myelin formed is disproportionately thin for 
the axon size. 
Developmental transgenic morphology. Delayed myelination is found with 
underexpression (null mutants) (AdIkofer et al. 1995); overexpression (Magyar et al. 1996) 
and mutations of the PMP22 gene. This suggests that PMP22 has a role in the initiation of 
myelination. The myelination process was arrested at the promyelin stage in all the PMP22 
mutants that we examined. This study showed that the axons separate normally into a 1: 1 
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relationship with individual Schwarm cells. The high proportion of fibres that are 
incompletely surrounded by Schwarm cell cytoplasm indicate that the first abnormality and, 
by implication, the first function of PMP22 predates myelin formation and involves the 
attachment and movement of the Schwann cell around the axon. This is related specifically 
to axons that are destined to myelinate and is not a generic feature of mutant Schwarm cells. 
There was no evidence of ensheathment abnormalities in the unmyelinated fibre population. 
Additional evidence for an early function of PMP22 in myelin initiation comes from the two 
most severely affected strains, C22 and D" homozygotes. These two strains could be 
distinguished from each other by differences in the initial ensheathment of axons. In 
homozygous Te' animals the two apposing edges of Schwarm cell cytoplasm failed to 
overlap but in the C22 strain there was usually a small overlap of Schwann cell membranes 
and initial mesaxon fon-nation. This suggests that PMP22 is involved in either mesaxon 
formation or the guidance/recognition processes involved in the spiralling of Schwarm cell 
cytoplasm to form the myelin sheath. 
Two features of this early developmental morphology can be produced by interrupting 
Schwann cell differentiation with the thymidine analogue, 5-bromodeoxyuridine (BrdU). 
Following treatment of demyelinated nerve with BrdU, Hall and Gregson (1977) reported an 
increased number of promyelin fibres with cytoplasm that was irregular in outline. These are 
morphologically very similar to the irregular fibres characteristic of T, -' heterozygote 
animals. Additionally many cells possessed pseudopodial processes a feature also commonly 
found in both heterozygous and homozygous Tr' nerves. 
These results raise 2 possible interpretations, firstly that the mutant phenotype results from a 
failure of the differentiation process or, secondly, that it results from disrupted cell/cell 
interactions. 
If the Schwann cells fail to differentiate fully in their myelinating phenotype, they are 
unlikely to be capable of responding appropriately to axonal signals to myelinate. During the 
differentiation process, Schwann cells cease to proliferate and grow both longitudinally 
(internode length) and radially (myelin sheath thickness). An inability of mutant Schwann 
cells to surround axons and subsequently to rotate around them to form myelin may be seen 
as an extension of failed differentiation. 
Alternatively. if PMP22 functions in mediating the interaction between cell types, it is 
possible that differentiation failure itself is secondary to defective cell interactions. In a 
previous study we proposed that adult Tranimals exhibited abnormalities that were 
consistent either with defective Schwarm cell/axon or Schwann cell/extracellular matrix 
interactions (Robertson et al. 1997). Axonal contact is known to be a prerequisite for the 
initiation of mvelination. If the Schwarm cell only partially surrounds the axon, the signal I 
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may be insufficient to produce differentiation and myelination. Similarly Schwarm cells in 
culture only cease to divide and commence myelin formation when they are in contact with 
the extracellular matrix (De Vries 1993). In this study, the only feature that distinguished the 
C61 (4 copy) strain from controls was the increased number of fibres that were not 
surrounded by Schwarm cell cytoplasm. This leads us to conclude that the axon/Schwann 
cell interaction is more likely to be the site of abnormality than Schwann cell/extracellular 
matrix interaction. 
In either of these 2 scenarios, the lack of myelination in these PMP22 disorders can be seen 
as a secondary feature. This is largely overcome with time in most of the models, the degree 
of myelination improving from PI 0-12 to adult. Tehomozygous animals all die at around 
P21 but it is difficult to suggest a reason for their death based on a lack of myclin: both Tr 
homozygotes and C22 progeny are equally severely dysmyelinated and yet C22 have a 
normal lifespan. Comparative observations on the severity of associated axonal loss will be 
of interest in the C61 strain, which is relatively unaffected during the early stages of 
development. In these a relatively small proportion of larger fibres (7%) become 
hypomyelinated in adult mice suggesting that a moderate overexpression of PMP22 leads to 
myelin instability later in life (data not shown). 
From the present results the increased Schwarm cell numbers found in adult Tel heterozygote 
and C22 animals appear not to result from persistent Schwann cell proliferation but mainly 
from a failure in the normal maturational decrease in density per unit length of nerve (or 
cross sectional area) related to the cessation of mitosis after myelination and the progressive 
increase in Schwarm cell length during development. If demyelination subsequently occurs, 
this will result in Schwarm cell proliferation. Schwann cell proliferation occurs at the onset 
of myelination. protracted length of the myelination period may result in the increase in 
Schwann cell number seen in Tr" heterozygote and C22 transgenic animals between P4 and 
P 12. 
Schwann cell proliferation. Schwann cell proliferation is a well documented feature 
of murine neuropathies involving altered PMP22. In these studies we have found that the 
number of Schwann cells in adult animals is increased in C22 and both heterozygous and 
homozygous Te' animals when compared with age matched controls. 
Several theories have been postulated to explain this increase, although they relate largely to 
the Tr mouse in which Schwann cells continue to divide throughout the animals' lifetime. In 
the animal models we have examined there is no evidence of continuing Schwann cell 
proliferation, the number of Schwann cell nuclei being relatively constant or even 
decreasing, from early postnatal to adult stages. 
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Myelin debris. The presence of myelin debris is a well documented stimulus for Schwann 
cell division (Komiyama & Suzuki 1992; Baichwal & DeVries 1989; Perry et al. 1987). In 
cell culture studies, proliferating Schwann cells were found to be the ones which were 
participating in the digestion of myelin debris (Salzer & Bunge 1980). This led Ayers and 
Anderson (1976) to postulate that the increase in Schwann cells in the Tr mouse was a 
reactive response to the presence of myelin debris (Ayers & Anderson 1976). This seems 
unlikely as the increase in Schwann cell nuclei in the Tr mouse is seen very early in 
development (P3) (Koenig et al. 1991). Three days following nerve injury Schwann cells 
begin to increase in number, this would leave barely enough time for the Schwann cells to 
react to myelin debris. In Te' and C22 animals there was very little active demyelination seen 
in animals older than one month. This may contribute to the fact that Schwann cells do not 
continue to divide in Tras they do Tr which do show increased amounts of myelin debris. 
Some authors (Aguayo et al. 1977; Aguayo et al. 1979) suggest that the abnormalities in tile 
Tr mouse are related to the Schwann cells being challenged to myelinate. While this is 
clearly a dominating factor it does not explain the increased number of SCN associated with 
unmyelinated fibres in Tej mice. The degree of SCN increase is clearly much less in 
unmyelinated fibres but this suggests that Schwann cell increases are not entirely related to 
the myelination process. They are also contributed to, either by another process occurring at 
a similar time in development, or to proliferation associated with a diffusable mitogenic 
stimulus that affects both the myelinated and unmyelinated populations (Archer & Griffin 
1993). 
Axonal stimulus. Low (1976) did not agree with Ayers and Anderson's (1976) theory that 
mvelm debris was likely to be the stimulus for Schwann cell division as in Tr animals the 
number of Schwann cells was already increased before myelin breakdown occurred (Low 
1976a. Low 1976b). He considered that the presence of a developing or markedly 
hypomyelinated axon would provide adequate stimulus for Schwarm cell division. Like 
myelin debris, naked axolemma and axolemmal fragments are also known to provide 
stimulus for Schwann cell division (Pellegrino & Spencer 1985; Wood & Bunge 1975). The 
present results suggest that a response to naked axotemma alone is unlikely to explain the 
increased numbers of Schwann cells, although it may contribute. If naked axolemma were 
the primary stimulus to Schwann cell division, we should also expect the number of SCN to 
reflect the difference in severity of demyelination between Ty' and C22 sciatic nerves. The 
proportion of axons with no detectable myelin was 30% in the C22 strain and only 15 % in 
Tr'. Similarly, in the ventral roots of 12 mo Te'animals, 60-65% of axons had no detectable 
myelin but in the dorsal root this was only 40-50%, yet the number of SCN did not differ. 
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Developmental failure of Schwann cell growth. Aguayo et a]. (1977) commented 
that, although the hypercellularity seen in the Te' mouse could be due to a chronic 
demyelinating process, it could also be secondary to a developmental failure of myelination. 
Sheath thickness has been found to relate not only to axon calibre but also to internode 
length. Foreshortened internodes have slightly thinner myelin than long internodes of the 
same fibre calibre (Friede 1985). If the myelin sheaths are relatively thin for the axon calibre, 
this is generally taken as a sign of insufficient myelin formation. Beuche and Friede (1985) 
noted that the reverse interpretation is also valid, proliferation of Schwann cells may cause 
excessively short. rudimentary internodes which develop only abortive sheaths. They also 
raised the possibility of the existence of dissociated and independent disturbances of myelin 
formation and of Schwann cell proliferation. 
Failure of Schwann cell growth is the most satisfactory explanation for the increased 
Schwarm cell numbers in PMP22 mutants. Protracted SC multiplication in young animals is 
likely to function as a compensatory mechanism to ensure ensheathment of individual axons. 
it is also plausible that the different levels of Schwann cell proliferation in the ventral and 
dorsal roots are related to this growth failure. There is a different growth pattern found in 
motor and sensory fibres with the largest (presumably motor) fibres being the first to 
myelinate (Williams & Wendell-Smith 197 1 b). Assuming that fibres in the dorsal root begin 
to myelinate slightly later than those in the ventral root and that, once they have begun to 
myelinate, they are capable of longitudinal growth (Koenig et al. 199 1 ), this is likely to 
correspond to the time period in which maximum body growth occurs. The degree of 
proliferation required to ensure axon coverage is likely to be greater. 
in conclusion Schwann cell proliferation in pmp22 mutant mice can been seen as a 
secondary manifestation of a myelination disorder rather than a primary Schwann cell defect. 
Schwann cell proliferation is manifest in almost any peripheral neuropathy as a consequence 
of demyelination or axonal degeneration. The only exception to this is radiation neuropathy. 
When mouse nerves are irradiated soon after crush injury (3 days), Schwann cell 
proliferation is severely and persistantly reduced. Many fibres show segmental failure of 
myelination and internodes adjacent to nonmyelinated regions were abnormally long (Love 
1983). 
PART 2 COMPARISONS 
Comparisons between PMP22 overexpressing humans and mice 
The morphologý of overexpressing mice was distinctly different from human duplication 
patients. The murine duplication models showed none of the hypertrophic changes or 
classical onion bulbs that characterise HMSN Ia. Instead many, fibres were surrounded by 
144 
basal laminal onion bulbs. The significance of the two types of onion bulb is unclear. Classic 
onion bulbs are composed of paired basement membranes that usually contain Schwarm cell 
cytoplasm. The Schwarm cells that compose classic onion bulbs are considered to be 
supernumerary cells related to recurrent demye I inati on/remyel 1 nation. In contrast, basal 
laminal onion bulbs are thought to be formed as a result of Schwann cell movement, the 
Schwarm cell extending processes and then withdrawing them leaving behind a single layer 
of basal lamina. Basal laminal onion bulbs are not necessarily associated with Schwann cell 
division. Although both the human and mouse duplications result in an excess of Schwann 
cells, they are likely to have developed from different types of responses. The excess number 
of Schwarm cells in the murine mutants probably result from a response to the lack of 
myelination seen early in development, presumably because the Schwarm cells divide to 
cover the length of the axon adequately. In contrast, the Schwarm cells in human classic 
onion bulbs divide and do not remain axon associated, they appear to be additional to what is 
necessary for axon coverage. 
Human duplication patients have a greatly reduced myelinated fibre density from an early 
age (10 y) (Gabre6s-Festen et al. 1995; Thomas et al. 1997; Fabrizi et al. 1998). Although 
our results show no difference in fibre density in the transgenic animals, our fibre counts 
have included those fibres with no detectable myelin. The proportion of these fibres is 
significant in all of the transgenic animals. This means that the myelinated fibre density is 
also likely to be decreased in all the transgenic strains. The present results show that the 
axons that are not surrounded by myelin do not degenerate. This differs from what is thought 
to happen in the human situation. In humans it is likely that axons are actually lost. In biopsy 
material there is evidence of axonal sprouting which must result from previous axonal 
degeneration (Dr R. King, personal communication). In affected humans determination of 
axonal loss is difficult as the variable degrees of nerve hypertrophy make fibre densities an 
unsuitable measure to quantify axonal loss. The alternative is counting all the myelinated 
fibres in a whole nerve at a specific level. As whole nerve biopsies are not commonly 
performed this is not a feasible option. Lack of axonal loss in the mouse is presumably due 
to a combination of factors. Mice have a considerably shorter life span in which to develop 
abnormalities. In addition, the smaller distance from the cell body to the nerve endings in the 
mouse could reduce the degree of strain imposed on the cell body in terms of maintaining the 
axon. 
In both human and mouse, axons are markedly decreased in size. In the C22 strain this is 
probably due to the fact that axons are never fully myelinated and never attain a normal size 
distribution. In the C61 strain it is more likely to represent atrophy as a result of 
demyelination. The lack of developmental data on the human duplication makes it difficult 
to determine whether decreased axon size is due to atrophy or retarded growth. 
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In models where we have murine/human comparisons, LI 6P and overexpression, the 
resulting phenotype differs significantly. In the overexpression studies it is likely that this is 
partly due to incompatibility between the human and mouse PMP22 genes. However, there 
are features which the two comparisons have in common. In both cases the mouse model 
does not produce 'classic' but 'basal laminal' onion bulbs. The mouse is capable of forming 
classic onion bulbs as they are commonly seen in antisense PMP22 mice (Adikofer et al. 
1995), although the number of Schwann cell layers is relatively small. There is also no 
evidence of nerve hypertrophy in either of the murine disorders. 
The composition of PNS myelin differs between species (Lees & Brostoff 1984) as does the 
carbohydrate compositions of a given protein (Schachner et al. 1995b). In human and bovine 
PNS, PO is the dominant carrier of the L2/HNK- I epitope, whereas in mouse, L2/HNK- I is 
predominantly carried by a 18-28 kDa protein, presumably PMP22. If the functional epitopes 
carried by PMP22 differ between species, this is likely to contribute to the different 
pathologies. 
In our previous study we noted that there appeared to be a threshold effect with respect to 
PMP22 dosage (Huxley et al. 1998). With two or fewer additional copies of the PMP22 
gene, there was little electrophysiological or histological effect. This threshold effect may 
also apply in humans, although in general the effects of increased gene dosage are more 
severe. Homozygous and heterozygous duplication patients, with 2 and I extra copy of the 
PMP22 gene respectively, have overlapping phenotypes. Within families homozygous 
children have variously been reported as being both more and less severely affected than 
heterozygous siblings (LeGuem et al. 1997; Lupski et al. 1991; Sturtz et al. 1997). This is 
consistent with what has been found in our studies, that below a certain threshold level of 
expression there appears to be an overlap of phenotypes. 
Comparisons between Trembler and Trembler-J mice. 
Although Tr and Tr" are essentially similar, demonstrating largely the same features, they are 
not identical. Tr" animals tend to be less severely affected than Tr. In the sciatic nerves of Te' 
almost all axons in a one-to-one relationship with a Schwarm cell are surrounded by at least a 
few turns of myelin. In contrast, in the Tr mouse many axons do not progress beyond the 
stage of single ensheathment (promyelin fibres) but remain completely devoid of myelin and 
often incompletely surrounded by Schwann cell cytoplasm. This lack of ensheathment is rare 
in the sciatic nerves of TY' animals but is commonly seen in the more severely affected spinal 
roots. 
In the early reports of pathology in the Tr mouse frequent onion bulbs were seen (Perkins et al. 1981 b). 
A reviexN, of the literature shows that these are a mixture of classic and basal larninal onion bulbs 
(Ayers & Anderson 1973; Ayers & Anderson 1975; Low 1977). There was very I 
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little evidence in Tr" either of active demyelination or of cycles of 
demyel i nation/remyel inat ion leading to concentric proliferation of Schwarm cells around 
nerve fibres with the formation of hypertrophic or'classic' onion bulbs. However most fibres 
were surrounded by well developed basal laminal onion bulbs. 
Perkins et at. (1981b) showed that Schwann cell proliferation continues throughout the life 
of the Tr animals, whereas in Tr" the number of Schwann cells does not appear to change 
beyond the initial stages of myelination. This may provide an explanation for the difference 
in the type of onion bulbs seen in the two strains. The ongoing demyelination and constant 
presence of myelin debris found in Tr, but not in Te', may lead to continuing Schwarm cell 
division followed by proliferation and remyelination with an excess of proliferated cells that 
accumulated circumferential ly around the axons thus producing the classic onion bulb, as 
originally suggested for human hypertrophic neuropathy (Thomas & Lascelles 1967). 
Whereas in Tr" there is no appreciable amount of active demyelination to begin this cycle-, 
they have instead almost exclusively basal laminal onion bulbs, reflecting Schwarin cell 
movement (Ayers & Anderson 1975). 
The literature reports that Trmice initially have frequent 'convulsions'. Convulsions were 
never seen in T? 'j animals although under deep anaesthesia they occasionally exhibited 
rigidity. A letter from Toyka et al (1997) describes neuromyotonia in aged mice either 
homozygously deficient for, or carrying an increased gene dosage of, PMP22 (Toyka et al. 
1997b). This probably represents the supposed convulsions seen in Tr mice. Neuromyotonia 
is a feature of a number of human neuropathies. 
Viability of homozygous mutants differs between the two point mutations. Homozygous Te' 
animals can be distinguished from littermates by P8-1 0, they are noticeably smal ier in size, 
not necessarily in body length but due to a lack of musculature. They exhibit a noticeable 
tremor, are extremely weak and move with difficulty. Most animals died at around P 18-20, 
but a few survive beyond weaning (a further 4-5 d). In contrast, homozygous Tr mutants 
were indistinguishable from heterozygous litter mates at 4 mo and appeared quite healthy at 
Iy despite a maximum number of 6 myelinated fibres(Henry & Sidman 1988). Adikofer et 
al. (1995) cross bred Tr/+ aniamls with PMP22 null mutants (PMP22 0/0). The resulting TrIO 
animals died at P 18-24. It is difficult to suggest a reason for the death of Trembler -J 
homozygotes based on a lack of myelin or why one copy of a mutant protein (TrIO) should 
have a more severe effect than two (TrITr), given that null mutants (PMP22 0/0) survive 
until adulthood (Adlkofer et al. 1995). 
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Defective transport of PMP22 to the plasma membrane has been proposed as a disease 
mechanism in both Tr" and Tr. PMP22 immunoreactivity in Tr animals has not only been 
seen in compact myelin but also in the cytoplasm of myelinating Schwarm cells (Naef et al. 
1997). Immunohistochernical studies of cells transfected with wildtype and/or Tr PMP22 
showed that. while wildty-pe PMP22 was transported to the plasma membrane, Tr protein 
was localised mainly in the endoplasmic reticulum. The Tr protein did not reach the plasma 
membrane, endocylic pathway or lysosomes. Further evidence that Tr PMP22 is not 
transported to myelin comes from Tr/O mice in which the myelin debris stained strongly for 
PO but not at all for PMP22 (Naef et al. 1997). As in Tr animals, Til, PMP22 
immunoreactivity also accumulates not only in compact myelin but also in the Schwann cell 
cytoplasm. Studies on PMP22 transport in Tr'j animals showed that in these animals PMP22 
is transported beyond the ER and transverses the Golgi apparatus, followed by accumulation 
in lysosomes (Notterpek et al. 1997). Abnormally high levels of both structural components 
of lysosomes (LAMP I) and lysosomal enzyme activity (CatD) are found in Te' nerves 
demonstrating activation of the endosomal /lysosomal pathways. PMP22, Po and MBP were 
all shown to be degraded at an increased rate in Tel nerve demonstrating Increased myelin 
tumover or decreased myelin stability (Notterpek et al. 1997). 
This idea of disrupted protein trafficking in PMP22 mutants has been corroborated by 
D'Urso et al. (1998) who demonstrated a similar effect in cultured Schwann cells expressing 
Tr and Trl; mutant PMP22. Both forms were abundantly present in the ER and Golgi 
apparatus, but were not targeted to the plasma membrane. This study did not show any 
difference in locallsation between Tr and D" mutations. Trafficking abnormalities have also 
been seen in humans with PMP22 mutations. The nerve of a patient with the LI 6P mutation 
showed an accumulation of PMP22 staining in the cell body of myelinating Schwann cells 
that was not seen in control patients or patients with an acquired inflammatory demyelinating 
polyneuropathy. (D'Urso et al. 1998). Naef and Suter (1998) have inserted the human HI 2Q 
mutation into COS cells and found that the protein was retained intracellularly. This provides 
support for disrupted trafficking as a common factor to the disease mechanism in peripheral 
neuropathies due to alterations in the PMP22 protein. 
In the normal situation almost all PMP22 is retained in the ER and rapidly degraded. A 
recent paper by Naef and Suter (1998) postulates that misfolding may be the reason for the 
intracellular degradation and that pathology in PMP22 mutants may result from increasing 
the amount of misfolded protein above a critical threshold level. This provides a possible 
explanation for point mutations and altered gene dosage resulting in similar pathology. 
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Different phenotypes produced by the L16P mutation in humans and mice. 
The nio-st obN lou-, difference betveen humans and mice with the L16P mutation is the degree 
of severit-v of the resulting neuropathy. The dominant pathological feature in the human is 
the almost complete absence of mvelin. This contrasts with the T11, mouse in which most of 
the fibres are surrounded by a thin layer of myelin. 
In the adult human mutant, most fibres (90%) are surrounded by onion bulbs. In the mouse. 
classic onion bulbs were not found at all. Although the majority of fibres were surrounded by 
redundant basal lamina there were seldom more than one or two layers. The increase in 
Sch, Aann cell numbers was also much greater in humans and of a different nature. In the 
human LI 6P mutants. axon associated Schwann cell nuclei represented 12,17.6 and 20.6 
nuclei,, 100 axons (patients 14-16 in (Gabre6s-Festen et al. 1995)). These values are similar 
those found in mice (13.9 ±0.8. ). In the human, a further 20-40 Schwann cell nuclei/] 00 
axons were found supernumerary to axons. In the Tr, ' mouse, supernumerary Schwann cells 
%%ere seldom seen. These two differences illustrate a fundamental difference in the murine 
and human response to the same mutation. 
PART 3 THE FUNCTION OF PMP22 
Proper PMP-22 expression is crucial for the formation and maintenance of PNS myelin. 
Functionalk. abnormalities caused bv alterations in the PMP22 gene all relate to the process 
of ni\ elination and m\ elin stability. The results of this study provide evidence that in 
addition to its role in maintaining the stability of compact myelin. PMP22 functions In the 
initiation of rnýelmation. Disruptions of this initial stage of myelin development also result 
in rnýelln deficiency. This maý reflect the mo different roles of PMP22 in the PNS (one 
earl\ and one late) it is unllkelý that the\ are part of a single function. 
MYELIN FORMATION AND STABILITY 
The initiation of myelination. The initial stages of myelin formation appear to be 
cmi-enicIN -scn-sitkc to aný perturbations in PMP22 expression. It is interesting to note that 
rnýelination is delayed at the promýelin stage in all the murine models with perturbations of 
the PMP22 gene. The spontaneousk occurring Tr (Ayers & Anderson 1975. Ayers & 
Anderson 1976: t. o\\ 1976a). Trý (lienrN et al. 1983). and the newly discovered Tr-Ncnp 
(Suh et al. 1997) mutants. all exhibit a dela-v in the progression of myelinogenesis, as do 
mice o%erexpressing (Magýar et al. 1996) and underexpressing (null mutants) (AdIkofer et 
al. 1995) The delaý of fibres at the promyelin stage in various spontaneous and 
transgenic rodent strains led to the suggestion that PMP22 'Aas involved in the initiation of 
m\ehnatlon (AdIkofer et al. 1995. Sereda et al. 1996). This is supported by the data obtained 
in this stud, - Fhe first abnormalit-\ noted in early postnatal mice \\ith perturbations 
in the 
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P%IP22 gene was the dela,, of myelination. We have extended this observation to show that 
the m,. elination delay is probably secondary to a failure of Schwarm cells to completely 
surround axons. The data from C22 and Tr-j homozygotes indicate that mesaxon formation 
and the initial spiralling of Schwarm cell membranes around the axon is dependant upon 
correct P%lP-"2 function. 
Thickness of the myelin sheath. Although PMP22 perturbations all ultimately result in 
a degree of hNponiNelination. its evolution differs between stains of mice. In the C22, and 
Trembler-J strains thin mvelm is largely a result of a developmental failure of myelination 
(dNsm%elination). This study also demonstrates that PMP222 functions in the maintenance of 
myelin sheath thickness later in development. In the C61, strain myelin appears to form 
normalk. the first incidence of thin mvelin sheaths was not noted until the animals were 4 
výk old. The number of affected fibres then increased with age. In the C2 strain there was no 
obvious myelm deficit even in 8mo animals. The small proportion of thinly myelinated 
fibres noted in morphometric studies are unlikely to represent any degree of functional loss. 
ADDITIONAL ROLES SUGGESTED FOR PMP22 
While maný of the roles postulated for PMP22 relate to the myelination process several 
additional roles ha,. e been proposed. Naef and Suter (1998) have speculated that promoter I 
has been acquired specificall-, during evolution to allow high level expression in myelinating 
Schm ann cells and that this additional function differs from the original role of PMP22. This 
type of scenario has been suggested for some members of the crystallin family which are 
expressed as stress related proteins in a variety tissues but also function as a structural 
component of the lens. Aspects of the regulation of PMP22 suggest that the second function 
of PMP22 is not restricted to the non-neural tissues it is expressed in but is also functional in 
Sch%karin cells. 
1. Growth arrest 
I lic fna. johtý ofthe eN idence for PMP22 acting as a growth arrest protein comes from cell 
culture studies. The PN-IP22 protein was first isolated from growth arrested fibroblasts and 
%%as expressed in resting but not proliferating cells. Altered levels of PMP22 expression were 
found to alter Sch,, %ann cell proliferation and DNA synthesis significantly. This led Zoidl et 
al. ( 1995) to propose that altered le%els of PMP22 gene expression may impair myelination 
directi, through the abnormal go-vNih of Sch%%ann cells. g 
Studies ha%e been performed on both the Tr and T71 i mice. In both cases, although the CD25 
m%elinating transcript was decreased. there was no evidence of any alteration in the grow1h 
arrest transcript. This is no%k not a plausible explanation for the increased number of 
Sch%%ann cells seen in these two strains. 
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2. Gene family suggestive either of differentiation or cell/cell interactions 
Differentiation. The morphological features of regenerating T? " nerve in many ways 
rLserrible those seen in derrivelmated nerve treated with 5-bromodeoxyuridine (BrdU), a 
thýrmdine analoguewhich has been widely used to inhibit differentiation in mammalian 
cells. In BrdU treated nerve Hall and Gregson (1978) described the Schwarm cell cytoplasm 
surrounding maný fibres as having an irregular outline and possessing pseudopodial 
processes. The m%elin that was formed was abnormally thin and sometimes uncompacted, 
both of these being features commonly found in Te'mice. In the present study axonal 
regeneration in Tr; animals appeared to proceed normally and there was no difference either 
in the total number of regenerating axons or in the proportion of axons that were in 
unmN el Mated bundles. Regenerating nerves of Tr, ' animals displayed a significant delay in 
the progression of axons from the promyelin to the myelinated state; this was also a 
prominent feature of BrdU treated nerve. 
In o% erexpressing transgenic mice. adult Schwarm cells expressed the markers low-affinity 
NGF receptor (LNGFR). NICAM and LI in a pattern similar to those normally seen in 
de, 6eloping Sch%%ann cells (Miagyar et al. 1996). These authors suggested that impaired 
Sch%Nann cell differentiation ma, * be the mechanism which results in myelination deficits in 
mice overexpressing PMP22. The similarity in morphology in Trand BrdU treated nerve 
suggests that a failure of differentiation may be the mechanism by which the Tl" mutation 
delays the process of myelination. 
Given the proposed role of the other members of the PMP22 family in differentiation and 
maintenance of the differentiated state is seems plausible that PMP22 has an early function 
in the initial stages of myelinogenesis related to a switch enabling or permitting the 
differentiation of Schwann cells beyond the promyelin stage. As early as 1981, Perkins et al. 
postulated that the Tr mutation could be reguarded as a failure of Schwarm cell 
differentiation beyond the stage of earlv mvelinogenesis. They regarded Schwann cell 
multiplication as a compensatory mechanism for a lack of radial (myelin thickness) and 
longitudinal Onternodal length) cell growth. 
It' P%IP22 does function in the sA itch between proliferating and differentiating phenotypes 
this nia,, explain the difference in Sch%kann cell proliferation between Tr and P". In Tr 
P%IP22 is thought not to exit the Golgi apparatus. therefore there would be almost no signal 
to differentiate. Hence the continued Schwarm cell multiplication and secondarily the low 
le, -els of mýelmation (28%). In Tr, ý hoNke%er the protein does exit the Golgi apparatus and is 
incorporated into the m,. elin sheath. but is thought to be degraded quickly. This may push 
the Schvann cell a little further along the differentiation path enabling better myelination. 
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Cell/cell interaction with the axon or cvtoskeleton. EMP-3 (HNMP-1), which has the 
amino acid honioloL,,,,,. to PMP22 (449zý'o). is transiently expressed by Schwann cells 
during sciatic nerve mNelination. The EMP-3 protein itself is axon associated and is thought 
to plaý a role in axon-Sch%kann cell interactions (Bolin et al. 1997). If PMP22 functions in 
mediating the interaction between cell types it is possible that differentiation failure itself is 
secondarý to defecti%e cell interactions. In a previous study we proposed that adult Te' 
animals exhibited abnormalities that were consistent either with defective Schwarm cell/axon 
or Sch%%ann ce]Llextracellular matrix interactions (Robertson et al. 1997). Axonal contact is 
known to be a prerequisite for the initiation of myelination. If the Schwann cell only partially 
surrounds the axon. the signal may be insufficient to produce differentiation and 
m,. elination. Similark SchNNann cells in culture only cease to divide and commence myelin 
formation Nkhen the% are in contact with the extracellular matrix (De Vries 1993). In this 
studý the only feature that distinguished the C61 (4 copy) strain from controls was the 
increased number of fibres that %Nere not surrounded by Schwann cell cytoplasm. This leads 
us to the conclusion that the axon/Schwann cell interaction is more likely to be the site of 
abnormalltN than Sch%%ann cell/extracellular matrix interaction. 
3. Adhesion function 
It V, tempting to speculate on the possible role of the L2/HNK-I epitope in this disorder. In at 
least 2 members (PMP22 and CL20) in the family of proteins the L2/HNK epitope is 
associated with the gl,, cos,, Iation site on the highly conserved Ist transmembrane domain 
(Marvin et al. 1995. Snipes et al. 1993). The HNK-l epitope forms the basis of a large 
famllý of recognition molecules and is thought to serve as a ligand for adhesion. (Kunemund 
et al. 1988. Griffith et al. 1992). L2/HNK-I is known to be expressed in developing 
peripheral nerve where it is thought to be involved in Schwann cell-axon interactions 
(Martini & Schachner 1986. Martini et al. 1994). L2/HNK-I is involved in cell/cell and 
ceIL'Iaminin interactions and antibodies directed against it are capable of functionally 
blocking neural adhesion to laminin in the presence of heparin (Kunemund et al. 1988-. 
Kellhauer et al. 1985. Hall et al. 1993). It is likely that PMP22 is the major L2/HNK-1 
expressing ghcoprotein in peripheral nerve (Snipes et al. 1993) and in the light of the 
ultrastructural abnormalities found in the Tej mouse it seems plausible that altered interaction 
of a mutated protein and the carbohydrate moiety may be involved. 
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